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ABSTRACT 
 
Methamphetamine (MA), also known as ‘Tik’, has detrimental short- and long-term 
psychological and morphological effects on the central nervous system (CNS). The 
lipophilic nature of MA allows it to cross the blood-brain barrier (BBB) which normally 
plays a protective role in limiting solute exchange (including narcotics) into the 
neuronal tissue. Numerous studies have indicated that MA not only crosses the BBB but 
is implicated in distorting its crucial role in that it increases the permeability of the 
endothelial cells and thereby compromises its core homeostatic function. The speculated 
mechanism by which MA elicits its effects involves elevated ROS production which 
may be reversed by antioxidant treatment. Rooibos herbal tea (Aspalathus linearis) 
which is well documented for its antioxidative properties and ROS scavenging abilities 
may therefore be the ideal candidate to reverse the harmful ROS-induced effects of MA.  
 
The aim of the study was to investigate the in vitro ameliorating potential of fermented 
rooibos (Rf) against the MA-induced effects on mouse brain endothelial (bEnd5) cells 
by utilizing various assays (trypan blue exclusion and XTT viability assays) and 
physiological parameters (cell numbers, viability, monolayer permeability and cell cycle 
phases) over a period of 96 hrs. Statistical analysis was performed using the Wilcoxon 
rank sum test with P<0.05 denoted as significant. 
 
Once-off exposure to physiological MA concentrations and Rf resulted in % viability 
similar to controls by 96 hrs with suppression observed only when the cells were 
exposed to daily MA (0.1-1000 µM) (P≤0.0063). Exposure to supraphysiological 
concentrations (≥100 µM) of MA greatly suppressed viability (P≤0.0463). Both daily 
and once-off treatment to the combinations initially resulted in increased viability 
however by 96 hrs was similar to- or exceeding the controls (P≤0.0180). MA exposure 
also resulted in decreased live cell numbers (P≤0.0339) with no effect when exposed to 
Rf by 96 hrs. The combinations resulted in cell numbers comparable to controls. Dose-
dependent increases in electrical resistance were observed in response to singular MA 
and Rf treatment with lower MA concentrations displaying significant decreases 
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(P≤0.0064). Similar trends were observed with combinations however greater resistance 
was observed. Increased G1-phase populations (P≤0.0495) in response to singular MA 
and Rf exposure was noted followed by decreased S-phase fractions (P≤0.0356). While 
MA decreased G2-M phase cells (P≤0.0498) it was unaffected by Rf. In contrast, the 
combination of MA and Rf decreased events in the G1-phase (P≤0.0483), with an 
increased S-phase population (P≤0.0415).  
 
In conclusion, the single compounds displayed mirroring effects, decreasing the cells’ 
permeability and causing G1-phase arrest. The modulatory effects of Rf in combination 
with MA was illustrated with the restoration of viability and live cell numbers 
comparable to that of controls, and a more restrictive monolayer as well as reversal of 
the G1-phase arrest. Findings suggest that Rf may reverse the adverse effects of MA on 
the BBB.  
 
Keywords: methamphetamine, rooibos, viability, permeability, cell cycles, cell numbers 
 
 
 
 
VII 
 
LIST OF ABBREVIATIONS 
 
A549   : adrenocarcinomic human alveolar basal epithelial cells 
A. linearis  : Aspalathus linearis 
AAE   : ascorbic acid equivalents 
AAPH   : 2-methylpropionamidine dihydrochloride 
ABTS   : 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid 
AC   : astrocyte 
AMPH   : amphetamine 
ARPE-9  : retinal pigment epithelial cells 
ATP   : adenosine triphosphate 
AWA   : acetone/water/acetic acid 
BBB   : blood-brain barrier 
bEnd5   : mouse brain endothelial cells 
BMVEC  : brain microvascular endothelial cells 
C20H10Na2O5  : fluorescein sodium salt 
cdc2   : cyclin-dependent 1 gene 
CE   : catechin equivalents 
CNS   : central nervous system 
CO2   : carbon dioxide 
CPUT   : Cape Peninsula University of Technology 
CSF   : cerebrospinal fluid 
CVD   : cardiovascular disease 
DA   : dopamine 
ddH2O   : double distilled water 
dH2O   : distilled water 
DMACA  : 4-dimethylaminocinnamaldehyde 
DMEM  : Dulbecco’s modified eagle medium 
DNA   : deoxyribose nucleic acid 
DO   : deferoxamine 
DP   : delphinidin 
 
 
 
 
VIII 
 
EA.hy926  : human embryonic endothelial cells 
EC   : endothelial cell 
e.g.   : example 
ERS   : electrical resistance system 
et al.   : “and others” 
EtOH   : ethanol 
FACS   : fluorescence activated cell sorter 
FBS   : fetal bovine serum 
Fe2+   : ferrous iron 
Fe3+   : ferric iron 
Fe3+-TPTZ  : ferric iron 2, 4, 6-tri [2-pyridyl]-s-triazine 
FeCl3.H2O  : iron (III) chloride hexahydrate 
FL2   : fluorescent channel 2 
FL2A   : fluorescent channel 2 area 
FL2W   : fluorescent channel 2 width 
FRAP   : ferric reducing antioxidant power assay 
FSC   : forward scatter 
G1/G1-phase  : gap phase 
G2/G2-phase  : second gap phase 
GAE   : gallic acid equivalents 
GPNT   : rat brain vascular endothelial cells 
GSH/GSSG  : glutathione/glutathione disulfide 
H295R   : human adrenocortical carcinoma cells 
hBMVEC  : human brain microvascular endothelial cells 
HCl   : hydrogen chloride/hydrochloric acid 
In situ   : “on site/in position” 
In vitro  : “in glass” 
In vivo   : “within the living” 
ISF   : interstitial fluid 
JNK   : Jun-N-terminal kinase 
M1/M1-phase  : mitotic phase 
 
 
 
 
IX 
 
MA   : methamphetamine 
MDH   : mitochondrial dehydrogenase activity 
MeOH   : methanol 
MMP   : matrix metalloproteinase 
MN9D   : dopaminergic cells 
MOA   : monoaminergic 
MRC   : Medical Research Council 
MTT   : 3-(4, 5-dimethylthiazol-2-YI)-2, 5 diphenyltetrazolium  
    bromide 
n   : sample number 
Na2CO3  : sodium carbonate 
Na2HPO4.2H2O : di-sodium hydrogen orthophosphate dehydrate 
NAC   : N-acetylcysteine 
NaH2PO4.H2O  : di-hydrogen orthophosphate-1-hydrate 
NEAA   : non essential amino acids 
NHF   : normal human embryonic fibroblasts 
NO    : nitric oxide 
nNOS   : neuronal nitric oxide synthase 
NVU   :  neurovascular unit 
OCM-1  : human melanoma cells 
OONO-  : peroxynitrate 
ORAC   : oxygen radical absorbance capacity 
OS   : oxidative stress 
P53   : tumour suppressor protein 53 
P-gp   : P-glycoprotein 
PA   : proanthocyanidin 
PBS   : phosphate buffered saline 
PC   : pericyte 
PCA   : perchloric acid 
PI   : propidium iodide 
QE   : quercetin equivalents 
 
 
 
 
X 
 
R1   : gate one 
R2   : singlet cells 
R2-cells  : rat cerebellum neural cells 
Rf   : fermented rooibos 
RNS   : reactive nitrogen species 
ROS   : reactive oxygen species 
rpm   : revolutions per minutes 
RT   : room temperature 
S-phase  : DNA synthesis phase 
SACENDU  : South African Community Epidemiology Network on  
    Drug Use 
SEM   : standard error of mean 
SH-SY5Y  : human neuroblastoma carcinoma cells 
SK-N-SH  : human neuroblastoma-dopaminergic cells 
SSC   : side scatter 
TE   : trolox equivalents 
TEAC   : trolox equivalent antioxidant capacity 
TEER   : transendothelial electrical resistance 
TC   : tissue culture 
TH   : Thunbergia laurifolia 
TJ   : tight junction 
TPTZ   : 2, 4, 6-tri [2-pyridyl]-s-triazine 
U-118   : human glioblastoma cells 
viz.   : namely 
XTT : 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)- 
2H-tetrazolium-5-carboxanilide 
 
 
 
 
XI  
UNITS OF MEASUREMENT AND SYMBOLS 
 
abs   : absorbance 
ca.   : circa 
g   : grams 
G   : G-force 
hr   : hour 
hrs   : hours 
M   : molar 
m2    : meters squared 
mAU   : milliabsorbance units 
mg   : milligrams 
mg/l   : milligrams per liter 
mg/ml   : milligrams per milliliter  
mg/kg   : milligrams per kilogram 
min   : minutes 
ml   : millilitres 
mM   : millimolar 
nm   : nanometer 
nM or nmol  : nanomolar 
µl   : microliters 
µg/ml   : micrograms per millilitre 
µM or µmol  : micromolar 
Ω.cm2   : ohms centimeters squared 
β   : beta 
C   : degrees Celsius 
%   : percentage 
±   : plus minus 
>   : greater than 
<   : less than 
≥   : greater or equal to 
≤   : less or equal to  
*   : significant increase 
#   : significant decrease 
~   : approximately 
 
 
 
 
  
TABLE OF CONTENTS 
 
DECLARATION        I 
PUBLICATIONS        II 
ACKNOWLEDGEMENTS       III 
ABSTRACT         V 
LIST OF ABBREVIATIONS       VII 
UNITS OF MEASUREMENT AND SYMBOLS    XI 
TABLE OF CONTENTS       XII 
LIST OF FIGURES        XVIII 
LIST OF TABLES        XXVII 
LIST OF APPENDICES       XXII 
 
CHAPTER 1………………………………………………………………………………………. 
1 Introduction        1 
1.1 Methamphetamine Statistics      1 
1.2 Current Trends in Methamphetamine Therapy    2 
1.3 Nomenclature and Chemical Properties of Methamphetamine  4 
1.4 Overview of Methamphetamine Synthesis and Its Effects  4 
1.5 Metabolism and Bioavailability of Methamphetamine   5 
1.6 Effects of Acute Methamphetamine Exposure    7 
1.7 Effects of Chronic Methamphetamine Exposure    7 
1.8 The Blood-Brain Barrier      8 
1.8.1 Localization and Functions of the Blood-Brain Barrier   8 
1.8.2 Composition of the Blood-Brain Barrier     9 
1.8.3 The Three Main Blood-Brain Barrier Components   10 
1.8.3.1 Pericytes        10 
1.8.3.2 Astrocytes        10 
1.8.3.3 Endothelial Cells       11 
1.8.4 Blood-Brain Barrier Disruption and Brain Disorders   11 
1.8.5 The Immortalized bEnd5 Cell Line as an In Vitro Blood-Brain Barrier  
Model         12 
1.8.6 Mechanisms of Methamphetamine on the Blood-Brain Barrier  12 
1.8.7 Methamphetamine Adversely Affects the Cell Cycle   13 
XII 
 
 
 
 
 
  
1.8.8 Methamphetamine Increases Blood-Brain Barrier Permeability  15 
1.9 Rooibos (Aspalathus linearis) Herbal Tea    18 
1.9.1 Anecdotal Properties of Aspalathus linearis    18 
1.9.2 Chemistry of Aspalathus linearis     19 
1.9.2.1 The Polyphenolic Contents of Aspalathus linearis   19 
1.9.2.2 Flavonoids Present in Aspalathus linearis    20 
1.9.3 Metabolism and Bioavailability of Rooibos (Aspalathus linearis) Herbal  
Tea         21 
1.9.4 The Antioxidative Properties of Aspalathus linearis   22 
1.10 Aims         25 
1.11 Objectives        25 
1.12 Hypothesis        26 
 
CHAPTER 2………………………………………………………………………………………. 
2 Methods and Materials       27 
2.1 Preparation of Aqueous Infusion of A. linearis    27 
2.2 Chemical Analysis of Fermented Rooibos    27 
2.2.1 Measurement of Polyphenols      28 
2.2.1.1 Principle (Measurement of Polyphenols)     28 
2.2.1.2 Chemicals Required for the Measurement of Polyphenols  28 
2.2.1.3 Sample Preparation and Analysis     28 
2.2.2 Measurement of Flavonols      29 
2.2.2.1 Principle (Measurement of Flavonols)     29 
2.2.2.2 Chemicals Required for the Measurement of Flavonols   29 
2.2.2.3 Sample Preparation and Analysis     29 
2.2.3 Measurement of Flavanols      30 
2.2.3.1 Principle (Measurement of Flavanols)     30 
2.2.3.2 Chemicals Required for the Measurement of Flavanols   30 
2.2.3.3 Sample Preparation and Analysis     30 
2.2.4 Oxygen Radical Absorbance Capacity (ORAC) assay   31 
2.2.4.1 Principle (ORAC)       31 
2.2.4.2 Chemicals Required for the ORAC assay    31 
2.2.4.3 Sample Preparation and Analysis     32 
XIII 
 
 
 
 
 
  
2.2.5 ABTS (TEAC) Radical Cation Scavenging assay   33 
2.2.5.1 Principle (ABTS/TEAC)      33 
2.2.5.2 Chemicals Required for the ABTS (TEAC) assay   33 
2.2.5.3 Sample Preparation and Analysis     33 
2.2.6 Ferric Reducing Antioxidant Power (FRAP) assay   34 
2.2.6.1 Principle (FRAP)       34 
2.2.6.2 Chemicals Required for the FRAP assay     34 
2.2.6.3 Sample Preparation and Analysis     35 
2.3 Experiments Performed on the Blood-Brain Barrier (bEnd5) Model 35 
2.3.1 Chemicals Required for In Vitro Analysis    35 
2.3.2 Mouse Brain Endothelial (bEnd5) Cell Culturing   36 
2.3.2.1 Principle  (Cell Culture)       36 
2.3.2.2 Method         37 
2.3.3 Trypan Blue Exclusion assay      38 
2.3.3.1 Principle (Trypan Blue Exclusion assay)     38 
2.3.3.2 Method         38 
2.3.4 MTT Viability assay       39 
2.3.4.1 Principle (MTT Viability assay)      39 
2.3.4.2 Method         39 
2.3.5 XTT Viability assay       40 
2.3.5.1 Principle (XTT Viability assay)      40 
2.3.5.2 Method         40 
2.3.6 Transendothelial Electrical Resistance (TEER)    41 
2.3.6.1 Principle (TEER)       41 
2.3.6.2 Method         41 
2.3.7 Flow Cytometry: Cell Cycle Analysis     42 
2.3.7.1 Principle (Flow Cytometry)      42 
2.3.7.2 Method         42 
2.3.7.3 Cell Cycle Analysis by Propidium Iodide Staining   42 
2.4 Statistical Analysis       43 
 
 
 
XIV 
 
 
 
 
 
  
CHAPTER 3………………………………………………………………………………………. 
3 Results         44 
3.1 The Effects of Methamphetamine on bEnd5 Cells   44 
3.1.1 Effects of 24 hr-MAE on Cell Numbers using the Trypan Blue Exclusion  
Method         44 
3.1.2 Effects of 24 hour-Methamphetamine-Exposure (24 hr-MAE) on Cell  
Viability (%) using the Trypan Blue Exclusion Method   45 
3.1.3 Effects of 24 hr-MAE on Cell Viability (%) using the Reduced Formazan  
Method (Observing Metabolic Activity)     46 
3.1.4 Effects of Daily-MAE on Cell Viability (%) using the Reduced Formazan  
Method (Observing Metabolic Activity)     47 
3.1.5 Effects of Daily-MAE on Monolayer Electrical Resistance (TEER) 48 
3.1.6 Effects of Methamphetamine Exposure on bEnd5 Cell Cycles  49 
3.1.6.1 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 24 hours   49 
3.1.6.2 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 48 hours   51 
3.1.6.3 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 72 hours    52 
3.1.6.4 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 96 hours    53 
3.2 The Effects of Fermented Rooibos Herbal Tea on bEnd5 Cells  55 
3.2.1 Chemical Analysis of Fermented Rooibos Extract   55 
3.2.2 Effects of 24 hr-RfE on Cell Numbers using the Trypan Blue Exclusion  
Method         57 
3.2.3 Effects of 24 hour Fermented-Rooibos-Exposure (24 hr-RfE) on Cell  
Viability (%) using the Trypan Blue Exclusion Method   58 
3.2.4 Effects of 24 hr-RfE on Cell Viability (%) using the Reduced Formazan 
Method (Observing Metabolic Activity)     59 
3.2.5 Effects of Daily-RfE on Cell Viability (%) using the Reduced Formazan  
Method (Observing Metabolic Activity)     60 
3.2.6 Effects of Daily-RfE on Monolayer Electrical Resistance (TEER)  61 
3.2.7 Effects of Fermented Rooibos Exposure on bEnd5 Cell Cycles  62 
3.2.7.1 Effects of 24 hr-RfE on Cell Cycles at 24 hours     62 
3.2.7.2 Effects of 24 hr-RfE on Cell Cycles at 48 hours     63 
3.2.7.3 Effects of 24 hr-RfE on Cell Cycles at 72 hours     64 
3.2.7.4 Effects of 24 hr-RfE on Cell Cycles at 96 hours    66 
XV 
 
 
 
 
 
  
3.3 Effects of the Methamphetamine and Fermented Rooibos Combinations 67 
3.3.1 Effects of 0.05% Fermented Rooibos and Selected Methamphetamine 
Concentrations (Combination 1)      67 
3.3.1.1 Effects of 24 hr Exposure to Combination 1 on Cell Numbers using the 
Trypan Blue Exclusion Method      67 
3.3.1.2 Effects of 24 hr exposure to Combination 1 on Cell Viability (%) using  
the Trypan Blue Exclusion Method      68 
3.3.1.3 Effects of 24 hr exposure to Combination 1 on Cell Viability (%) using  
the Reduced Formazan Method (Observing Metabolic Activity)  69 
3.3.1.4 Effects of Daily Exposure to Combination 1 on Cell Viability (%) using 
the Reduced Formazan Method (Observing Metabolic Activity)  70 
3.3.1.5 Effects of Daily Exposure to Combination 1 on Monolayer Electrical  
Resistance (TEER)       71 
3.3.1.6 Effects of Combination 1 on bEnd5 Cell Cycles    72 
3.3.1.6.1 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 24 hours 72 
3.3.1.6.2 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 48 hours 73 
3.3.1.6.3 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 72 hours 74 
3.3.1.6.4 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 96 hours 76 
3.3.2 Effects of 0.1% Fermented Rooibos and selected Methamphetamine 
Concentrations (Combination 2)      77 
3.3.2.1 Effects of 24 hr Exposure to Combination 2 on Cell Numbers using  
the Trypan Blue Exclusion Method     77 
3.3.2.2 Effects of 24 hr Exposure to Combination 2 on Cell Viability (%) using  
the Trypan Blue Exclusion Method     78 
3.3.2.3 Effects of 24 hr Exposure to Combination 2 on Cell Viability (%) using  
the Reduced Formazan Method (Observing Metabolic Activity)  79 
3.3.2.4 Effects of Daily Exposure to Combination 2 on Cell Viability (%) using  
the Reduced Formazan Method (Observing Metabolic Activity)  80 
3.3.2.5 Effects of Daily Exposure to Combination2 on Monolayer Electrical  
Resistance (TEER)       81 
3.3.2.6 Effects of Combination 2 on bEnd5 Cell Cycles    82 
3.3.2.6.1 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 24 hours 82 
3.3.2.6.2 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 48 hours 83 
3.3.2.6.3 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 72 hours 84 
XVI 
 
 
 
 
 
  
3.3.2.6.4 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 96 hours 85 
 
CHAPTER 4………………………………………………………………………………………. 
4 Discussion and Conclusions      87 
 
CHAPTER 5………………………………………………………………………………………. 
5 Future Perspectives       103 
 
CHAPTER 6………………………………………………………………………………………. 
6.1 References        104 
6.2 Web-Based References       128 
 
APPENDICES A-U…………………………………………………………..………….. 129 
XVII 
 
 
 
 
 
LIST OF FIGURES 
 
1 Introduction 
 
Figure 1.1 Chemical structure of MA (Hendrickson et al., 2006)...........................................4 
 
Figure 1.2 Forms of MA administered for recreational purposes: A Crystalline powder 
(most common) form (http://sshs.amaisd.org/index.php/alcohol-and-drug-prevention/meth/). 
B Pill/tablet form (http://www.methproject.org/answers/whats-meth-made-of.html#Whats-
in-Meth). C Rock form (http: //nurseandlawyer.com/page/2/). D Paste/base form 
(http://methdata.tripod.com/)....................................................................................................5 
 
Figure 1.3 Components of the BBB comprised of endothelial cells, astrocytes and pericytes 
(http://home.szbk.uszeged.hu/~krizbai/index.html)..................................................................9  
 
Figure 1.4 The different phases and activities that take place in the cell cycle (http://www. 
ch.ic.ac.uk/local/projects/s_liu/Html/Graphics/CellCycle.gif)……………………………...14  
 
Figure 1.5 Physical characteristics of the two forms of rooibos (A. linearis) herbal tea: A 
Unfermented form also known as green tea (http://www.carmientea.co.za/tea-variants/ 
rooibos/). B Resulting form after fermentation also known as red tea (the beverage) (http:// 
amavida.com/learn/)…………………………………………………………………………18 
 
Figure 1.6 Molecular structures of the flavonoids present in A. linearis: A Chrysoeriol. B 
Orientin. C Quercetin. D Iso-quercetin. E Aspalathin and nothofagin. F Luteolin. G Iso-
orientin and iso-vitexin. H Rutin (Joubert and Ferreira, 1996; van der Merwe et al., 2010).21 
 
2 Methodology 
 
Figure 2 The BBB model and its closely related in vivo BBB components. A The bicameral 
chamber consisting of the well and insert which represent the basolateral and apical 
compartments, respectively (http://www.biocompare.com/Editorial-Articles/147111-Cells-
on-the-Go-Cellular-Migration-Assays/). B The major components of the in vivo BBB: 
endothelial cells, pericytes and astrocytes (http://home.szbk.u-szeged.hu/~krizba 
i/index.html). C The endothelial TJ proteins in the paracellular compartment of adjacent ECs 
(http://imgarcade.com/ 1/junction-proteins/)...........................................................................37 
XVIII 
 
 
 
 
 
3 Results 
 
Figure 3.1 Live cell number in response to 24 hr exposure of selected MA concentrations 
and time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in live 
cell number is denoted with * whereas significant decreases are denoted with #..................44 
 
Figure 3.2 Cell Viability (%) in response to 24 hr exposure of selected MA concentrations 
and time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #.....................45 
 
Figure 3.3 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of 
selected MA concentrations and time. Results are expressed as mean ± SEM (n=5). Controls 
were normalized to 100% and experimental groups expressed relative to controls. 
Significant (P<0.05) increases in cell viability are denoted with * whereas significant 
decreases are denoted with #..................................................................................................46 
 
Figure 3.4 Mitochondrial dehydrogenase activity (%) in response to daily exposure of 
selected MA concentrations and time. Results are expressed as mean ± SEM (n=5). Controls 
were normalized to 100% and experimental groups expressed relative to controls. 
Significant (P<0.05) increases in cell viability are denoted with * whereas significant 
decreases are denoted with #..................................................................................................47 
 
Figure 3.5 Transendothelial electrical resistance in response to daily exposure of selected 
MA concentrations and time. Results are expressed as mean ± SEM (n=4). Significant 
(P<0.05) increases in TEER are denoted with * whereas significant decreases are denoted 
with #.......................................................................................................................................48 
 
Figure 3.6 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 24 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA……….....49 
 
Figure 3.7 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 24 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #...................................................................................................50 
 
XIX 
 
 
 
 
 
Figure 3.8 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 48 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA………......51 
 
Figure 3.9 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 48 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #...................................................................................................51 
 
Figure 3.10 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 72 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA………......52 
 
Figure 3.11 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 72 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #...................................................................................................52 
 
Figure 3.12 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 96 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA……………....53 
 
Figure 3.13 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 96 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #...................................................................................................53 
 
Figure 3.14 Detection of Aspalathin at 16.024 mAU using HPLC (Analysis performed by 
Oxidative Stress Research Centre, CPUT)............................................................................56 
 
Figure 3.15 Live cell number in response to 24 hr exposure of selected Rf concentrations 
and time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in live 
cell number are denoted with * whereas significant decreases are denoted with #................57 
 
XX 
 
 
 
 
 
Figure 3.16 Cell Viability (%) in response to 24 hr exposure of selected Rf concentrations 
and time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #.....................58 
 
Figure 3.17 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of 
selected Rf concentrations and time. Results are expressed as mean ± SEM (n=5). Controls 
were normalized to 100% and experimental groups expressed relative to controls. 
Significant (P<0.05) increases in cell viability are denoted with * whereas significant 
decreases are denoted with #..................................................................................................59 
 
Figure 3.18 Mitochondrial dehydrogenase activity (%) in response to daily exposure of 
selected Rf concentrations and time. Results are expressed as mean ± SEM (n=5). Controls 
were normalized to 100% and experimental groups expressed relative to controls. 
Significant (P<0.05) increases in cell viability are denoted with * whereas significant 
decreases are denoted with #..................................................................................................60 
 
Figure 3.19 Transendothelial electrical resistance in response to daily exposure of selected 
Rf concentrations and time. Results are expressed as mean ± SEM (n=4). Significant 
(P<0.05) increases in TEER are denoted with * whereas significant decreases are denoted 
with #.....................................................................................................................................61 
 
Figure 3.20 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 24 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf......................................................................62 
 
Figure 3.21 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected Rf concentrations at 24 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #..................................................................................................62 
 
Figure 3.22 Histograms illustrating cell cycle results after 24 hr exposure to selected 
concentrations at 48 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf…………………………………………….63 
 
 
XXI 
 
 
 
 
 
Figure 3.23 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
Rf selected concentrations at 48 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #.................................................................................................63 
 
Figure 3.24 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 72 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf......................................................................64 
 
Figure 3.25 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected Rf concentrations at 72 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #..................................................................................................65 
 
Figure 3.26 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 96 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf......................................................................66  
 
Figure 3.27 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected Rf concentrations at 96 hrs. Results are expressed as mean ± SEM (n=3). 
Significant (P<0.05) increases in relative cell no. are denoted with * whereas significant 
decreases are denoted with #.................................................................................................66 
 
 Figure 3.28 Live cell number in response to 24 hr exposure of 0.05% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are 
expressed as mean ± SEM (n=5). Significant (P<0.05) increases in live cell number is 
denoted with * whereas significant decreases are denoted with #..........................................71 
 
Figure 3.29  Cell Viability (%) in response to 24 hr exposure of 0.05% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are 
expressed as mean ± SEM (n=5). Significant (P<0.05) increases in cell viability is denoted 
with * whereas significant decreases are denoted with #.......................................................68 
 
Figure 3.30 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of 
0.05% fermented rooibos in combination with selected methamphetamine concentrations, 
and time. Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% 
XXII 
 
 
 
 
 
and experimental expressed relative to controls. Significant (P<0.05) increases in cell 
viability is denoted with * whereas significant decreases are denoted with #........................69 
 
Figure 3.31 Mitochondrial dehydrogenase activity (%) in response to daily exposure of 
0.05% fermented rooibos in combination with selected methamphetamine concentrations, 
and time. Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% 
and experimental expressed relative to controls. Significant (P<0.05) increases in cell 
viability is denoted with * whereas significant decreases are denoted with #........................70 
 
Figure 3.32 Electrical resistance in response to daily exposure of 0.05% fermented rooibos 
in combination with selected methamphetamine concentrations, and time. Results are 
expressed as mean ± SEM (n=4). Significant (P<0.05) increases in TEER is denoted with * 
whereas significant decreases are denoted with # ..................................................................71 
 
Figure 3.33 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 24 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................72 
 
Figure 3.34 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.05% fermented rooibos and selected MA concentrations at 
24 hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in  
relative cell no. is denoted with * whereas significant decreases are denoted with #..........72 
 
Figure 3.35 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 48 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................73 
 
Figure 3.36 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.05% fermented rooibos and selected MA concentrations at 
48 hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in  
relative cell no. is denoted with * whereas significant decreases are denoted with #..........73 
 
Figure 3.37 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 72 hrs using flow 
XXIII 
 
 
 
 
 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................74 
 
Figure 3.38 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.05% fermented rooibos and selected MA concentrations at 
72 hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in  
relative cell no. is denoted with * whereas significant decreases are denoted with #..........75 
 
Figure 3.39 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 96 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................76 
 
Figure 3.40 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.05% fermented rooibos and selected MA concentrations at 
96 hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in  
relative cell no. is denoted with * whereas significant decreases are denoted with #..........76 
 
Figure 3.41 Live cell number in response to 24 hr exposure of 0.1% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are 
expressed as mean ± SEM (n=5). Significant (P<0.05) increases in live cell number is 
denoted with * whereas significant decreases are denoted with #..........................................77 
 
Figure 3.42 Cell Viability (%) in response to 24 hr exposure of 0.1% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are 
expressed as mean ± SEM (n=5). Significant (P<0.05) increases in cell viability is denoted 
with * whereas significant decreases are denoted with #.......................................................78 
 
Figure 3.43 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of 
0.1% fermented rooibos in combination with selected methamphetamine concentrations, and 
time. Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% and 
experimental expressed relative to controls. Significant (P<0.05) increases in cell viability is 
denoted with * whereas significant decreases are denoted with #..........................................79 
 
XXIV 
 
 
 
 
 
Figure 3.44 Mitochondrial dehydrogenase activity (%) in response to daily exposure of 
0.1% fermented rooibos in combination with selected methamphetamine concentrations, and 
time. Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% and 
experimental expressed relative to controls. Significant (P<0.05) increases in cell viability is 
denoted with * whereas significant decreases are denoted with #..........................................80 
 
Figure 3.45 Electrical resistance in response to daily exposure of 0.1% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are 
expressed as mean ± SEM (n=5). Significant (P<0.05) increases in TEER is denoted with * 
whereas significant decreases are denoted with #..................................................................81 
 
Figure 3.46 Histograms illustrating cell cycle results after exposure to 0.1% fermented 
Rooibos in combination with selected methamphetamine concentrations at 24 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................82 
 
Figure 3.47 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.1% fermented rooibos and selected MA concentrations at 24 
hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in % 
relative cell no. is denoted with * whereas significant decreases are denoted with #..........82 
 
Figure 3.48 Histograms illustrating cell cycle results after exposure to 0.1% fermented 
Rooibos in combination with selected methamphetamine concentrations at 48 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................83 
 
Figure 3.49 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.1% fermented rooibos and selected MA concentrations at 48 
hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in % 
relative cell no. is denoted with * whereas significant decreases are denoted with #..........83 
 
Figure 3.50 Histograms illustrating cell cycle results after exposure to 0.1% fermented 
Rooibos in combination with selected methamphetamine concentrations at 72 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................84 
  
XXV 
 
 
 
 
 
Figure 3.51 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.1% fermented rooibos and selected MA concentrations at 72 
hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in % 
relative cell no. is denoted with * whereas significant decreases are denoted with #..........85 
 
Figure 3.52 Histograms illustrating cell cycle results after exposure to 0.1% fermented 
Rooibos in combination with selected methamphetamine concentrations at 96 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1 µM MA. C 1 µM. D 10 
µM as follows.........................................................................................................................85 
 
Figure 3.53 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr 
exposure to a combination of 0.1% fermented rooibos and selected MA concentrations at 96 
hrs. Results are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in % 
relative cell no. is denoted with * whereas significant decreases are denoted with #..........86 
 
 
 
XXVI 
 
 
 
 
 
LIST OF TABLES 
 
1 Introduction 
 
Table 1 Polyphenols present in A. linearis (McKay and Blumberg, 2007; Ferreira et al., 
1995)…………………………………………………………………………………….………20 
 
2 Methodology 
 
Table 2.1 Preparation of gallic acid stock standard concentrations with respective contents per 
tube for the measurement of polyphenols………………………………………………….….129 
 
Table 2.2 Preparation of quercetin stock standard concentrations with respective contents per 
tube for the measurement of flavonols……………………………………………….………..129 
 
Table 2.3 Preparation of catechin stock standard concentrations with respective contents per 
tube for the measurement of flavonols…………………………………………….…………..130 
 
Table 2.4 Preparation of Trolox stock standard concentrations with respective contents per tube 
for the Oxygen Radical Absorbance Capacity (ORAC) assay………………………………...130 
 
Table 2.5 Preparation of Trolox stock standard concentrations with respective contents per tube 
for the ABTS (2,2’-azino-di-3-ethylbenzthialozine sulphonate) (TEAC) radical cation 
scavenging assay………………………………………………………………………...…….131 
 
Table 2.6 Preparation of ascorbic acid stock standard concentrations with respective contents 
per tube for the Ferric Reducing Antioxidant Power (FRAP) assay………………………......131 
 
3 Results 
 
Table 3.1 Constituents present in the fermented A.linearis aqueous extract divided into A. 
Analysis for components with respect to standards, and B. Total antioxidant activity/property 
analysed with respect to standards..………………………………………………..…………..55 
 
XXVII 
 
 
 
 
 
Table 3.2 Effects on live cell numbers after 24 hr exposure to selected MA concentrations using 
trypan blue over various time intervals (Mean ± SEM, n=5)………………………..………...132 
 
Table 3.3 Effects on % viability after 24 hr exposure to selected MA concentrations using 
trypan blue viability assay over various time intervals (Mean ± SEM, n=5)…………..…..….132 
 
Table 3.4 Effects on % viability after 24 hr exposure to selected MA concentrations using XTT 
viability assay over various time intervals (Mean ± SEM, n=5)…………………..………..…132 
 
Table 3.5 Effects on % viability after daily exposure to selected MA concentrations using XTT 
viability assay over various time intervals (Mean ± SEM, n=5)……………...…….…………133 
 
Table 3.6 Effects on monolayer electrical resistance after daily exposure to selected MA 
concentrations using transendothelial electrical resistance (TEER) assay over various time 
intervals (Mean ± SEM, n=4)……………………………………………………………..…...133 
 
Table 3.7 Effects on cell cycle phases after 24 hr exposure to selected MA concentrations using 
flow cytometry at 24 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed)……...………….133 
 
Table 3.8 Effects on cell cycle phases after 24 hr exposure to selected MA concentrations using 
flow cytometry at 48 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed)…...…………….133 
 
Table 3.9 Effects on cell cycle phases after 24 hr exposure to selected MA concentrations using 
flow cytometry at 72 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed) ……….………...134 
 
Table 3.10 Effects on cell cycle phases after 24 hr exposure to selected MA concentrations 
using flow cytometry at 96 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed)……...……134 
 
Table 3.11 Effects on live cell numbers after 24 hr exposure to selected Rf concentrations using 
trypan blue over various time intervals (Mean ± SEM, n=5)………..………………………...134 
 
Table 3.12 Effects on % viability after 24 hr exposure to selected Rf concentrations using 
trypan blue viability assay over various time intervals (Mean ± SEM, n=5)……………....….134 
 
XXVIII 
 
 
 
 
 
Table 3.13 Effects on % viability after 24 hr exposure to selected Rf concentrations using XTT 
viability assay over various time intervals (Mean ± SEM, n=5)…….………………..……….135 
 
Table 3.14 Effects on % viability after daily exposure to selected Rf concentrations using XTT 
viability assay over various time intervals (Mean ± SEM, n=5)……...………….……………135 
 
Table 3.15 Effects on electrical resistance after daily exposure to selected Rf concentrations 
using transendothelial electrical resistance (TEER) assay over various time intervals (Mean ± 
SEM, n=4)………………………………….……………………………………………….…135 
 
Table 3.16 Effects on cell cycle phases after 24 hr exposure to selected Rf concentrations using 
flow cytometry at 24 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed).............…………136 
 
Table 3.17 Effects on cell cycle phases after 24 hr exposure to selected Rf concentrations using 
flow cytometry at 48 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed)……….…………136 
 
Table 3.18 Effects on cell cycle phases after 24 hr exposure to selected Rf concentrations using 
flow cytometry at 72 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed)………..………...136 
 
Table 3.19 Effects on cell cycle phases after 24 hr exposure to selected Rf concentrations using 
flow cytometry at 96 hours (Mean ± SEM, n=3, ≥ 10 000 events analysed)………..………...136 
 
Table 3.20 Effects on live cell numbers after 24 hr exposure to 0.05% Rf and selected MA 
concentrations using trypan blue over various time intervals (Mean ± SEM, n=5)…………...136 
 
Table 3.21 Effects on % viability after 24 hr exposure to 0.05% Rf and selected MA 
concentrations using trypan blue viability assay over various time intervals (Mean ± SEM, 
n=5)………………………………………………………………………….………………...137 
 
Table 3.22 Effects on % viability after 24 hr exposure to 0.05% Rf and selected MA 
concentrations using XTT viability assay over various time intervals (Mean ± SEM, n=5).…137 
 
Table 3.23 Effects on % viability after daily exposure to 0.05% Rf and selected MA 
concentrations using XTT viability assay over various time intervals (Mean ± SEM, n=5)….137 
XXIX 
 
 
 
 
 
 Table 3.24 Effects on electrical resistance after daily exposure to 0.05% Rf and selected MA 
concentrations using transendothelial electrical resistance (TEER) assay over various time 
intervals (Mean ± SEM, n=4)……………………………………………………………….....137 
 
Table 3.25 Effects on cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and 
selected MA concentrations using flow cytometry at 24 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)……………………...……………………………………………………..…137 
 
Table 3.26 Effects on cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and 
selected MA concentrations using flow cytometry at 48 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)………………...…………………………………………………..…………138 
 
Table 3.27 Effects on cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and 
selected MA concentrations using flow cytometry at 72 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)……………...………………………………………………………………..138 
 
Table 3.28 Effects on cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and 
selected MA concentrations using flow cytometry at 96 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)………………………………………………………………………..……138 
 
Table 3.29 Effects on live cell numbers after 24 hr exposure to 0.1% Rf and selected MA 
concentrations using trypan blue over various time intervals (Mean ± SEM, n=5)……...138 
 
Table 3.30 Effects on % viability after 24 hr exposure to 0.1% Rf and selected MA 
concentrations using trypan blue viability assay over various time intervals (Mean ± SEM, 
n=5)……………………………………………………………………………………………139 
 
Table 3.31 Effects on % viability after 24 hr exposure to 0.1% Rf and selected MA 
concentrations using XTT viability assay over various time intervals (Mean ± SEM, n=5)….139 
 
Table 3.32 Effects on % viability after daily exposure to 0.1% Rf and selected MA 
concentrations using XTT viability assay over various time intervals (Mean ± SEM, n=5)….139 
 
XXX 
 
 
 
 
 
Table 3.33 Effects on electrical resistance after daily exposure to 0.1% Rf and selected MA 
concentrations using transendothelial electrical resistance (TEER) assay over various time 
intervals (Mean ± SEM, n=4)…………………………………………..……………………...139 
 
Table 3.34 Effects on cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and 
selected MA concentrations using flow cytometry at 24 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)…………………………………...………………………………………..…139 
 
Table 3.35 Effects on cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and 
selected MA concentrations using flow cytometry at 48 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)……………………...………………………………………………..………140 
 
Table 3.36 Effects on cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and 
selected MA concentrations using flow cytometry at 72 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)…………………...…………………………………………………………..140 
 
Table 3.37 Effects on cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and 
selected MA concentrations using flow cytometry at 96 hours (Mean ± SEM, n=3, ≥ 10 000 
events analysed)……………...………………………………………………………………..140 
 
XXXI 
 
 
 
 
 
LIST OF APPENDICES 
 
Appendix A Preparation of various stock standard concentrations with respective contents per 
tube for the measurement of specific assay…………………………………………….……...129 
 
Appendix B Effects of MA on bEnd5 cells using various assays…………….………………132 
 
Appendix C Effects of Rf on bEnd5 cells using various assays……………….……………...134 
 
Appendix D Effects of 0.05% Rf and selected MA on bEnd5 cells using various  
assays……………………………………………………………………………..……………136 
 
Appendix E Effects of 0.1% Rf and selected MA on bEnd5 cells using various assays...........138 
 
Appendix F These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph……………………………………………………….…..141 
 
Appendix G These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph…………………………………………………………...141 
 
Appendix H These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph………………………………………………….………..142 
 
Appendix I These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph………………………………………………….………..142 
 
XXXII 
 
 
 
 
 
Appendix J These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph……………………………………………………………….………143 
 
Appendix K These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph…………………………………………………………….…………143 
 
Appendix L These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph…………………………………………………………………….…144 
 
Appendix M These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph……………………………………………………………………….144 
 
Appendix N These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph……………………………………………………………………………………...……145 
 
Appendix O These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph………………………………………………………………………………………...…145 
 
Appendix P These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
XXXIII 
 
 
 
 
 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph………………………………………………………………………………………...…146 
 
Appendix Q These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph……………………………………………………………………………...……………146 
 
Appendix R These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph………………………………………………………………………………………...…147 
 
Appendix S These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph…………………………………………………………...………………………………147 
 
Appendix T These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph…………………………………………………………………………………………...148 
 
Appendix U These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar 
graph……………………………………………………………………………………...…....148 
 
XXXIV 
 
 
 
 
 
CHAPTER 1 
 
1 Introduction 
 
1.1 Methamphetamine Statistics  
The use of methamphetamine (MA) has become a pandemic problem which continues 
to increase with devastating outcomes on socio-economic status, crime and violence 
rates, and general progression. Globally, the estimated number of users range between 
13.7-56.5 million of which the percentage of the population, aged between 15-64 years 
old, range between 0.3-1.3%. The Asian region accounts for the highest annual users 
(±38.2 million) followed by the African (±6.2 million) and American regions, 
respectively. There is however only data on MA usage in the Southern African sub-
region with none obtained from the remaining sub-regions. Therefore, the total is 
subject to change (United Nations Office on Drugs and Crime, 2011) and thus these 
numbers may be higher than reported. More recently, it has been reported that in Africa, 
the trends in MA drug use has increased between 2000 and 2011. There is a direct 
correlation between the elevated usage and the need for rapid manufacturing as seizures 
of amphetamine (AMPH)-type stimulants also increased globally by 66% in 2011 from 
2010 (United Nations Office on Drugs and Crime, 2013). 
 
In South Africa, MA (commonly referred to as ‘tik’) abuse has become an alarming 
problem in the communities of Cape Town, Western Cape. Its abuse is strongly noted in 
the youth sector as 7% of learners between grade 8 and 11 admitted to long term use of 
MA (Reddy et al., 2013). The highest user level is reported among those under 19 years 
old. Moreover, according to the Medical Research Council (MRC), 98% of “tik” addicts 
who seek help in South Africa are from the Western Cape. Treatment data from South 
African Community Epidemiology Network on Drug Use (SACENDU) indicated that 
compared to other Republic of South Africa provinces, use of MA as a primary drug of 
abuse is highest in the Western Cape (35%) followed by the Eastern Cape at 5%. In 
2002, less than 1% of clients at one of the largest drug treatment centres in the Western 
Cape, Cape Town Drug Counseling Centre, used “tik”. This amount increased to 52% 
1 
 
 
 
 
 
in 2008 (Modernization Programme, 2010). The demand for treatment for the use of 
MA and MA-related problems sharply increased from 2002 to 2008 as the majority 
(currently 70%) is in treatment for the first time (Plüdderman et al., 2009).  
 
Treatment demand data collected by the MRC’s SACENDU project from 25 specialist 
treatment centres indicate that between 2002 and 2008, the total number of patients 
admitted for various drugs increased from 1551 to 2537. The number of patients 
admitted for MA as a primary drug choice was 13 in the last 6 months of 2002 which 
rapidly rose to 944 in the first 6 months of 2008. The overall ages ranged between 13-
61 years old with an alarming 30-50% accounting for patients between the ages of 13 
and 15. Patients that utilized MA as their primary drug choice and attended Cape Town 
treatment centres in 2008 are from over 180 suburbs or towns. More than 20 patients 
seeking help emanated from Bellville, Eerste River, Kraaifontein, Manenberg and 
Mitchell’s Plain. The sharp increase of patients seeking treatment could be an indication 
that MA and associated drugs popularity are also increasing amongst the community 
(Plüdderman et al., 2009). Treatment centers which attend to MA abuse and relapses 
largely employ psychosocial approaches as no accepted medical treatments have been 
established. Thus, there is a pivotal requirement for treatment development. 
 
1.2 Current Trends in Methamphetamine Therapy 
In the absence of accepted medical treatment for MA abuse, there is a desperate need to 
accelerate the very slow pace of clinical testing for new possible therapies in the 
treatment of MA addiction (Cretzmeyer et al., 2003). The proposed reason for the 
difficulty in treatment is thought to be that with MA abuse, the “memories” of addiction 
might be “hardwired” and involve actual structural changes to brain neurons (e.g. 
dendritic spine density) that make addiction resistant to therapeutic intervention (Kish, 
2008). Preliminary data support the possibility that “drug substitution therapy” might be 
useful in the treatment of MA addiction. The mechanism explaining the transition from 
MA-liking to intense compulsive wanting could involve a “pathological learning” 
process in which dopamine (DA) facilitates (Kish, 2008). Based on the research 
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available on MA treatment abuse, promising interventions can be identified, but no 
clear treatment of choice could be found (Cretzmeyer et al., 2003). 
 
According to the MRC, treatment strategies include introducing science-based models 
of substance abuse treatment into community settings, brief screening, monitoring and 
interventions (Plüdderman et al., 2009). Frawley and Smith (1992) investigated 
treatment using aversion therapy where patients were treated in different 
compartmentalized sections (educational groups, individual and family counseling, and 
aftercare planning) based on need. This form of treatment had no significant outcome. 
Huber et al. (1997) involved extensive data collection on outpatient matrix model 
program (which is designed to integrate several disparate interventions into a 
comprehensive, structural approach comprising of individual therapy, relapse therapy 
and family education groups, urine testing and 12-step program involvement) and 
results for process variables only were reported which concluded that the findings 
provide a benchmark for the effectiveness of psychosocial interventions allowing 
comparisons with other treatments. Research was also done on matrix treatment 
programs and desipramine (an anti-depressant) which evaluated the impact of 
psychosocial intervention rather than pharmacotherapy. The results indicated no 
significant differences with better rates observed when treatment was increased coupled 
with an extended duration (Shoptaw et al., 1994).  
 
Other pharmacological approaches also deemed fruitless involved aripiprazol (Stoops et 
al., 2006), GABA agents such as gabapentin, baclofen (Heinzeling et al., 2006), 
vigabatrin (Fechtner et al., 2006), selective serotonin reuptake inhibitors (Piasecki et al., 
2002), ondansetron (Johnson et al., 2008) and mirtazapine (Harper and Napler, 2005), 
and a PROMETA™ treatment programme used primarily for MA addiction consisting of 
flumazenil, gabapentin and hydroxyzine (Ling et al., 2011). Studies involving 
bupropion (Elkashef et al., 2008) and modafinil (McElhiney et al., 2009) have 
demonstrated potential as a treatment on the effects of MA. Anti-methamphetamine 
monoclonal antibodies have shown potential by reducing MA administration, locomotor 
effects and discriminative stimulus effect in rats and pigeons (Byrnes-Blake et al., 2005; 
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Daniels et al., 2006). The relatively unsuccessful remedial programs mentioned in the 
forgoing studies concentrated on addressing the physiological aspects without taking 
into account the psychological aspects of addiction.  
 
1.3 Nomenclature and Chemical Properties of Methamphetamine 
Methamphetamine (MA) is also chemically known as N, α-dimethylphenethylamine 
having a chemical formula of C10H15N (Figure 1.1). It also referred to as 
desoxyephedrine, methylamphetamine, phenylisopropylmethylamine, and a variety of 
other similar systematic names. MA has a molecular weight of 149.9 g/mol and belongs 
to the family, phenethylamine and the class, AMPHs (Logan, 2002). 
 
Figure 1.1 Chemical structure of MA (Hendrickson et al., 2006). 
 
1.4 Overview of Methamphetamine Synthesis and Its Effects 
MA is a potent, addictive psychostimulant that affects many areas of the central nervous 
system (CNS) by causing neurotoxicity. It is commonly a white, odourless, bitter-
tasting crystalline powder that readily dissolves in water or alcohol (Chen et al., 2003; 
Thiriet et al., 2005; Chen et al., 2012). MA is also found in three other forms: 
crystalline/powder, pill/tablet, rock and paste/base form (Figure 1.2) (Topp et al., 2002; 
Degendhart and Topp, 2003; Dore and Sweeting, 2006). Based on these forms, it can be 
snorted, orally ingested or injected intravenously. In South Africa, MA is predominantly 
smoked as the user experiences a rapid onset and intense “high” of the drug (Logan, 
2002; Nordahl et al., 2003; Kish, 2008). The drug can easily be made in clandestine 
laboratories using the red-phosphorus and the lithium-ammonia reduction method 
(Logan, 2002). However, the active ingredient required, pseudoephedrine, must be 
present which can easily be obtained from relatively inexpensive over-the-counter 
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medications such as Advil Cold, Sudafed, Bromfed, etc. (Armellin et al., 2006; Barker 
and Antia, 2007). There are environmental and health dangers that accompany illicit 
production due to the exposure of a combination of corrosive gases or chemicals 
produced. The mild effects include: nausea, dizziness, headaches, anxiety, coughing, 
chest pain, shortness of breath and lethargy. More serious effects include: pulmonary 
edema, kidney failure, liver damage, irritation and severe chemical burns to the skin and 
to the mucous membranes of the nose, mouth and throat, frostbite, conjunctivitis, 
corneal injury, blindness, damage to the CNS, and death (Oregon Department of Human 
Resources, 1988). 
 
 
Figure 1.2 Forms of MA administered for recreational purposes: A Crystalline powder (most 
common) form (http://sshs.amaisd.org/index.php/alcohol-and-drug-prevention/meth/). B 
Pill/tablet form (http://www.methproject.org/answers/whats-meth-made-of.html#Whats-in-
Meth). C Rock form (http://nurseandlawyer.com/page/2/). D Paste/base form 
(http://methdata.tripod.com/). 
 
1.5 Metabolism and Bioavailability of Methamphetamine 
Although MA ultimately affects various organs, it is of vital importance to establish the 
metabolic route of MA as well as the amount of MA the tissues get exposed to. When 
MA is administered, it is mainly metabolized in the liver through p-hydroxylation, β-
hydroxylation, N-demethylation and deamination in rats (Dring et al., 1970; Caldwell et 
al., 1972a). This is similar with AMPH (Dring et al., 1970). In humans however, both 
aromatic hydroxylation and demethylation are significant reactions in MA metabolism 
(Caldwell et al., 1972a, Caldwell et al., 1972b; Kanamori et al., 2005). Initially, MA 
undergoes N-demethylation, aromatic hydroxylation and aliphatic hydroxylation 
metabolic reactions (Caldwell et al., 1972a). Demethylation accounts for 30% of all 
metabolites and ultimately produces benzoic acid (Caldwell et al., 1972a; Caldwell et 
Fig A. Crystalline powder Fig B. Pill/tablet Fig C. Rock Fig D. Paste/base
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al., 1972b). Deamination has a low occurrence in humans, accounting for 6% of the 
dose (5% benzoic acid and 1% benzyl methyl ketone) (Caldwell et al., 1972a). 
Aromatic hydroxylation on the other hand accounts for approximately one third of 14C 
excreted in 24 hours (Dring et al., 1970; Caldwell et al., 1972a). In addition, secondary 
reactions may involve β-hydroxylation (Caldwell et al., 1972a; Kanamori et al., 2005). 
 
Dring et al. (1970) and Caldwell et al. (1972a) observed similar results when they 
performed AMPH metabolic studies on various species (human, guinea pig and rat) 
after administrating 14C-labelled AMPH. After 3-4 days, 90% of AMPH and MA were 
present in human urine samples and approximately 54-65% in the first day. Moreover, 
up to 30% of the drug remained unchanged and 20% as total benzoic drug. Minor 
metabolites included hippuric acid, norepinephrine, an acid labile precursor of benzyl 
methyl ketone, 4-hydroxynorepinephrine, 4-hydroxymethamphetamine, and 4-
hydroxyamphetamine (Dring et al., 1970; Caldwell et al., 1972a; Caldwell et al., 
1972b). Moreover, Caldwell et al. (1972a) also investigated biliary excretion of AMPH 
and MA in rat and found the major metabolites in agreement with their previous 
mentioned findings. After 24 hours, 18% of MA metabolites were found in bile while 
69% of AMPH metabolites were found in urine and 16% in bile. Moreover, MA and 
AMPH metabolites in bile are reabsorbed and excreted in the urine (Caldwell et al., 
1972b). Renal clearance for both smoked and intravenous routes was equivalent with a 
significant amount of MA (37 - 45%) excreted in urine (Cook et al., 1993). In addition, 
suspended hepatocyte cultures incubated with MA revealed the presence of the 
following metabolites in the culture supernatants: AMPH, p-hydroxymethamphetamine 
and p-hydroxyamphetamine which are consistent with the previous findings (Kanamori 
et al., 2005).  
 
Once MA is reabsorbed into the blood stream, it has a circulating half-life of 5 hours 
(Kish, 2008) and similar results have illustrated the geometric half-life of MA to be 11.1 
hours when smoked, 11.4-12.2 hours when intravenously injected, and 10.7 hours when 
administered via the intranasal route (Cook et al., 1993; Harris et al., 2003; Schifano et 
al., 2007; Cruickshank and Dyer, 2009; Shabani et al., 2012) with bioavailabilities of 
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79% for intranasal (Harris et al., 2003), 90.3 ± 10.4% for smoked MA hydrochloride 
and 67.2 ± 3.1% for oral MA administration (Schifano et al., 2007). A drug with a high 
bioavailability will have more pronounced psychoactive effect (Schifano et al., 2007). 
This could explain the popularity of smokable MA as a high bioavailability can be 
achieved with this formulation (Cook et al., 1993; Schifano et al., 2007). Studies on the 
bioavailability of MA have been restricted to blood and urine analysis (Melega et al., 
2007; Schifano et al., 2007), while reports investigating the bioavailability of MA to the 
CNS are limited to Martins and colleagues, 2011.  
 
1.6  Effects of Acute Methamphetamine Exposure 
After acute MA administration, the release of epinephrine, norepinephrine and 
dopamine in the sympathetic nervous system takes place which accounts for the 
common effects including euphoria, increased energy, performance and self-confidence 
(Cretzmeyer et al., 2003; Nordahl et al., 2003; Moszczynska et al., 2004; Plüdderman et 
al., 2009). These initial effects make the drug more attractive however the drug on a 
regular basis causes insomnia, suppressed appetite, hyperthermia, restlessness, 
irritability, increased/heightened sexual behaviour and tremors (Cretzmeyer et al., 2003; 
Nordahl et al., 2003; Thiriet et al., 2005; Barr et al., 2006; Plüdderman et al., 2009). 
Respiratory effects include increased respirations, hypertension and pulmonary edema, 
and a decreased lung capacity. Cardiovascular effects include increased heart rate and 
blood pressure, tachycardia and/or arrhythmias (Logan, 2002; Cretzmeyer et al., 2003; 
Barr et al., 2006; Plüdderman et al., 2009). Users run the risk of over dose characterised 
by dehydration, hyperthermia, convulsions, renal failure, stroke and myocardial 
infarction (Logan, 2002; Cretzmeyer et al., 2003; Nordahl et al., 2003; ; Thiriet et al., 
2005; Barr et al., 2006; Plüdderman et al., 2009). 
 
1.7  Effects of Chronic Methamphetamine Exposure 
Chronic abuse results in detrimental, and sometimes fatal, effects. These effects include 
severe weight loss/anorexia, severe dermatological problems (“MA mouth”), higher risk 
of seizures and uncontrollable rage/violent behavior (Nordahl et al., 2003; Thiriet et al., 
2005; Barr et al., 2006; Plüdderman et al., 2009). Long-term use also increases the risk 
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of contracting human immunodeficiency virus and Hepatitis C due to drug use and 
increase sexual risk behavior (Cretzmeyer et al., 2003; Plüdderman et al., 2009). A shift 
from the favourable mode of administration to intravenous route has been observed due 
to physical difficulties from smoking which include; damage to the nasal tract, 
coughing up blood, choking and difficulty in breathing (Cretzmeyer et al., 2003; 
Plüdderman et al., 2009). MA is also known to affect the CNS to cause mental health 
deficits such confusion, impaired concentration and memory, hallucinations, insomnia, 
depressive and psychotic reactions, paranoid reactions and panic disorders (Logan, 
2002; Cretzmeyer et al., 2003; Nordahl et al., 2003; Barr et al., 2006; Plüdderman et 
al., 2009). It has to cross a physiologically restrictive barrier (blood-brain barrier) in 
order to ultimately influence the CNS. 
 
1.8  The Blood-Brain Barrier 
 
1.8.1  Localization and Functions of the Blood-Brain Barrier 
There are three physiological barriers that restrict and control molecular exchange at the 
interfaces between the blood and tissue or its fluid spaces. The blood-brain barrier 
(BBB) is located between the blood and brain interstitial fluid, the choroid plexus 
epithelium separates the blood and ventricular cerebrospinal fluid (CSF), and the 
arachnoid epithelium is situated between the blood and subarachnoid CSF (Abbott et 
al., 2006; Weiss et al., 2008). However, it is the BBB that exerts the most control over 
the immediate microenvironment of brain cells (Abbott et al., 2006). The BBB 
functions to maintain the CNS homeostasis, which includes the regulation of 
inflammatory cells to act in response to the local environment (Cardoso et al., 2010) 
and the continual turnover and drainage of CSF and interstitial fluid (ISF). Moreover, it 
supplies the brain with essential nutrients, mediates efflux of many waste products and 
importantly protects the brain from ionic concentration fluctuations that can occur after 
a meal or exercise which would disrupt synaptic and axonal signaling (Abbott et al., 
2006). It also restricts ionic and fluid movements between the blood and the brain 
thereby regulating ionic traffic. The latter produces the ISF that provides an optimum 
environment for neuronal functions and is essential in protection against harmful 
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substances, variations in blood composition and the breakdown of concentration 
gradients (Abbott et al., 2006; Cardoso et al., 2010). Thus it serves to protect the brain 
against foreign material, toxins and other substrates (Weiss et al., 2008; Cardoso et al., 
2010; Li et al., 2010) including narcotics such as MA. 
 
1.8.2  Composition of the Blood-Brain Barrier 
The BBB is often considered to be three-cell archetype consisting of the supporting 
pericyte (PC), the astrocyte (AC) and brain microvascular endothelial cell (BMVEC), 
(Gumbleton and Audus, 2001). Although the biochemical properties of BMVECs 
controls the BBB permeability, overall brain microvascular biology results from 
interactions of these cells with the basement membrane and neighbouring glial cells, 
such as microglia and ACs, as well as neurons and perivascular PCs (Cardoso et al., 
2010). The various cell types (basement membrane, neurons, microglia, PCs, 
endothelial cells and ACs) collectively constitute the neurovascular unit (NVU) (Figure 
1.3), which is required for both health and CNS function (Cardoso et al., 2010) and are 
indirectly involved in the establishment and maintenance of the BBB (Weiss et al., 
2008). 
 
Figure 1.3 Components of the BBB constituted by endothelial cells, astrocytes and pericytes 
(http://home.szbk.u-szeged.hu/~krizbai/index.html). 
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1.8.3  The Three Main Blood-Brain Barrier Components 
 
1.8.3.1 Pericytes  
Most elements of the basement membrane including a number of proteoglycans are 
synthesized by vascular pericytes (PCs). It is a process thought to be a crucial step in 
the differentiation of the BBB (Cardoso et al., 2010). PCs are integral constituents of 
each capillary with various frequencies in different vascular beds and are most abundant 
in the CNS and retina (Liebner et al., 2011). Along with endothelial cells (ECs), they 
communicate via tight junctions (TJs), gap junctions and adhesion plaques. The proper 
association of PCs and microvascular is essential in maintaining structural support and 
junctional integrity. The association with blood vessels has been suggested to regulate 
EC proliferation, migration and differentiation. Importantly, in response to stress 
stimuli, as during severe and prolonged oxygen deprivation, PCs make regulatory 
adjustments (Cardoso et al., 2010) and have been correlated with the barrier capacity of 
the endothelium. PCs are actively involved in maintenance of the integrity of the vessel, 
vasoregulation and restricted BBB permeability (Weiss et al., 2008). 
 
1.8.3.2  Astrocytes 
Astrocytes (ACs) play a major role in promoting proteoglycan synthesis with a resultant 
increase in BMVEC charge selectivity and the induction of BBB functions (Cardoso et 
al., 2010). Specifically, ACs are involved in physiological and biochemical activities 
such as neural parenchyma compartmentalization, maintenance of the ionic homeostasis 
of the extracellular space, pH regulation and neurotransmitter uptake and processing. It 
also provides energy rich substrates to the neurons and mediates signals from the brain 
to the vascular system. Moreover, ACs are believed to play a decisive role in the 
maintenance of the BBB properties and in controlling the cerebral flow (Liebner et al., 
2011). They are also required for proper neuronal function and the close proximity of 
neural bodies to brain capillaries suggests that the interactions between these elements 
are essential for a functional NVU (Cardoso et al., 2010). Astrocyte- and glial-released 
factors have also been suggested to contribute to BBB integrity, including glial-derived 
neurotrophic factor, angiopoietin-1 and angiotensin II (Weiss et al., 2008). 
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1.8.3.3  Endothelial Cells 
Endothelial cells (ECs) present pivotal properties that restrict the free movement of 
molecules and are therefore considered the anatomic basis of the BBB. The restrictive 
function is due the presence of TJ proteins located paracellularly, between adjacent ECs 
(Cardoso et al., 2010). One of the brain endothelium’s most important characteristics in 
mammals is its highly restricted and controlled permeability to compounds and ions. 
The latter is reflected by a very high transendothelial electrical resistance (TEER). The 
endothelial lining presents a large surface area (total estimated interface area is 350 m2) 
for the exchange of materials between the blood and the brain (Michiels, 2003). 
Moreover, the differences between brain and non-brain ECs allows for the necessary 
restrictive functioning of the BBB. The differences result in low level of non-specific 
transcytosis (pinocytosis) and paracellular diffusion of hydrophilic substances, strong 
metabolic activity due to the high number of mitochondria, and the polarized expression 
of membrane receptors and transporters responsible for the active transport of blood-
borne nutrients as well as the efflux of potentially toxic substances from the cerebral 
region to the vascular compartment (Weiss et al., 2008). 
 
1.8.4  Blood-Brain Barrier Disruption and Brain Disorders 
The origin of diseases may differ but the role played by the brain endothelium usually 
shares some basic trends such as augmented leukocyte adhesion and migration, 
enhanced expression of immunologically relevant antigens and changes in the BBB 
permeability and function, which all results in BBB disruption. Short periods of hypoxia 
may lead to hyperpermeability observed using mouse brain endothelial (bEnd5) cells 
and BBB injury is present to a varying degree in all multiple sclerotic lesions. A number 
of pathologies and several disorders seem to involve the disturbances of endothelial-
glial interaction and may even exacerbate the adverse effects on the BBB permeability 
(Lundquist and Renftel, 2002; Hawkins and Davis, 2005; Abbott et al., 2006; Yang et 
al., 2007; Palmela et al., 2011).  
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1.8.5  The Immortalized bEnd5 Cell Line as an In Vitro Blood-Brain Barrier 
Model 
The BBB is formed, in large, by the ECs that line cerebral microvessels (Abbott et al., 
2006) which limit solute exchange between the blood and CNS (Mahajan et al., 2008). 
In order to establish a relationship between the BBB, the brain and exogenous 
compounds, the bEnd5 cell line can be used to investigate transport across the BBB to 
the brain. These cells have a spindle-cell shape (Yang et al., 2007; Steiner et al., 2011) 
and were established as a cell line from isolated mouse brain endothelial cells by using 
Polyoma virus middle T-antigen (Williams et al., 1989; Reiss et al., 1998; Yang et al., 
2007; Steiner et al., 2011; Watanabe et al., 2013). An immortalized cell line has the 
advantage of being less labor intensive and the tedious procedures of isolating the brain 
endothelial can be avoided, however a disadvantage may include continuous sub-
culturing of the cells which could result in a change of occludin expression and 
incomplete TJ formation (Lundquist and Renftel, 2002). Mouse models may also prove 
more advantageous due to their availability of transgenic and gene-targeted animals and 
the wide range of antibodies (Steiner et al., 2011). Using in vitro models however, 
minimizes the number of animals required for experiments. The bEnd5 cell line has 
been shown to reach a TEER value of 121 Ω.cm2 (Audus et al., 1990; Yang et al., 
2007). Furthermore, the cell line expresses three important junction proteins: claudin-5, 
occludins, and zona occludins-1 in addition to vascular endothelial-cadherin, von 
Willebrand factor, platelet endothelial cell adhesion molecule-1, endoglin, intercellular 
adhesion molecule-2 and transporters such as P-glycoprotein, sodium-potassium-
chloride-/NKCC co-transporters, glucose transporter-1 and most protein kinase C 
isoforms (Yang et al., 2007; Steiner et al., 2011; Paolinelli et al., 2013; Watanabe et al., 
2013). The existence of TJs in bEnd5 cells, which is a core component in restrictive 
BBB function, has been clearly demonstrated. Using this proposed cell line, 
mechanisms involving MA and the BBB could then be elucidated. 
 
1.8.6  Mechanisms of Methamphetamine on the Blood-Brain Barrier 
MA’s potent and toxic action on the sympathetic and CNS makes a strong case for the 
urgency in which MA use should be addressed. The adverse outcomes of MA have been 
12 
 
 
 
 
 
well established however the mechanisms behind these effects are poorly understood. 
Due to MA’s high lipid solubility and the additional methyl group, large amounts of the 
drug can readily cross the BBB via non-specific diffusion (Syed et al., 2001; Nordahl et 
al., 2003; Bloom et al., 2008). Once in the neuronal setting, it is characterized by the 
disruption of monoamine neurotransmitter production, synaptic integrity of the 
dopaminergic system (Ramirez et al., 2009) and adverse effects on the serotonin and 
cholinergic systems (Nordahl et al., 2003). Physiological concentrations have been 
shown to cause both short-term and persistent DA depletion as MA ultimately results in 
DA efflux, a consequence of transport reversal (Goodwin et al., 2003; Moszczynska et 
al., 2004; Cervinski et al., 2005; Kish, 2008). Positron emission tomography imaging 
and post-mortem studies in humans provide evidence of MA’s neurotoxicity, with 
regular users showing a loss of DA nerve terminals in the caudate and putamen, reduced 
glucose metabolism in the thalamus, caudate and putamen, and an increased glucose 
metabolism in the parietal cortex (Davidson et al., 2001; Volkow et al., 2001; Kish, 
2008). These structural brain changes are associated with both long- and short-term 
impairment in cognitive processing, memory and emotion (Parry et al., 2004). 
However, these effects become prominent only after MA affects the integrity of the 
BBB.  
 
1.8.7  Methamphetamine Adversely Affects the Cell Cycle 
Essentially, there are 4 phases of the cell cycle: G1, S, G2 and M1 (Figure 1.4). The G1 
(gap phase) is the phase where the cells prepare for deoxyribose nucleic acid (DNA) 
replication. DNA synthesis occurs in the S phase and the G2 (second gap) phase prepare 
the cells for division. During the M1 (mitosis) phase, the replicated chromosomes are 
divided into separate nuclei and cytokinesis takes place to produce two daughter cells. 
There is also a G0 phase which describes cells that have exited the cycle and become 
quiescent (Johnson and Walker, 1999). The timing and order of events are monitored 
via cell cycle checkpoints which ensure that the particular phase is completed before a 
new phase is initiated. This prevents the formation of genetically abnormal cells. In 
response to intracellular and extracellular environments, cycle progression can be 
ceased at these checkpoints (Murray, 1994). Apoptosis and proliferation are therefore 
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strongly coupled to cell cycle and can affect both cell division and cell death thus an 
imbalance could result in tissue atrophy or growth (King and Cidlowski, 1998). 
Moreover, cell proliferation is a vital mechanism for repairing the monolayer adjacent 
to the lesion or site of injury (Buşu et al., 2013) and therefore maintains a functional 
BBB. 
 
Figure 1.4 The different phases and activities that take place in the cell cycle 
(http://www.ch.ic.ac.uk/local/projects/s_liu/Html/Graphics/CellCycle.gif). 
 
Cell cycle progression has been associated with an increase in intracellular 
glutathione/glutathione disulfide (GSH/GSSG) levels which modulates the function of 
redox-sensitive protein cysteines. This ultimately plays a role in cell growth, 
proliferation, differentiation and apoptosis. Buşu et al. (2013) conducted an experiment 
involving GSH and cell cycle activities on BMVECs and observed a decrease in nuclear 
GSH associated with enhanced DNA damage. This finding was coupled with the lack of 
endothelial GSH synthesis and a lengthened resident time of ECs in the S-phase. They 
concluded that the delay in S-to-G2-to-M progression allows for extended time for 
DNA repair and cell survival. However, MA has shown to affect the DNA synthesis in 
the S-phase. Yuan et al. (2011) demonstrated that in vivo MA administration resulted in 
a decreased pool of S-phase progenitors without specific alterations in the S-phase 
dynamics of the cell cycle. This result was accompanied by inhibited hippocampal 
proliferation coupled with immature neurons being inhibited proposed as result of 
maladaptive modifications in the development of neural progenitors and increases in 
cell death. Since MA interferes with the S-phase, the synthesis of new cells is inhibited. 
Maturation of hippocampal progenitors into glutamatergic neurons in adulthood is 
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thought to contribute to and maintain adult hippocampal structure and function 
(Earnhart et al., 2007), which may influence the relapse rates of recreational users.  
 
In both, in vivo and in vitro models, MA cytotoxicity involves the mitochondrial-
dependent death pathway which is strongly linked to DA deregulation (Genca et al., 
2007). MA has been reported to diffuse into the mitochondria and ultimately results in 
the disruption of the electrochemical gradient (Chance and Williams, 1956) which in 
turn initiates apoptotic processes (Lemasters et al., 1999). In addition, various 
proapoptotic factors (cytochrome-c, cell death cysteine proteinases and caspases) also 
arise from dysfunctional mitochondria (Murphy et al., 1999). The resultant apoptotic 
cascades are irreversible once the proapoptotic factors have been released (Davidson et 
al., 2001). Necrosis could also be affiliated with MA induced excitotoxicity which is the 
overstimulation of nerve cells (Stout et al., 1998) and has been shown to occur in 
several brain areas (cortex, striatum and hippocampus) after MA administration (Deng 
et al., 2001). Most of the research relating to MA and its possible effects on cell cycles 
is largely focused on neuronal tissue with little being reported on the in vitro MA-
induced effects on the BBB. It is however possible that these effects could also occur in 
ECs which would generate novel insight into the mechanisms of MA-induced cell cycle 
results.  
 
1.8.8  Methamphetamine Increases Blood-Brain Barrier Permeability 
The BBB’s ability to sustain its obstructive function, is dependent on its low 
permeability which is mirrored by a very high TEER of approximately > 1000 Ω.cm2 
(Gumbleton and Audus, 2001; Abbott et al., 2006; Martins et al., 2011). TEER in 
principle is a quantitative measurement describing the barrier integrity which in essence 
is the electrical, ohmic resistance of the cell layer (Benson et al., 2013). Studies have 
illustrated MA’s ability to decrease TEER readings on numerous in vitro monolayers 
(Abdul-Muneer et al., 2005; Mahajan et al., 2008; Ramirez et al., 2009; Zhang et al., 
2009; Martins et al., 2010; Carey et al., 2012; Rosas-Hernandez et al., 2013) which was 
often accompanied with an increase in leukocyte migration (Afghajanian et al., 2008; 
Dietrich, 2009; Ramirez et al., 2009). These two MA-induced mechanisms strongly 
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partake in the progression of vascular endothelial dysfunction and the pathophysiology 
of various vascular-related diseases (Lum and Roebuck, 2001; Afghajanian et al., 
2008). MA’s adverse influence on BBB permeability is further supported by 
observations with increases in albumin- and Evans Blue extravasation leakages 
(Bowyer and Ali, 2006; Sharma and Ali, 2006; Kiyatkin and Sharma, 2009; Martins et 
al., 2011; Sharma et al., 2012; Kiyatkin, 2013; O’Shea et al., 2014) which would 
otherwise be detained by the presence of an intact BBB. In addition, MA has also 
shown to modulate TJ expression (Mahajan et al., 2008; Martins et al., 2011). Another 
proposed mechanism is the activation of myosin long chain kinase which increases 
BBB permeability through the modification of TJs and cytoskeleton thereby causes a 
breach in BBB integrity (Ramirez et al., 2009).  
 
There is an increasing amount of evidence suggesting that the main source for MA-
induced neurotoxicity is dependent on the production of reactive oxygen species (ROS) 
which is suggested to be of the bi-products of DA accumulation, subsequent enzymatic 
oxidation, DA auto-oxidation and increased glutamate release (Davidson et al., 2001; 
Chen et al., 2003). Apart from ROS, reactive nitrogen species (RNS) have also been 
reported to contribute to neurotoxicity caused by MA usage (Fleckenstein et al., 1997; 
Lin et al., 1999; Cervinski et al., 2005; Ramirez et al., 2009). ROS production initiates 
a cascade of events which ultimately results in BBB dysfunction. These events include 
nitric oxide (NO) production and excess glutamate release as well as the activation of 
glial cells and matrix metalloproteinases (MMP) (Oppenheim et al., 2013). Anderson 
and Itzhak (2006) reported an increase in striatal nitrate (stable NO product), neuronal 
nitric oxide synthase (nNOS) expression and nitration results which is coupled with 
MA-induced dopaminergic neurotoxicity and results in the activation of apoptotic 
cascades (Imam et al., 2005) thus NO has the ability to contribute to tissue damage (de 
Vries et al., 1997). Martins et al. (2013) concluded that the BBB opening they observed 
involves endothelium-derived NO or NO-mediated trancytosis. In addition, NO 
generated by nNOS has also been shown to activate MMPs (Haddad and Yu, 2009). 
These proteases have been reported to degrade and redistribute components of the 
extracellular matrix and tight junctions (van der Goes et al., 2001; Nordahl et al., 2003; 
16 
 
 
 
 
 
Shreibelt et al., 2007; Dietrich, 2009; Martins et al., 2011; Lakhan et al., 2013). MA has 
also been associated with increased glutamate levels (Yamamoto and Raudensky, 2008; 
Northrop et al., 2011) and microglial activation (Thomas et al., 2004; Sekine et al., 
2008) which then resulted in neuroinflammation (Yamamoto and Raudensky, 2008; 
Coelho-Santos et al., 2012) and further cytokine release. These events ultimately caused 
neuroinflammation and TJ rearrangement thus exacerbation of BBB dysfunction 
(Nordahl et al., 2003; Martins et al., 2011; Martins et al., 2013). 
  
The role of MA-induced oxidative stress (OS) is further supported by the finding that 
Trolox (Ramirez et al., 2009), N-Acetylcysteineamide (Zhang et al., 2009; Carey et al., 
2012), metallothioneine, zinc (Ajjimaporn et al., 2005), melatonin (Parameyong et al., 
2013), mannitol, ascorbic acid, vitamin E (De Vito and Wagner, 1989), phenyl-butyl-
nitrone (Yamamoto and Zhu, 1998) and selenium (Imam and Ali, 2000) attenuates the 
increased lipid peroxidation (Zhang et al., 2009; Carey et al., 2012), monocyte 
migration (Ramirez et al., 2009), peroxynitrate generation (Imam and Ali, 2000) and 
cell death (Ajjimaporn et al., 2005; Zhang et al., 2009; Carey et al., 2012; Parameyong 
et al., 2013) as well as decreased TEER (Ramirez et al., 2009; Zhang et al., 2009; Carey 
et al., 2012), glutathione peroxidase and GSH levels (Zhang et al., 2009; Carey et al., 
2012), DA and serotonin levels in the striatum (De Vito and Wagner, 1989; Yamamoto 
and Zhu, 1998) brought about by MA. MA-induced ROS levels were also significantly 
decreased as a result of these antioxidants (Ajjimaporn et al., 2005; Zhang et al., 2009; 
Carey et al., 2012; Parameyong et al., 2013). Since the adverse effects caused by MA 
are reduced by ROS scavengers and anti-oxidants, novel treatments possessing 
scavenging properties may have the potential to ameliorate BBB injury. Natural herbal 
teas, such as Aspalathus linearis have been reported to possess antioxidant capabilities 
but has as yet, not been investigated against MA. 
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1.9  Rooibos (Aspalathus linearis) Herbal tea 
 
1.9.1  Anecdotal Properties of Aspalathus linearis 
Aspalathus linearis is the only edible shrubby legume belonging to the genus 
Aspalathus which includes more than 270 species (Joubert and Ferreira, 1996; Villaño 
et al., 2010; Breiter et al., 2011; Joubert and de Beer, 2011). The plants’ leaves and 
stems undergoes a process of fermentation (Ferreira et al., 1995; Joubert, 1996) in order 
to manufacture the local endemic tea viz. rooibos herbal tea (Figure 1.5), which is a 
drinking beverage with acclaimed beneficial health effects (Krafczyk and Glomb, 
2008). The herbal tea has been found to possess a myriad of properties which include: 
anti-oxidant, -atherosclerotic, -inflammatory, -mutagenic, -carcinogenic, -allergic, -
tumor and -viral activities, hepatoprotective properties and immune-modulating effects 
(Ferreira et al., 1995; Joubert and Ferreira, 1996; Nijveldt et al., 2001; McKay and 
Blumberg, 2007; Villaño et al., 2010). It also has been established to have effect on 
dermatological diseases such as Behcet’s disease, Sweet disease and photosensitive 
dermatitis (Ferreira et al., 1995; Joubert and Ferreira, 1996). Moreover, the herbal tea is 
prescribed against nervous tension, allergies and various stomach and indigestion 
problems (Ferreira et al., 1995; Joubert, 1996; Joubert and Ferreira, 1996). The 
potential health benefits and bioactivity of A. linearis have been linked to its 
polyphenolic content naturally occurring in the plant (Ferreira et al., 1995; Joubert and 
Ferreira, 1996; McKay and Blumberg, 2007; Joubert and de Beer, 2011) 
 
 
Figure 1.5 Physical characteristics of the two forms of rooibos (A. linearis) herbal tea: A. 
Unfermented form also known as green tea (http://www.carmientea.co.za/tea-variants/rooibos/). 
B. Resulting form after fermentation also known as red tea (the beverage) 
(http://amavida.com/learn/). 
Fig A. Unfermented (green) tea Fig B. Fermented (red) tea
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1.9.2  Chemistry of Aspalathus linearis 
 
1.9.2.1 The Polyphenolic Contents of Aspalathus linearis 
Antioxidant activity is reported to be the result of polyphenols present in the herbal tea 
(Ferreira et al., 1995; Joubert and Ferreira, 1996). Polyphenols, a class of 
phytochemicals include classes of chromones, coumarins, lignans, stilbenes, xanthones 
and the ubiquitous flavonoids (McKay and Blumberg, 2007). A. linearis boasts a large 
yield of flavonoids with very high contents of C-glycosides. It also possesses minerals, 
ascorbic acid, is caffeine-free and has low tannin levels (Ferreira et al., 1995; van der 
Merwe et al., 2006; Krafczyk and Glomb, 2008; Joubert and de Beer, 2011). A study 
done by Krafczyk and Glomb (2008) characterized the phenolic compounds in 
processed A. linearis (Table 1). In addition, lignans, flavones diglycosides, (+)-catechin, 
a phenylpyruvic acid glycoside, the flavonol quercetin-3-O-robinobioside and the 
coumarins, esculetin and esculin, have also been identified in A. linearis (Krafczyk and 
Glomb, 2008; Joubert and de Beer, 2011). Infusion of fermented rooibos herbal tea has 
also been reported to contain 1.29 µg/ml fluoride, a sodium content of 43.33 µg/ml, and 
minute amounts of aluminium (Joubert and de Beer, 2011). Green tea (Camelia 
sinensis) is also known to contain a high phenolic content and was compared to rooibos 
herbal tea. There was a significant difference in total polyphenols (41%-green vs. 29%-
rooibos) with lower percentages of flavonoids and non-flavonoids in rooibos. These 
differences may relate to the difference in enzymatic and chemical modifications 
occurring during fermentation and processing (McKay and Blumberg, 2007).  
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Table 1 Polyphenols present in A. linearis  
Class of Phytochemicals Individual component 
Flavan-3-ols Catechin 
Flavanones Eriodictyol 
Flavones Chrysoeriol, iso-orientin, iso-vitexin, luteolin, 
orientin and vitexin 
Flavonols Quercetin, iso-quercetin and rutin 
Dihydrochalcones Aspalathin and nothofagin 
Proanthocyanadins Present 
Phenolic acids Caffeic, ferulic, p-coumaric, p-
hydroxybenzoic, 4-hydroxy-3,5-
dimethoxycinnamic, protocatechuic acid, 
syringic and vanillic acid 
(Ferreira et al., 1995; McKay and Blumberg, 2007) 
 
1.9.2.2  Flavonoids Present in Aspalathus linearis 
The polyphenol group can be further divided into the subgroups of flavonoids. The 
flavonoid content of A. linearis has been described by Van der Merwe et al. (2010) and 
Joubert and Ferreira (1996) (Figure 1.6). However, rooibos herbal tea is unique since it 
contains large amounts of aspalathin (2’.3,4,4’,6’-penthydroxy-3-C-β-D-
glycopyranosyldihydrochalcone) that can only be isolated from A. linearis and is the one 
of two known sources of nothofagin in much lower quantities (Joubert, 1996; Joubert 
and Ferreira, 1996; McKay and Blumberg, 2007; Snijman et al., 2009; Villaño et al., 
2010; Joubert and de Beer, 2011). The two C-linked dihydrochalcone glycosides are the 
major flavonoid constituents in unfermented (green) rooibos herbal tea (van der Merwe 
et al., 2010). Aspalathin contributes ~43% of the total antioxidant capacity of aqueous 
extracts of unfermented rooibos and has comparable radical scavenging potency to the 
well-known flavonoid antioxidants namely quercetin and epigallocatechin gallate. 
Aspalathin also constitutes ca. 0.55% of soluble solids of the processed herbal tea and 
in unprocessed tea aspalathin comprises as much as 9.3% of the plant material (Joubert, 
1996) as it is greatly reduced via the oxidative process of fermentation. This process 
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results in the formation of the two flavones analogues, iso-orientin and orientin as major 
products which also contributes to antioxidant potency (Joubert et al., 2008; Krafczyk 
and Glomb, 2008; Snijman et al., 2009; Joubert et al., 2010; Joubert and de Beer, 2011). 
The presence of flavonoids are presumed to contribute significantly to the scavenging 
effects on active oxygen species (Ferreira et al., 1995). Therefore, an important property 
of polyphenols is their ability to scavenge of ROS (Ferreira et al., 1995; Nijveldt et al., 
2001). 
 
Figure 1.6 Molecular structures of the flavonoids present in A. linearis: A Chrysoeriol. B 
Orientin. C Quercetin. D Iso-quercetin. E Aspalathin and nothofagin. F Luteolin. G Iso-orientin 
and iso-vitexin. H Rutin (van der Merwe et al., 2010; Joubert and Ferreira, 1996). 
 
1.9.3  Metabolism and Bioavailability of Rooibos (A. linearis) Herbal Tea 
After consumption of A. linearis, flavonoids are predominantly metabolized in the 
colon and liver. Phase II biotransformations in the liver include glucuronidation, 
sulfation or methylation of the phenolic hydroxyl groups. Variables such as absorption, 
inter-individual variability, bioavailability and mechanism of redox endogenous 
regulation, play an important role in defining the absorption and the efficiency of 
dietary antioxidants in vivo (Villaño et al., 2010). Stalmach et al. (2009) conducted a 
study using ten volunteers who ingested 500 ml herbal tea containing total fermented 
flavonoid contents of 84 µmol. In the collected urine, 8 metabolites were identified. 
Two of the main compounds identified were O-methyl-aspalathin-O-glucuronide and 
eriodictyol-O-sulfate, whereas no metabolites were detected in the plasma samples. The 
overall metabolite levels excreted were 82 nmol, accounting for 0.09% of the flavonoids 
Fig A. Chrysoeriol Fig C. Quercetin Fig D. Iso-quercetinFig B. Orientin R1=OH
Vitexin R1= H
Fig E. Aspalathin R1=OH
Nothofagin R1= H
Fig G. Iso-orientin R1=OH
Iso-vitexin R1= H
Fig H. Rutin
Fig F. Luteolin
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in the fermented beverages. Most of the aspalathin metabolites (80-90%) were excreted 
within 5 hours of herbal tea consumption with a urinary recovery of 15 ± 3.5 nmol of 
metabolites which corresponded to 0.18% of intake suggesting that aspalathin 
absorption took place in the small intestine with a very limited bioavailability. 
Moreover, excretion of eriodictyol-O-sulfate metabolites occurred mainly during the 5-
12 hour collection period with relatively low recoveries of 0.3% following consumption 
of 23 µmol of eriodictyol-O-sulfate in fermented beverages suggesting that absorption 
had occurred in the large intestine (Stalmach et al., 2009).  
 
Breiter et al. (2011) observed seven derived metabolites, aspalathin and nothofagin 
were identified including their unchanged forms in pig and human urine samples. It was 
also concluded that the dihydrochalcone, flavone-C, and flavanol-O-glycosides in 
unfermented rooibos herbal tea are bioavailable to a certain extent and as a 
consequence, it is assumed that the main constituents of flavonoids directly reach the 
large intestine. Furthermore, the flavonoids not absorbed in the upper gastrointestinal 
tract are degraded by bacteria residing in the colon, with subsequent hydrolysis of 
conjugates and glycosides, and ring fusion of the aglycones to phenolic acids, followed 
by reabsorption (Villaño et al., 2010). Aspalathin is not subject to the degradation in the 
stomach as a 100% recovery rate was observed when incubated with artificial gastric 
juice for up to 2 hours (Stalmach et al., 2009). In addition, the absence of detectable 
quantities of metabolites of dihydrochalcones and flavanone C-glycosides in plasma 
most probably reflects their rapid removal from circulation (Villaño et al., 2010). 
However, unmetabolized compounds were recently confirmed in plasma (Breiter et al., 
2011). Despite low bioavailability of aspalathin, its in vivo bioactivity confirms the 
importance and relevance of this flavonoid as a potent ROS scavenger (Stalmach et al., 
2009; Joubert et al., 2010; Breiter et al., 2011; Joubert and de Beer, 2011). 
 
1.9.4  The Antioxidative Properties of Aspalathus linearis 
Antioxidants have a similar “preservative” effect on biological systems and particularly 
on human life (Joubert and Ferreira, 1996). Interaction of the phenolic constituents with 
free radical species in different phases provides different perspectives on their anti- or 
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pro-oxidant properties (Joubert, 1996). Primary or chain-breaking antioxidants interfere 
with lipid peroxidation which is followed by the chelation of metals, scavenging of 
oxygen, quenching of singlet oxygen and reduction of hydroperoxides to non-radical 
products which contribute in retarding the rate of lipid peroxidation (Joubert and 
Ferreira, 1996). Flavonoids have been described as antioxidants by means of their 
superoxide dismutase mimetic substances (Ferreira et al., 1995; Nijveldt et al., 2001). 
Aspalathin, catechins, phenolic carboxylic acids (protocatechuic acid, ferulic acid and 
caffeic acid), flavones (luteolin), flavanones (quercetin, iso-quercetin and rutin) and 
phenolic carboxylic acids (protocatechuic acid, ferulic acid and caffeic acid) in A. 
linearis possess antioxidant properties and contribute to the powerful scavenging 
abilities for protection of the body against ROS (Ferreira et al., 1995; Joubert and 
Ferreira, 1996; Nijveldt et al., 2001). A mechanisms by which flavonoids function is 
direct through scavenging where they are oxidized by radicals which then results in a 
more stable, less-reactive radical (Nijveldt et al., 2001).  
 
A. linearis has been shown to scavenge the physiologically relevant ROS, superoxide 
anion (Joubert et al., 2008), peroxynitrate (ONOO-) and interfere with nitric oxide 
synthase activity which reacts with free radicals to produce ONOO- radicals which then 
ultimately results in cell membrane damage. Rutin and quercetin inhibit xanthine 
oxidase which serves as an oxygen free radicals source. Luteolin was reported to be the 
most powerful inhibitor of the enzyme (Nijveldt et al., 2001). A. linearis displays 
superior scavenging activity for both the xanthine or xanthine oxidase-generated 
superoxide and hydrogen peroxide (Fernandes et al., 2004). A. linearis also protects 
against lipid peroxidation and scavenges alkyl peroxyl radicals, reduces compliment 
activation, and the release of peroxidase and arachidonic acid (Joubert et al., 2008), thus 
ultimately preventing inflammatory responses and the production of ROS. ROS and 
inflammation has been strongly linked to tumor progression to which rooibos has also 
been associated with.  
 
Studies report the ability of rooibos to inhibit cancer progression by reducing cancer-
associated changes in animal cells induced by mutagens benzo[a]pyrene and mitomycin 
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C (Sasaki et al., 1993), cancerous transformations of mouse cells exposed to x-rays 
(Komatsu et al., 1994), age-related lipid peroxide accumulation in rat brains (Inanami et 
al., 1995) and the development of large esophageal papillomas by decreasing the 
number and size (Sissing et al., 2011). Rooibos also showed chemoprotective effects 
against cancer promotion in a liver carcinogenic model and skin cancer in mouse 
models (Marnewick et al., 2005; Petrova, 2009). Moreover, numerous positive effects 
of rooibos have also been shown against cardiovascular disease (CVD) by illustrating a 
decrease in lipid peroxidation (Inami et al., 2008; O’Keefe et al., 2008), atherosclerosis 
(Basu and Lucas, 2007), myocardial infarction occurrence (Mukamal et al., 2002) and 
angiotensin-converting enzyme (Samani et al., 1996; Persson et al., 2010) which is 
linked to CVD. In essence, A. linearis demonstrated protective effects in studies relating 
to cancer and CVD disease in which it is proposed that ROS played a critical role. It is 
therefore plausible that rooibos could protect against MA-induced OS and thus help 
maintain the integrity of the BBB.  
 
Reports strongly suggest that rooibos could potentially protect against MA-induced 
effects on the integrity of the BBB which can be attributed to MA’s potential to 
compromise the BBB’s permeability. The presence of high levels of anti-oxidants aid in 
maintaining an intact BBB (Plateel et al., 1995), however, the lipophilic nature of MA 
allows it to readily cross the BBB in which its effects have been linked to excess ROS 
and RNS. These molecules give rise to cascades involving NO, MMP, increased 
glutamate, mitochondrial dysfunction, lipid peroxidation and, microglial and cytokine 
activation which in turn activates additional ROS and vice versa (Sekine et al., 2008; 
Yamamoto and Raudensky, 2008; Oppenheim et al., 2013; Northrop et al., 2011). Thus, 
it may be proposed that BBB dysfunction may be a result of a combination of events 
caused indirectly by MA. Interaction of rooibos polyphenols and/or non-polyphenolic 
compounds with ROS may prove to be useful in ameliorating BBB dysfunction brought 
about by MA and provide a foundation for natural therapeutic targets against narcotics. 
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1.10  Aims 
The aim of the study was to determine the in vitro effects of pure methamphetamine on 
the blood-brain barrier in a cell culture model using the bEnd5 cell line, and investigate 
the potential protective effects of fermented rooibos (Aspalathus linearis) herbal tea. 
 
1.11 Objectives 
The following parameters were investigated in order to determine the effects of MA and 
Rf, individually and in combination, on bEnd5 cells over selected time intervals: 
 
1. To determine cell numbers and % viability using, the trypan blue viability 
assay at 24, 48, 72 and 96 hours using selected concentrations of MA, Rf and 
combinations of the compounds. The conditions used in this assay included 
only 24 hour (once-off) exposure to the compounds. 
 
2. To analyze the compounds effects on bEnd5 cell metabolic activity and 
viability using, the MTT/XTT viability assay at 24, 48, 72 and 96 hours using 
selected concentrations of MA, Rf and combinations of the compounds. The 
conditions used in this assay included 24 hour (once-off) and daily exposure 
to the compounds. 
 
3. To investigate the permeability status in response to compound exposure 
using transendothelial electrical resistance (TEER) at 24, 48, 72, 96, 120 and 
144 hours with exposure to selected concentrations of MA, Rf and 
combinations of the compounds. The conditions used in this assay included 
only daily exposure to the compounds. 
 
4. To determine the compounds effects on bEnd5 cell cycles using flow 
cytometry at 24, 48, 72 and 96 hours using selected concentrations of MA, Rf 
and combinations of the compounds. The conditions used in this assay 
included only 24 hour (once-off) exposure to the compounds. 
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1.12  Hypothesis 
The working hypothesis is that the adverse effects of pure methamphetamine on the 
blood-brain barrier will be ameliorated by fermented rooibos herbal tea. 
 
 
26 
 
 
 
 
 
CHAPTER 2 
 
2 Methods and Materials 
 The aim of the study was to determine the effects that 24 hour (hr) and daily exposure 
of methamphetamine (MA) and fermented rooibos (Rf) has on mouse brain endothelial 
(bEnd5) cells over selected time intervals. bEnd5 cells were also subjected to a 
combination of the compounds to investigate potential mitigating effects of Rf against 
MA on the endothelial cells. The chemical analysis of the Rf sample was achieved by 
determining the polyphenol, flavonol and flavanol quantities expressed against a 
selected standard in addition to investigating the antioxidant activities using FRAP, 
ORAC and ABTS/TEAC assays. The chemical analysis is discussed in more detail 
below.  
 
2.1 Preparation of Aqueous Infusion of A. linearis 
A. linearis (South African Rooibos Council, Batch no. P06/02KK) was prepared by 
steeping the dried leaves in boiling water for 30 minutes (min). A 20% aqueous extract 
was pre-filtered through cheesecloth and subsequently through Whatman no. 4 followed 
by no. 1 filter paper. The filter extract was stored at -20 degrees Celsius (°C) and 
protected from light. 
 
2.2 Chemical Analysis of Fermented Rooibos 
Chemical analysis of the Rf aqueous extract was carried out under the supervision of 
Prof J. Marnewick at Cape Peninsula University of Technology (CPUT)’s Oxidative 
Stress Research Centre (Bellville, Cape Town, South Africa) with the following routine 
and standardizing tests: measurement of flavonols and flavanols (Wallace and Giusti, 
2010; Li et al., 1996), ferric reducing antioxidant power (FRAP) assay (Benzie and 
Strain, 1996), oxygen radical absorbance capacity assay (ORAC) assay (Huang et al., 
2005), ABTS (2,2’-azino-di-3-ethylbenzthialozine sulphonate) or Trolox equivalent 
antioxidant capacity (TEAC-total antioxidant status) assay (Zulueta et al., 2009) and the 
measurement of polyphenols (Schofield et al., 2001; Blainski et al., 2013; Berker et al., 
2013). 
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2.2.1 Measurement of Polyphenols 
 
2.2.1.1 Principle 
This method made use of the redox reagent Folin Ciocalteu which oxidizes the 
polyphenols present in the tea extract. The redox reagent is formed by a blue 
chromophore complex consisting of a mixture containing phosphotungstic acid and 
phosphomolybdic acid. After oxidation, the previous mentioned acids are reduced to 
tungsten and molybdenum, respectively. The blue colouration can be quantified by 
visible-light spectrophotometry with a maximum absorbance in the region of 750 nm 
and is directly proportional to the total quantity of phenolic compounds originally 
present (Schofield et al., 2001; Blainski et al., 2013; Berker et al., 2013). 
 
2.2.1.2 Chemicals Required for the Measurement of Polyphenols 
The chemicals used in order to measure polyphenols included: 10% ethanol (EtOH) 
(Saarchem, Cat no. 2233540 LP), Folin Ciocalteu reagent (Merck, Cat no. 109001), 
7.5% sodium carbonate (Na2CO3) (Sigma Aldrich, Cat no. 223530), gallic acid (Sigma, 
Cat no. G7384) was used as standard with which to determine the polyphenols in the 
extract. Stock standard concentrations were prepared as follows: 40 mg gallic acid was 
dissolved in 50 ml 10% EtOH to give a gallic acid stock standard concentration of 800 
mg/l. The gallic acid stock control was prepared as follows: 10 mg gallic acid was 
dissolved in 50 ml 10% EtOH. All solutions were prepared on the day of analysis. 
 
2.2.1.3 Sample Preparation and Analysis 
The 20% Rf aqueous extract sample was directly used in the analysis. To avoid 
precipitates, the sample was centrifuged for 3 min at 4300.8 G-force (G) (4000 
revolutions per minute (rpm)) and the supernatant was used in the analysis. Preparation 
of the sample was done on ice throughout the procedure. All samples were stored at -40 
°C. The gallic acid stock standard concentrations were prepared (See Appendix A: 
Table 2.1) and 25 µl of the standard, control and sample was added (in triplicate) to 
designated wells, respectively. This was followed by the addition of 125 µl Folin 
Ciocalteu reagent to each well. The plate was left for 5 min at room temperature (RT) 
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and 100 µl Na2CO3 was added to each well. The plate was then left for an additional 2 
hours (hrs) at RT before reading, using a Multiskan™ plate reader (Fisher Scientific) at 
760-765 nm. 
 
2.2.2 Measurement of Flavonols 
 
2.2.2.1 Principle 
The analysis made use of quercetin as the standard which was used to determine total 
phenolic subgroup within the Rf extract at 360 nm. 
 
2.2.2.2 Chemicals Required for the Measurement of Flavonols 
The chemicals necessary for the measurement of flavonols included: 10% EtOH, 95% 
EtOH, 0.1% hydrogen chloride (HCl) (Saarchem, Cat no. 100319 LP) in 95% EtOH, 
2% HCl, The quercetin stock standard solution (80 mg/l) was prepared as follows: 4 mg 
quercetin (Sigma, Cat no. Q0125) was weighed and added to 50 ml 95% EtOH. The 
quercetin stock control was prepared as follows: 1.5 mg quercetin was weighed and 
added to 50 ml 95% EtOH. All solutions were prepared on the day of analysis. 
 
2.2.2.3 Sample Preparation and Analysis 
The 20% Rf aqueous extract sample was directly used in the analysis. To avoid 
precipitates, the sample was centrifuged for 3 min at 4300.8 G (4000 rpm) and the 
supernatant was used in the analysis. All samples were stored at -40 °C. The quercetin 
acid stock standard concentrations were prepared (See Appendix A: Table 2.2) and 12.5 
µl added to designated wells, respectively. In addition, 12.5 µl of the control and sample 
(in triplicate) was added to designated wells. The solution, which contained 12.5 µl 
0.1% HCl in 95% EtOH, was then added followed by the addition of 225 µl 2% HCl to 
each well. The plate was then left for 30 min at RT and read at 360 nm with the 
temperature set to 25 °C using a Multiskan™ spectrum plate reader. 
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2.2.3 Measurement of Flavanols 
 
2.2.3.1 Principle 
This assay was employed for the detection and quantification of proanthocyanidins 
(PAs). PAs (also known as condensed tannins) are polymeric condensation products of 
flavanols and the aromatic aldehyde, 4-dimethylaminocinnamaldehyde (DMACA), has 
an affinity for the C8 position of the A-ring and thus reacts with the terminal units of 
PAs. Specifically, aldehydes react with m-diphenol present in the A-ring of flavanols, 
which forms the blue coloured carbonium ion in acidic environment observed when 
using the assay. The method has a maximum absorbance of 640 nm (Li et al., 1996; 
Wallace and Giusti, 2010).  
 
2.2.3.2 Chemicals Required for the Measurement of Flavanols 
The chemicals utilized to determine the amount of flavanols in the extract included: 
32% HCl-methanol (MeOH) solution prepared as follows: 250 ml HCl was added to 
750 ml MeOH (Saarchem, Cat no. 4164080 LC) and mixed thoroughly. 4-
Dimethylamino-cinnamaldehyde (DMACA) (Merck, Cat no. 822034) was prepared as 
follows: 0.25 g DMACA was dissolved in 500 ml HCl-MeOH mixture. Catechin 
hydrate (Sigma, Cat no. C1251) was used as a standard with which to measure the 
flavanols in the extract. The 1 mM catechin stock standard was prepared as follows: 
0.0145 g catechin hydrate added to 50 ml methanol. The 200 µM catechin stock control 
was prepared as follows: 0.0029 g catechin hydrate was added to 50 ml MeOH. All 
solutions were prepared on the day of analysis.  
 
2.2.3.3 Sample Preparation and Analysis 
The 20% Rf aqueous extract sample was directly used in the analysis. To avoid 
precipitates, the sample was centrifuged for 3 min at 4300.8 G (4000 rpm) and the 
supernatant was used in the analysis. All samples were stored at -40 °C. The catechin 
acid stock standard concentrations were prepared (See Appendix A: Table 2.3) and 50 
µl of the standard, control and sample was added (in triplicate) to designated wells, 
respectively. 250 µl DMACA was added to all wells for reaction initiation. The plate 
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was then left for 30 min at RT and absorbance was read at 640 nm using a Multiskan™ 
spectrum plate reader (After reading, if any of the flavanol values were greater than the 
standard curve range, a 10-fold dilution was performed on the samples by using 100 µl 
of the sample supernatant and 900 µl of MeOH. The flavanol assay with the diluted 
sample was then repeated). 
 
2.2.4 Oxygen Radical Absorbance Capacity (ORAC) assay  
 
2.2.4.1 Principle 
The ORAC method was used to analyze the lipid-soluble antioxidant samples by 
introducing randomly methylated beta-cyclodextrin in 50% acetone water mixture. The 
mixture made lipid-soluble antioxidants soluble in phosphate buffer. This method is 
unique in its analysis as it takes into account the inhibition time and degree into a single 
quantity by measuring the area under the curve. Antioxidant capacity is measured by the 
inhibition of free radical damage. It is reflected by protection against probe fluorescent 
change and the fluorescent intensity changes indicate the degree of free radical damage 
(Huang et al., 2005). 
 
2.2.4.2 Chemicals Required for the ORAC assay 
The chemicals utilized for the ORAC assay included: hexane (Saarchem, Cat no. 
2868040 LC) which was stored at RT. Acetone/water/acetic acid (AWA) solution stored 
at RT comprised of 700 ml acetone (Saarchem, Cat no. 1022040 LC), 295 ml distilled 
water (dH2O) and 5 ml glacial acetic acid (Saarchem, Cat no. 1021000). The 75 mM, 
pH 7.4 phosphate buffer consisted of 2 solutions. The first solution consisted of 1.035 g 
sodium di-hydrogen orthophosphate-1-hydrate (NaH2PO4.H2O) (Sigma Aldrich, Cat no. 
S9638) and 100 ml double distilled water (ddH2O) which was mixed until dissolved. 
The second solution consisted of 1.335 g di-sodium hydrogen orthophosphate dihydrate 
(Na2HPO4.2H2O) (Merck, Cat no. 5822880EM) added to 100 ml ddH2O and was mixed 
until dissolved. 18 ml of the first solution and 82 ml of the second solution was then 
mixed to obtain 75 mM, pH 7.4 phosphate buffer. The phosphate buffer was stored at 4 
°C and the pH of the solution was always re-checked for consistency before use. 
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Fluorescein sodium salt (C20H10Na2O5) (Sigma, Cat no. F6377) stock stored at 4 °C in a 
dark container consisted of 0.0225 g C20H10Na2O5 dissolved in 50 ml phosphate buffer. 
The 25 mg/ml peroxyl radical which is AAPH (2, 2'-Azobis (2-methylpropionamidine) 
dihydrochloride (Sigma Aldrich, Cat no. 440914). 0.5 M perchloric acid (PCA) 
(Saarchem, Cat no. 494612) which consists of 195 ml dH2O mixed with 15 ml 70% 
PCA and stored at RT. Trolox (Sigma Aldrich, Cat no. 238831) was used as a standard 
in this assay. The 500 µM Trolox stock standard solution was prepared by the addition 
of 0.00625 g 6-hydroxy-2,5,7,8-tetra-methylchroman-2-carboxylic acid (Sigma Aldrich, 
Cat no. 238831) to 50 ml phosphate buffer which was mixed until dissolved. The 250 
µM Trolox stock control comprised 0.00312 g 6-hydroxy-2,5,7,8-tetra-methylchroman-
2-carboxylic acid added to 50 ml phosphate buffer and was mixed until dissolved).  
 
2.2.4.3 Sample Preparation and Analysis 
The 20% Rf aqueous extract sample was directly used in the analysis. To avoid 
precipitates, the sample was centrifuged for 3 min at 4300.8 G (4000 rpm) and the 
supernatant was used in the analysis. All samples were stored at -40 °C. The Trolox 
stock standard concentrations were prepared (See Appendix A: Table 2.4) and 12 µl of 
the standard, control and sample was added (in triplicate) to designated wells, 
respectively. From the fluorescein stock solution, 10 µl was added into 2 ml phosphate 
buffer. This solution was then diluted as follows: 240 µl of the fluorescein-phosphate 
buffer mixture was added to 15 ml phosphate buffer. 138 µl of this diluted solution was 
added into each well. 6 ml of the phosphate buffer was added to the 25 mg/ml AAPH 
(prepared fresh) and was mixed well until dissolved. 50 µl of this solution was 
transferred to each well and the final volume of the assay was 200 µl. The plate was 
then read using a Multiskan™ plate reader with an excitation wavelength set at 485 nm 
and the emission wavelength at 530 nm. 
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2.2.5 ABTS (2,2’-azino-di-3-ethylbenzthialozine sulphonate) (TEAC) radical 
cation scavenging assay 
 
2.2.5.1 Principle  
This method was used to estimate antioxidant capacity based on scavenging of the 
ABTS+ radical cation, typically has bluish-green colour, by the antioxidants present in a 
sample. Antioxidants present in the reaction medium capture the free radical, which is 
translated into a loss of colour and therefore a reduction in absorbance. The latter 
corresponds quantitatively to the concentration of antioxidants present, thus a decrease 
in colour indicates a stronger antioxidant presence and vice versa (Zulueta et al., 2009). 
 
2.2.5.2 Chemicals Required for the ABTS (TEAC) assay  
The chemicals required for the ABTS assay included: 7mM ABTS (2,2’-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) diammonium salt (Sigma, Cat no. A1888) and 
140 mM potassium-peroxodisulphate (Merck, Cat no. 105091) using dH2O. ABTS mix 
was prepared 24 hrs before starting the assay in a dark room as follows: 88 µl of 
potassium-peroxodisulphate solution was added to 5 ml ABTS and was mixed well. 
Trolox was used as a standard in this assay. The 1 mM Trolox stock standard was 
prepared as follows: 0.0125 g Trolox was added to 50 ml of EtOH. The 200 µM Trolox 
stock control was comprised of 0.0025 g Trolox dissolved in 50 ml of EtOH. Both 
Trolox stock standard and control was prepared on the day of analysis.  
 
2.2.5.3 Sample Preparation and Analysis 
The 20% Rf aqueous extract sample was directly used in the analysis. To avoid 
precipitates, the sample was centrifuged for 3 min at 4300.8 G (4000 rpm) and the 
supernatant was used in the analysis. Preparation of the sample was done on ice 
throughout the whole procedure. All samples were stored at -40 °C. The Trolox stock 
standard concentrations were prepared (See Appendix A: Table 2.5) and 25 µl of the 
standard, control and sample was added (in triplicate) to designated wells, respectively. 
The ABTS mix solution was diluted as follows: 1 ml ABTS mix was added and mixed 
with 20 ml EtOH which read an absorbance of approximately 2 (±0.1). Of this diluted 
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ABTS mix, 300 µl was added to each well. The plate was then left for 30 min at RT 
before taking a reading. The plate was read using a Multiskan™ plate reader at 734 nm 
with a temperature set to 25 °C. 
 
2.2.6 Ferric Reducing Antioxidant Power (FRAP) assay  
 
2.2.6.1 Principle 
The FRAP assay uses antioxidants as reductants in a redox-linked colorimetric method, 
employing an easily reduced oxidant present. At low pH, reduction of a ferric 
tripyridyltriazine (Fe3-TPTZ) complex to the ferrous form, results in an intense blue 
colour. The reaction is non-specific, in that any half-reaction that has a lower redox 
potential than that of the ferric or ferrous half-reaction will drive the ferric (Fe3+) to 
ferrous (Fe2+) reaction. The change in absorbance is therefore directly related to the 
reducing power of the antioxidants present in the reaction mixture (Benzie and Strain, 
1996). 
 
2.2.6.2 Chemicals Required for the FRAP assay 
The chemicals necessary to perform the FRAP assay included: acetate buffer 300 mM, 
pH 3.6 comprised of 1.627 g sodium acetate and 16 ml glacial acetic acid which was 
made up with dH2O to 1 litre. 40 mM HCl and 10 mM TPTZ (2, 4, 6-tri [2-pyridyl]-s-
triazine) (Sigma, Cat no. T1253) comprised of 0.0093 g TPTZ and 3 ml of 40 mM HCl. 
20 mM iron (III) chloride hexahydrate (FeCl3.6H2O) (Sigma, Cat no. F2877) which was 
comprised of 0.054 g FeCl3.6H2O and 10 ml dH2O L-ascorbic acid (Sigma, Cat no. 
A5960) was used as a standard in this assay. The 1 mM L-ascorbic acid stock standard 
solution was prepared as follows: 0.0088 g ascorbic acid was weighed and dissolved in 
50 ml dH2O. The 400 µM L-ascorbic acid stock control was prepared as follows: 
0.00352 g ascorbic acid was added to 50 ml dH2O and mixed until dissolved. All 
solutions were prepared on the day of analysis. 
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2.2.6.3 Sample Preparation and Analysis 
The 20% Rf aqueous extract sample was directly used in the analysis. To avoid 
precipitates, the sample was centrifuged for 3 min at 4300.8 G (4000 rpm) and the 
supernatant was used in the analysis. All samples were stored at -40 °C. The straw-
coloured FRAP reagent was prepared in a 50 ml conical tube which contained the 
following reagents: 30 ml Acetate buffer, 3 ml TPTZ solution, 3 ml iron chloride 
solution, and 6.6 ml dH2O. The ascorbic acid stock standard concentrations were 
prepared (See Appendix A: Table 2.6) and 10 µl of the standard, control and sample 
was added (in triplicate) to designated wells, respectively. Moreover, 300 µl of the 
FRAP reagent was then added to each well with a multichannel pipette and the final 
volume of the assay was 310 µl. The plate was incubated for 30 min in an incubating 
oven set at 37 °C. The plate was then read using a Multiskan™ plate reader at 593 nm. 
 
2.3 Experiments Performed on the Blood-Brain Brain (bEnd5) Model  
 
2.3.1 Chemicals Required for In Vitro Analysis  
The following reagents were required for in vitro analysis: 10 % fetal bovine serum 
(FBS) (Whitehead Scientific (Pty) Ltd, Cat no. DE 14-801 FI), 1 % non-essential amino 
acids (NEAA) (Whitehead Scientific (Pty) Ltd, Cat no. BE 13-114E), 1 % antibiotic 
Penicillin-Streptomycin Amphotericin B mixture (Whitehead Scientific (Pty) Ltd, Cat 
no. 17-745E), 1 % sodium pyruvate (Whitehead Scientific (Pty) Ltd, Cat no. BE 13-
115E), 500 ml Dulbecco’s modified eagle medium (DMEM) (Whitehead Scientific 
(Pty) Ltd, Cat no. BE 12-719F). Mouse brain endothelial (bEnd5) cell line (Highvelt 
Biological, agents for ATCC), 0.25% trypsin (Whitehead Scientific (Pty) Ltd, Cat no. 
BE 02-007E), phosphate buffer serum (PBS) (Sigma, Cat no. D8662), trypan blue 
(Sigma Cell Culture Reagents®, T-8154), fermented rooibos (Rf) (South African 
Rooibos Council, Batch no. P06/02KK), pure methamphetamine (MA) (Sigma Aldrich, 
CAS no. 51-57-0), 20 µl MTT (5 mg/ml) (Promega, Cat no. G4000), cell proliferation 
kit XTT II (Roche Products (Pty) Ltd, Cat no. 11465015001), 500 nM hydrocortisone 
(Sigma, Cat no. H0888), 500 µl dimethyl Sulfoxide (Whitehead Scientific (Pty) Ltd, Cat 
no. sc-358801), 70% EtOH (Saarchem, Cat no. 2233540 LP), RNase (20 mg/ml) 
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(Invitrogen life technologies, Cat no. 12091-039), propidium iodide (PI) (Fluka, CAS 
no. 25535-16-14).   
 
2.3.2 Mouse Brain Endothelial (bEnd5) Cell Culturing 
 
2.3.2.1 Principle 
The in vitro analysis made use of cell culturing which produces a 2-dimensional cell 
growth with gene expression signaling that is advantageous in being more quantifiable. 
It allows for the development of optimized culture conditions, initially for cell 
proliferation but ultimately for functional expression (Freshney et al., 2007; Souza et 
al., 2010). By removing and subculturing from the in vivo host, the cultured cells 
portray events that would ultimately occur in that in vivo setting. Endothelial cells are 
the core component of the BBB and our model uses an established brain endothelial cell 
line namely mouse brain endothelial (bEnd5) cells. The bEnd5 cells display both 
morphological (ECs comprise of different vascular beds or undergo different vascular 
processes which employs a myriad of mechanisms) and functional characteristics (the 
barrier properties of these specialized ECs notably depend on TJs between adjacent 
cells) of cells in the in vivo state. These cells are grown on cellulose membrane (insert) 
which mimics the in vivo basement membrane where the apical compartment of the 
bicameral chamber represents the circulatory environment (blood) and the basolateral 
compartment (brain parenchyma) is represented by the well.  
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Figure 2 The BBB model and its closely related in vivo BBB components. A The bicameral 
chamber consisting of the well and insert which represent the basolateral and apical 
compartments, respectively (http://www.biocompare.com/Editorial-Articles/147111-Cells-on-
the-Go-Cellular-Migration-Assays/). B The major components of the in vivo BBB: endothelial 
cells, pericytes and astrocytes (http://home.szbk.u-szeged.hu/~krizbai/index.html). C The 
endothelial TJ proteins in the paracellular compartment of adjacent ECs (http://imgarcade.com/ 
1/junction-proteins/). 
 
2.3.2.2 Method 
The Tissue Culture medium (complete medium) was supplemented by adding 10% 
FBS, 1% NEAA, 1% antibiotic Penicillin-Streptomycin Amphotericin B mixture and 
1% sodium pyruvate to 500 ml DMEM as previously described (Reiss et al., 1998). The 
mouse brain endothelial (bEnd5) cell line was removed from the liquid nitrogen store 
and thawed. Cells were centrifuged for 5 min at 268.8 G (1000 rpm) at RT and the top 
was wiped off with 70% ethanol. The supernatant was then discarded. The cell pellet 
was re-suspended in 1 ml complete medium and then transferred to a 25 cm2 tissue 
culture treated (TC) flask containing the desired amount of complete medium. 
Incubation at 37 ºC then proceeded and the cell cultures were checked after 24 hrs to 
ensure attachment, using the Inverted Phase Contrast Microscope. 
 
After attachment, the medium was poured off and 2-3 ml PBS were used to rinse the 
attached cells. The PBS was then aspirated. Trypsin (1 ml of 0.25%) was added which 
dislodges the attached cells from the TC flask surface (Huang et al., 2010) and 
incubated at 37 ºC for 10-15 min, after which 1 ml of medium (the same volume as 
trypsin added in the previous step) was added. The dislodged cells were then aspirated 
Pericyte
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into a 15 ml conical tube and centrifuged at 1680 G (2500 rpm) for 5 min at RT. After 
centrifuging, the supernatant was poured off and the desired amount of medium was 
then added to the cell pellet and re-suspended. A cell count was done using trypan blue 
in order to seed the required amount of cells necessary for the selected assays. For each 
assay, the cells were seeded and allowed to attach for 24 hrs. The cells were exposed to 
selected concentrations of MA and Rf which was made up following suitable dilutions 
(MA: 10-fold and Rf: 2-fold dilutions) using complete medium from a 20% Rf and 
99.9% MA stock, respectively.  
 
2.3.3 Trypan Blue Exclusion assay 
 
2.3.3.1 Principle 
Trypan Blue is a carcinogenic dye used to determine the amount of viable cells present 
in a sample. It does so by non-viable cells absorbing the trypan blue due to their non-
selective permeability, whereas viable cells will not absorb the dye, thus when viewed 
under a light microscope, non-viable cells were stained blue while viable cells were 
translucent and fluoresce (Mascotti et al., 2000). 
 
2.3.3.2 Method 
Cells were seeded at 5 x 104 cells per ml/35 mm petri dishes (n = 5, day = 0) . Selected 
MA concentrations (0.1, 1, 10, 100, 1000 µM) and Rf concentrations (1, 0.5, 0.25, 
0.125, 0.0625 and 0.05%) were added (day = 1), respectively. In addition, the cells were 
also exposed to a combination of MA (0.1, 1, 10 and 100 µM) and Rf (0.05 and 0.1%). 
The Rf concentrations used in the combinations were selected based on the viability 
results after Rf exposure. After 24 hr (only) exposure to the compounds, the cells were 
incubated at 37 ºC, 5% carbon dioxide (CO2). Results were recorded at 24, 48, 72 and 
96 hrs. An established ratio of cells, trypan blue dye and complete medium was used to 
determine cell viability (0.4% trypan blue was made up in isotonic buffer i.e. PBS, pH 
7.2 to 7.3). Since trypan blue results in cell death after prolonged exposure, the cells 
were added last to the complex. This was followed by the addition of 10 µl to the 
appropriate sections on the Neubauer hemocytometer and observed under an Inverted 
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Phase Contrast Microscope (Zeiss) for cell counts. The following equation was used in 
order to determine % cell viability: 
 Cell Viability (%) = Number of unstained (live) cellsTotal number of (live and dead) cells  x 100 
 
2.3.4 3-(4, 5-Dimethylthiazol-2-YI)-2, 5 Diphenyltetrazoium Bromide (MTT) 
Viability assay 
 
2.3.4.1 Principle 
The 3-(4, 5-Dimethylthiazol-2-YI)-2, 5 Diphenyltetrazolium Bromide (MTT) assay is a 
colorimetric assay that makes use of the water-soluble, yellow MTT dye which is 
converted to water-insoluble, purple formazan derivative by mitochondrial 
dehydrogenases via reduction cleavage of the tetrazolium ring in living cells. The 
formazan product is impermeable to the cell membranes and therefore accumulates in 
healthy cells. The intensity of the colour is directly proportional to the amount of viable 
cells or metabolic activity present (Edmondson et al., 1988; Lappalainen et al., 1994; 
Fotakis and Timbrell, 2005; Funk et al., 200,). 
 
2.3.4.2 Method 
A 96-well flat bottomed, clear microtiter plate was seeded with 2 x 103 cells/well (n = 5, 
day = 0) and exposed to the selected concentrations (as per trypan blue viability assay) 
of MA (day = 1) which was followed by incubation for 24, 48, 72 and 96 hrs at 37 ºC, 
5% CO2. The cells underwent both 24 hr and daily exposure to the compound with the 
addition of 2000 and 3000 µM for once-off exposure only. After incubation, 20 µl MTT 
(5 mg/ml) were added and the plate was re-incubated for 2 hrs at 37 ºC, 5% CO2. The 
plate was then read at 490 nm on a microtiter plate reader (Glomax, Promega). 
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2.3.5 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide (XTT) Viability assay 
 
2.3.5.1 Principle 
The XTT assay is a colorimetric assay where viable cells reduce the tetrazolium salt 
2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) to an 
orange-coloured water-soluble formazan product. This assay makes use of an electron 
coupling agent for optimal formazan yield. Mitochondrial succinate dehydrogenase, 
cytochrome P450 and flavoprotein oxidases contribute to the formation of the formazan. 
The formazan is quantified photometrically and correlates with the number of viable 
cells (Altman, 1976; Stevens and Olsen, 1993; Funk et al., 2007; Smith and Hunter, 
2008). 
 
2.3.5.2 Method 
Cells were seeded at 2 x 103 cells/well  in a 96-well flat bottomed (n = 5, day = 0), clear 
microtiter plate. The cells were then exposed to MA (0.1, 1, 10, 100, 1000 µM) Rf and 
(0.1, 0.05, 0.025%, 0.0125, 0.00625 and 0.003125%). In addition, the cells were also 
exposed to a combination of MA (0.1, 1, 10, 100 µM) and Rf (0.05 and 0.1%) 
concentrations. Care was taken to control for false positives resulting from the 
concentrations of Rf used in this particular experiment. The cells underwent both 24 hr 
and daily exposure to the compounds with the exception of MA exposure which was 
only daily. After the compound exposure, the plate was incubated at the selected time 
intervals as per MTT assay protocol. Reconstituted XTT (50 µl) was added to each well 
and further incubated for 4 hrs at 37 ºC, 5% CO2. The plate was then read at 450 nm on 
a microtiter plate reader. The following equation was used in order to determine % cell 
viability for both the MTT and XTT viability assay: 
 Cell Viability (%)  = Experimental absorbance (abs)−  Experimental media absControl abs− Control media abs  
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2.3.6 Transendothelial Electrical Resistance (TEER) 
 
2.3.6.1 Principle 
Using an Ohm Millicell-Electrical Resistance System (ERS) ®, the integrity of the cell 
membrane is assessed (Verma et al., 2009) by measuring electrical resistance across a 
cell monolayer in vitro in order to investigate changes in resistance and transendothelial 
permeability. It qualitatively measures cell monolayer health and quantitatively 
measures cell confluence across an in vitro monolayers. Furthermore a decrease in 
TEER is inversely proportional to an increase in paracellular permeability of tight 
junction indicators and vice versa (Konsoula and Barile, 2007). 
 
2.3.6.2 Method 
Cells were seeded  at a density of 1x106 cells/matrigel coated, Millicell inserts (Bio-
Smart Scientific, Cat no. 35024) in a 24-well flat bottomed, clear microtiter plate (n = 4, 
day = 0) and incubated at 37 ºC, 5% CO2. The ranges of MA (0.1, 1, 10 and 100 µM) 
and Rf (0.1, 0.05, 0.025, 0.0125 and 0.00625%) concentrations (respectively) were 
added in the presence of 500 nM hydrocortisone which was dissolved in 500 µl 
dimethyl sulfoxide to the cells as described (Hoheisel et al., 1998; Schrot et al., 2005). 
Cells were also exposed to a combination of MA (0.1, 1, 10 µM) and Rf (0.05 and 
0.1%) concentrations. The cells were exposed to the compounds daily. TEER for cell 
monolayers was measured every 3 hrs with the Millicell electrical resistance system 
(Millicell®-ERS, Millipore), for 24, 48, 72, 96, 120, 144 hrs. Cell measurements were 
recorded 3 times/day.  
 
The resistance mode of the voltohmeter was used for measurements. In brief, the short 
electrode was immersed in the apical compartment (insert) while the long electrode was 
immersed in the basolateral compartment (well of the plate). Care was taken to avoid 
contact with cells growing on the membrane to prevent piercing the cell monolayer and 
insert membrane, thus creating an open circuit. The resistance was then measured and 
recorded. Resistance measurements were corrected by subtracting the resistance reading 
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of the blank wells (inserts without cells) from the experimental wells (insert with cells). 
These measurements were further standardized for the surface area of the insert. 
 
2.3.7 Flow Cytometry: Cell Cycle Analysis 
 
2.3.7.1 Principle 
This method is used to determine cell repartition in the various cell cycle phases and 
allows for the accurate determination of drugs effects in the cycle. Furthermore, it is 
performed using propidium iodide which is used for nuclear staining. The fluorescence 
emitted is proportional to the DNA content present in the cells, provided that RNA has 
been removed (Jayat and Ratinaud, 1993; Riccardi and Nicoletti, 2006). 
 
2.3.7.2 Method 
Cells were seeded at 5 x 105 cells/25 cm2 TC flasks (n = 3, day = 0) and incubated 
overnight at 37 °C, 5% CO2. The cells were the exposed (day = 1) to selected 
concentrations of MA (0.1, 1 and 10µM), Rf (0.1 and 0.05%), and combinations of the 
latter compounds for 24 hrs (once-off) only. This was followed by incubation for 24, 
48, 72, 96, 120 and 144 hrs at 37 °C, 5% CO2. The cells were exposed to the 
compounds for only 24 hrs (once-off). At the respective time interval, the medium was 
aspirated into 15 ml centrifuge tubes. The cells were then washed with 1 ml PBS and 
the PBS transferred into the respective centrifuge tubes. Trypsin (0.5 ml of 0.25%) was 
added to the flasks followed by incubation for 15 min at 37 °C, 5% CO2. To neutralize 
the cells, 1 ml complete medium was added and the suspension transferred to the 
conical tubes followed by centrifuging for 5 min at 268.8 G (1000 rpm). The 
supernatant was poured of and the pellet resuspended in 2 ml medium followed by a cell 
count using trypan blue for each sample. EtOH (70%) was added to a final volume of 10 
ml and stored at -20 °C for a minimum of 2 hrs. 
 
2.3.7.3 Cell Cycle Analysis by Propidium Iodide Staining 
On the day of the analysis, the cells were centrifuged for 5 min at 268.8 G (1000 rpm) 
and the supernatant was carefully removed leaving approximately 1 ml EtOH. The cells 
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were re-centrifuged for 1 min at 268.8 G (1000 rpm) and most of the remaining EtOH 
was removed without disturbing the pellet. PBS (1 ml) was added and centrifuged for 1 
min at 268.8 G (1000 rpm) followed by the removal of the PBS. The latter step was 
repeated. RNase (20 mg/ml) diluted in PBS at a ratio of 1: 199 was prepared and the 
required volume (50 µl/5 x 105 cells) added and incubated at RT for 30 min or at 37 °C, 
5% CO2 for 15 min. PI staining solution was made up (1 mg/ml) and added (450 µl/5 x 
105 cells) 20 min prior to analysis. The samples were analysed using the Becton 
Dickinson FACS (fluorescence activated cell sorter) Calibur flowcytometer with a 488 
nm Argon laser. Each analysis was based on 10 000 events and the software used for the 
acquisition of the data was Cellquest Pro version 5. 2. 1. The cell population was 
identified and gated (R1) on a forward scatter (FSC) vs. side scatter (SSC) dot plot in 
acquisition mode. Fluorescent Channel 2 (FL2) at 575 nm was used for PI detection. A 
dot plot of FL2A (area) vs. FL2W (width) was used to identify single cells (R2) and 
thus eliminate doublets. A histogram plot of FL2A was used to enumerate G1/G0, S-
phase and G2/M populations. The combined parameters of FSC, SSC, FL2A and FL2W 
displayed the results. A threshold of 53 on the FSC channel was set to remove sample 
debris. Nile Red fluorescent particles were used for instrument standardization, stability 
and reproducibility. Analysis of the results was performed using Modfit version 2.0 
software (Verity Software House). 
 
2.4 Statistical Analysis 
Statistical analysis of the data yielded was done using the MedCalc (version 11.5.1) 
program (Medcalc Software Company). Normality was determined using the 
Kolmogorov-Smirnov test followed by use of the Wilcoxon Rank Sum test for not-
normally distributed paired samples. Outliers were statistically determined using the 
Box-and-Whisker plot and removed prior to determining significance, where P<0.05 
was denoted as being significantly different. 
 
43 
 
 
 
 
 
CHAPTER 3 
 
3 Results 
 
3.1 The Effects of Methamphetamine on bEnd5 Cells 
 
3.1.1 Effects of 24 hr-MAE on Cell Numbers using the Trypan Blue Exclusion 
Method 
  
 
Figure 3.1 Live cell number in response to 24 hr exposure of selected MA concentrations and 
time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in live cell 
number are denoted with * whereas significant decreases are denoted with #. 
 
From 24 to 72 hrs, exposure of the cells to MA significantly increased cell growth 
(P≤0.0495) coupled with biphasic growth expressions at the latter time intervals. In 
contrast, at 96 hrs, exposure to the entire range of MA concentrations resulted in 
significant growth suppression (P≤0.0399). Specifically, significant increases in the live 
cell numbers were observed at 0.1, 1 and 10 µM (P≤0.0143) after 24 hr exposure. 
Exposure to all MA concentrations at 48 hrs resulted in an increase in cell numbers 
(P≤0.0253). The intermediate concentrations resulted in elevated cell growth at 72 hrs 
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(P≤0.0495). Exposure to 10 µM MA at both 48 (15.52±2.11 live cell no.) and 72 hrs 
(46.66±5.00 live cell no.) resulted in the highest increase in comparison to their 
controls. At 96 hrs a significant decrease in cell numbers was observed when exposed to 
all MA concentrations (P≤0.0339). Moreover, 1 µM MA at the 96 hr time period 
significantly decreased (P=0.0253) the cell numbers to approximately half (59.90±4.06 
live cell no.) that of the controls (119.22±5.35 live cell no.). In addition, no dose-
response trend was observed at 96 hrs (See Figure 3.1 and Appendix B: Table 3.2). 
 
3.1.2 Effects of 24 hour-Methamphetamine-Exposure (24 hr-MAE) on Cell 
Viability (%) using the Trypan Blue Exclusion Method  
 
 
Figure 3.2 Cell Viability (%) in response to 24 hr exposure of selected MA concentrations and 
time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #. 
 
Exposure to different concentrations of MA resulted in no statistical significant 
differences in cell viability from the controls for all MA exposed concentrations across 
all the time intervals. This, therefore, illustrated a non-toxic effect in response to the 
selected MA concentrations as seen with an overall cell toxicity of <5.22% (cell toxicity 
was determined by expressing the dead cell numbers over an entire (live and dead cells) 
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population). Furthermore, the non-toxic effect was also clearly demonstrated at 96 hrs 
(See Figure 3.2 and Appendix B: Table 3.3). 
 
3.1.3 Effects of 24 hr-MAE on Cell Viability (%) using the Reduced Formazan 
Method (Observing Metabolic Activity) 
 
 
Figure 3.3 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of selected 
MA concentrations and time. Results are expressed as mean ± SEM (n=5). Controls were 
normalized to 100% and experimental groups expressed relative to controls. Significant 
(P<0.05) increases in cell viability are denoted with * whereas significant decreases are denoted 
with #. 
 
The functional state of MA is a reflection of the viability of a cell. The XTT assay 
measures the mitochondrial state by evaluating the mitochondrial dehydrogenase 
(MDH) activity, thus by definition viability will therefore be referred to as MDH 
activity. MA exposure at 24 hrs resulted in no statistical significant differences in 
viability when compared to the controls. At 48 hrs, small statistical significant decreases 
in MDH activity were observed after exposure to 100 and 1000 µM MA (P ≤0.0105). 
However, when exposed to the range of 0.1-2000 µM MA at 72 hrs, a marked elevation 
in MDH activity (P≤0.0463) was observed (with the exception of 100 µM). The highest 
0
20
40
60
80
100
120
140
160
180
24 48 72 96
%
 M
ito
ch
on
dr
ia
l D
eh
yd
ro
ge
na
se
 A
ct
iv
ity
Time (Hrs)
Ctrl
0,1
1
10
100
1000
2000
3000
#
#
*
*
#
# #
µM
46 
 
 
 
 
 
viability (150.51±1.09%) across all time intervals was observed at 10 µM MA at 72 hrs. 
At 96 hrs, a significant decline was observed in response to the lowest (P=0.0071) MA 
concentrations. The lowest viability across all time intervals was also observed at 96 hrs 
(36.60±10.97%). Exposure to 3000 µM MA resulted in consistently lower viability than 
all selected concentrations for all time intervals (P≤0.0105) (See Figure 3.3 and 
Appendix B: Table 3.4). 
 
3.1.4 Effects of Daily-MAE on Cell Viability (%) using the Reduced Formazan 
Method (Observing Metabolic Activity) 
 
 
Figure 3.4 Mitochondrial dehydrogenase activity (%) in response to daily exposure of selected 
MA concentrations and time. Results are expressed as mean ± SEM (n=5). Controls were 
normalized to 100% and experimental groups expressed relative to controls. Significant 
(P<0.05) increases in cell viability are denoted with * whereas significant decreases are denoted 
with #. 
 
There were no statistical differences observed at 24 hrs when comparing the MA-
exposed cells to the control (as was observed with the once-off (24 hr) exposure). At 48 
hrs, a small statistically significant increase in viability was observed at 100 µM MA 
(P=0.0028). At 72 and 96 hrs, exposure to the entire range of MA resulted in a 
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statistically significant decrease (P≤0.0063) in viability. The highest concentration of 
MA resulted in the lowest viability ((P≤0.0463) for all timelines except at 24 hrs. The 
lowest viability across all time intervals was observed at 96 hrs (47.47±0.24%). When 
comparing the cell viability in response daily exposure to that of once-off, suppression 
was observed at both 72 and 96 hrs as opposed to suppression displayed occurring at 
only 96 hrs with once-off exposure (See Figure 3.4 and Appendix B: Table 3.5). 
 
3.1.5 Effects of Daily-MAE on Monolayer Electrical Resistance (TEER) 
 
 
Figure 3.5 Transendothelial electrical resistance in response to daily exposure of selected MA 
concentrations and time. Results are expressed as mean ± SEM (n=4). Significant (P<0.05) 
increases in TEER are denoted with * whereas significant decreases are denoted with #. 
 
The permeability across the monolayer was analysed by measuring the electrical 
resistance across this monolayer. Increases in electrical resistance indicated a decrease 
in permeability across the monolayer whereas a decrease would indicate an increase in 
permeability. Dose-dependent increases (P≤0.0302) were observed across all time 
intervals after exposure of the cells to MA. The highest MA concentration (100 µM) 
resulted in the highest electrical resistance (P≤0.0068) across all time intervals with 
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exception to 24 and 72 hrs where exposure to 100 µM MA resulted in decreased 
resistance (P≤0.0432) at 72 hrs. In addition, the lowest MA concentration (0.1µM) 
resulted in the lowest TEER (P≤0.0064) across all time intervals with exception to 96 
hrs. The highest TEER reading was observed at 96 hrs (24.96±0.56 Ω.cm2) and the 
lowest at 48 hrs (14.23±0.30 Ω.cm2) when exposed to 100 and 0.1 µM, respectively. 
Thus, there permeability of the monolayer was increased by the lowest MA 
concentrations with exposure to the higher concentrations resulting in a less permeable 
monolayer (See Figure 3.5 and Appendix B: Table 3.6). 
 
3.1.6 Effects of Methamphetamine Exposure on bEnd5 Cell Cycles 
The flow cytometry analysis is depicted from a profile of cell cycle phases of a 
population of cells at a predefined point of time. 
  
3.1.6.1 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 24 hours 
 
 
Figure 3.6 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 24 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA.  
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Figure 3.7 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 24 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
Majority of the cells for both controls and exposed cells were detected in the G1-phase 
(≥45.19±2.40%) while the least amount of cells was observed in the G2-M phase 
(≤9.99±5.00%), at 24 hrs. In addition, a significant decrease (P<0.0495) was observed 
when exposed to 0.1 µM MA in G1-phase which also resulted in an increase 
(P<0.0495) in the S-phase. Significant decreases (P≤0.0317) were displayed at 1 µM 
MA in both the G2-M- and S-phase. Despite the small statistical significant differences, 
the data depicts a normal profile of cell division (See Figure 3.6 and 3.7, Appendix B: 
Table 3.7 and Appendix F). 
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3.1.6.2 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 48 hours 
 
 
Figure 3.8 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 48 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA.  
 
 
Figure 3.9 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 48 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
More than 50% of the controls and MA-exposed cells were detected in the G1-phase at 
48 hrs. The lowest numbers were detected in the G2-M phase (≤10.75±3.13%). In 
addition, significant increases (P≤0.0430) were observed in the G-phase when cell were 
exposed to 0.1 and 10 µM MA. The lowest MA concentration also resulted in a 
decrease (P=0.0356) in S-phase. Significant decreases (P≤0.0440) in the G2-M phase 
occurred at 1 and 10 µM. Despite the small statistical significant differences, the data 
0
10
20
30
40
50
60
70
80
90
100
G1 S G2-M
R
el
at
iv
e C
el
l N
o.
 (%
)
Cell Cycle Phases
Ctrl
0.1
1
10
#
*
*
#
µM
51 
 
 
 
 
 
depicts a normal profile of cell division (See Figure 3.8 and 3.9, Appendix B: Table 3.8 
and Appendix G). 
 
3.1.6.3 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 72 hours  
 
 
Figure 3.10 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 72 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA.  
 
 
Figure 3.11 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 72 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
At 72 hrs, G1-phase contained the most cells (≥52.71±3.06%) with the least cells 
observed in the G2-M phase (≤12.22±8.34%). Exposure to 0.1 µM MA resulted in a 
marked increase (P=0.0186) and decrease (P=0.0264) in the G1- and S-phase. The 
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intermediate concentration displayed a marked decrease (P=0.0498) in the G2-M phase. 
Despite the small statistical significant differences, the data depicts a normal profile of 
cell division (See Figure 3.10 and 3.11, Appendix B: Figure 3.9 and Appendix H). 
 
3.1.6.4 Effects of 24 hr-MAE on bEnd5 Cell Cycles at 96 hours  
 
 
Figure 3.12 Histograms illustrating cell cycle results after 24 hr exposure to selected MA 
concentrations at 96 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.1 µM MA. C Exposure to 1 µM MA. D Exposure to 10 µM MA.  
 
 
Figure 3.13 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected MA concentrations at 96 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
The G1 phase at 96 hrs had the highest amount of detected cells (≥60.66±6.65). The 
lowest numbers were detected in the G2-M phase (≤7.70±2.00). In the G1-phase, 1 and 
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10 µM displayed significant increases (P≤0.0299) in % relative cell numbers whereas 
only 1 µM resulted in the decreases at both the S- (P=0.0299) and G2-M-phases 
(P=0.0239) when compared to controls. Moreover, a dose-dependent increase was 
observed in the G2-M phase. The data clearly suggests the accumulation of cells in the 
G1-phase thus, subsequently preventing entry into the S1- and G2-M phase at 96 hrs 
(See Figure 3.12 and 3.13, Appendix B: Table 3.10 and Appendix I). 
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3.2 The Effects of Fermented Rooibos Herbal Tea on bEnd5 Cells 
 
3.2.1 Chemical Analysis of Fermented Rooibos Extract 
 
Table 3.1Constituents present in the fermented A.linearis aqueous extract divided into A. 
Analysis for components with respect to standards, and B. Total antioxidant activity/property 
analysed with respect to standards. 
Analysis Performed 
Quantity expressed against standard 
Expressed as 
standard/aqueous Rf 
Expressed as 
standard/dried Rf 
A. Analysis for components with respect to 
standards 
Aspalathin 
 
 
Polyphenols 
 
 
Flavonols 
 
 
Flavanols 
 
 
B. Total antioxidant activity/property 
analysed with respect to standards 
 
ORAC 
 
 
ABTS (TEAC) 
 
 
FRAP 
 
 
 
 
mg/100ml 
21.30 
 
mg GAE/100ml 
1086.24 
 
mg QE/100ml 
90.96 
 
mg CE/100ml 
156.05 
 
 
 
 
 
µmol TE/100ml 
21148.92 
 
µmol TE/100ml 
4905.80 
 
µmol AAE/100ml 
7395.24 
 
 
 
mg/g 
1.07 
 
mg GAE/g 
54.34 
 
mg QE/g 
4.55 
 
mg CE/g 
7.80 
 
 
 
 
 
µmol TE/g 
1057.45 
 
µmol TE/g 
245.29 
 
µmol AAE/100g 
369.76 
GAE-Gallic acid equivalents, AAE-ascorbic acid equivalents, TE-Trolox equivalents, QE-quercetin 
equivalents, CE-catechin equivalents), FRAP-ferric reducing antioxidant power, ORAC-oxygen radical 
absorbance capacity, ABTS-2,2’-azino-di-3-ethylbenzthialozine sulphonate, TEAC-trolox equivalent 
antioxidant capacity.      
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Figure 3.14 The data obtained from high performance liquid chromatography analysis 
illustrated the large amount of Aspalathin at 16.024 mAU (Analysis performed by Oxidative 
Stress Research Centre, CPUT). 
 
Table 3.1 displays the constituents of the fermented A. linearis producing standardized 
information necessary for this study. Polyphenols as a group of compounds were 
expressed in terms of gallic acid equivalents yielding 1086.24 mg GAE/100 ml and 
54.34 mg GAE/g. The two flavonoid subgroups, flavonols and flavanols, are expressed 
in terms of catechin and quercetin, respectively. Flavonols yielded 90.96 mg CE/100 ml 
and 4.55 mg CE/g. Flavanols yielded 156.05 mg QE/100 ml and 7.80 mg QE/g. There 
was also 21.30 mg/100ml and 1.07 mg/g dihydrochalcone aspalathin detected in the 
sample (see also figure 3.17).  
 
The ABTS and ORAC analyses measured the antioxidant strength based on trolox 
equivalents resulting in 21148.92 µmol TE/100 ml and 1057.45 µmol TE/g for ORAC, 
and 4905.80 µmol TE/100ml and 245.29 µmol TE/g for ABTS/TEAC. FRAP results, 
expressed in terms of ascorbic acid equivalents were 7395.24 µmol AAE/100ml and 
369.76 µmol AAE/g. 
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3.2.2 Effects of 24 hr-RfE on Cell Numbers using the Trypan Blue Exclusion 
Method 
  
 
Figure 3.15 Live cell number in response to 24 hr exposure of selected Rf concentrations and 
time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in live cell 
number are denoted with * whereas significant decreases are denoted with #. 
 
A biphasic growth expression was observed after exposing the cells to an Rf range of 
0.0625-1% with small statistically significant increases observed (P≤0.0494) in 
response to all concentrations with exception to lowest Rf concentration (0.0625% Rf). 
In contrast, significant dose-dependent growth suppression (P≤0.0032) was observed at 
the remaining time intervals (48-96 hrs). At 48 hrs, a significant increase (P=0.0003) 
was observed at 0.0625%, coupled with decreases observed at 0.5% and 1% 
(P≤0.0015). The lowest concentration (0.0625%) resulted in an increase (P=0.0002) at 
72 hrs while 0.125 and 0.25% resulted in decreases (P≤0.0041). All Rf concentrations 
resulted in significant decreases (P≤0.0073) in cell numbers at 96 hrs in comparison to 
controls. Exposure to 1% Rf resulted in the greatest suppression (P≤0.0032) in contrast 
to the lowest concentration (0.0625%) at all time intervals (Figure 3.15 and Appendix 
C: Table 3.11). 
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3.2.3 Effects of 24 hour Fermented-Rooibos-Exposure (24 hr-RfE) on Cell 
Viability (%) using the Trypan Blue Exclusion Method  
 
 
Figure 3.16 Cell Viability (%) in response to 24 hr exposure of selected Rf concentrations and 
time. Results are expressed as mean ± SEM (n=5). Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #. 
 
Exposure of cells to all Rf concentrations resulted in cell viability similar to that of the 
controls across all the time intervals. This, as with exposure to the selected MA 
concentrations, illustrated a non-toxic effect in response to the selected Rf 
concentrations as seen with an overall cell toxicity of <2.47% (cell toxicity was 
determined by expressing the dead cell numbers over an entire (live and dead cells) 
population) (Figure 3.16 and Appendix C: Table 3.12). 
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3.2.4 Effects of 24 hr-RfE on Cell Viability (%) using the Reduced Formazan 
Method (Observing Metabolic Activity) 
  
 
Figure 3.17 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of selected 
Rf concentrations and time. Results are expressed as mean ± SEM (n=5). Controls were 
normalized to 100% and experimental groups expressed relative to controls. Significant 
(P<0.05) increases in cell viability are denoted with * whereas significant decreases are denoted 
with #. 
 
Rf exposure at 24 hrs resulted in a dose-dependent increase (P≤0.0030), however, these 
doses initially displayed suppressed MDH activity with the lowest concentrations 
(0.003125-0.0125% Rf) displaying the greatest suppression (P<0.0001). Exposure at the 
remaining time intervals resulted in small statistical significant elevation in MDH 
activity at 48 and 96 hrs (P≤0.0105) when compared to respective controls. Significant 
increases (P≤0.0105) in viability was observed in response to 0.003125-0.05% at 48 hrs 
coupled with a small statistical significant decrease at 0.1% (P=0.0071).  Similarly, the 
two lowest concentrations (0.003125 and 0.00625%) resulted in the significant 
increases (P≤0.0071) observed at 96 hrs. No significant differences were observed 72 
hrs (Figure 3.17 and Appendix C: Table 3.13). 
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3.2.5 Effects of Daily-RfE on Cell Viability (%) using the Reduced Formazan 
Method (Observing Metabolic Activity) 
  
 
Figure 3.18 Mitochondrial dehydrogenase activity (%) in response to daily exposure of selected 
Rf concentrations and time. Results are expressed as mean ± SEM (n=5). Controls were 
normalized to 100% and experimental groups expressed relative to controls. Significant 
(P<0.05) increases in cell viability are denoted with * whereas significant decreases are denoted 
with #. 
 
Dose-dependent increases (P≤0.0165) were observed at 24 and 48 hrs however, these 
doses initially displayed suppressed MDH activity when the cells were exposed to the 
Rf range of 0.003125-0.1%, with the lowest concentration displaying the greatest 
suppression (P≤0.0165) (as seen with 24 hr-RfE). A small statistically significant 
increase (P<0.0001) was also observed at 48 hrs after exposure to 0.025% Rf. 
Furthermore, at 72 and 96 hrs, exposure to Rf resulted in no statistical significant 
differences with significant decreases (P≤0.0188) occurring at only 96 hrs when 
exposed to the higher Rf concentrations (0.025, 0.05 and 0.1%). The highest viability 
(129.43±10.88) was observed at 48 hrs when exposed to 0.05% and the lowest viability 
(61.19±7.58) was observed at 96 hrs when exposed to 0.1% Rf (Figure 3.18 and 
Appendix C: Table 3.14). 
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3.2.6 Effects of Daily-RfE on Monolayer Electrical Resistance (TEER)  
 
 
Figure 3.19 Transendothelial electrical resistance in response to daily exposure of selected Rf 
concentrations and time. Results are expressed as mean ± SEM (n=4). Significant (P<0.05) 
increases in TEER are denoted with * whereas significant decreases are denoted with #. 
 
Exposure of the cells to an Rf range of 0.00625-0.1% at 24 hrs resulted in a dose-
dependent increase (P≤0.0167) in resistance with the lowest concentration (0.00625% 
Rf) displayed the lowest TEER (P≤0.0100) and the highest concentration (0.1% Rf) 
displaying the highest TEER (P≤0.0001). However, despite observing a lower TEER, it 
was consistently greater than the controls. The significant dose-related trend was also 
observed at 72 (P≤0.0100) and 120 hrs (P≤0.0071). On the alternative days, a 
statistically significant flat-increase (P≤0.0418) was observed with a small statistical 
significant decrease (P=0.0418) in TEER observed at 96 hrs, at only 0.05% Rf (Figure 
3.19 and Appendix C: Table 3.15). 
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3.2.7 Effects of Fermented Rooibos Exposure on bEnd5 Cell Cycles 
 
3.2.7.1 Effects of 24 hr-RfE on Cell Cycles at 24 hours  
 
 
Figure 3.20 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 24 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf. 
 
 
Figure 3.21 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected Rf concentrations at 24 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
The highest cell numbers for both controls and exposed cells were observed in the G1-
phase (≥55.79±3.29%) while the least amount of cells were observed in the G2-M phase 
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(7.47±4.20%) at 24 hrs. In addition, significant increases (P≤0.0031) were observed at 
G2-M phase when exposed to both Rf concentrations in comparison to controls. Despite 
the small statistical significant differences, the data depicts a normal profile of cell 
division (See Figure 3.20 and 3.21, Appendix C: Table 3.16 and Appendix J).  
 
3.2.7.2 Effects of 24 hr-RfE on Cell Cycles at 48 hours  
  
 
Figure 3.22 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 48 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf. 
 
 
Figure 3.23 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to Rf 
selected concentrations at 48 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
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The G2-M phase displayed the least amount of cells detected (≤7.62±1.87%) with the 
most cells detected at the G1 phase (≥73.18±2.26%). Moreover, significant increases 
(P≤0.0356) were observed at G2-M phase when exposed to both Rf concentrations in 
comparison to controls. As with 24 hrs, the small statistical significant differences, the 
data depicts a normal profile of cell division (See Figure 3.22 and 3.23, Appendix C: 
Table 3.17 and Appendix K). 
 
3.2.7.3 Effects of 24 hr-RfE on Cell Cycles at 72 hours  
  
 
Figure 3.24 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 72 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf. 
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Figure 3.25 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected Rf concentrations at 72 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
The most cells were recorded in the G1-phase (≥ 52.71±3.06%) and the least in the S-
phase (≤3.82±1.59%). Exposure to 0.05% Rf resulted in a marked increase (P=0.0062) 
and decrease (P=0.0087) in the G1- and S-phase, respectively. The data depicts a 
normal profile of cell division despite the small statistical significant differences (See 
Figure 3.24 and 3.25, Appendix C: Table 3.18 and Appendix L).  
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3.2.7.4 Effects of 24 hr-RfE on Cell Cycles at 96 hours  
 
 
Figure 3.26 Histograms illustrating cell cycle results after 24 hr exposure to selected Rf 
concentrations at 96 hrs using flow cytometry (≥ 10 000 events analysed). A Control. B 
Exposure to 0.05% Rf. C Exposure to 0.1% Rf. 
 
 
Figure 3.27 Relative cell numbers (%) at distinct phases of the cell cycle after exposure to 
selected Rf concentrations at 96 hrs. Results are expressed as mean ± SEM (n=3). Significant 
(P<0.05) increases in relative cell no. are denoted with * whereas significant decreases are 
denoted with #. 
 
At 96 hrs, G1-phase had the highest relative cell numbers (≥86.41±0.13), with the S-
phase having the least (≤33.04±7.34%). Exposure to both Rf concentrations resulted in a 
marked increases (P≤0.0158) and decreases (P≤0.0240) in the G1- and S-phase, 
respectively. A normal cell division profile was not observed at 96 hrs since the cells 
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have accumulated in the G1-phase preventing DNA synthesis as seen with S-phase cell 
population suppression (See Figure 3.26 and 3.27, Appendix C: Table 3.19 and 
Appendix M).  
 
3.3 Effects of the Methamphetamine and Fermented Rooibos Combinations  
Note: In order to prevent confusion for the reader the combination of various 
methamphetamine concentrations combined with two selected concentrations of Rf 
(0.05 and 0.1%), were catagorised into Combination 1 (0.05% with selected MA 
concentrations) and Combination 2 (0.1% with selected MA concentrations) 
 
3.3.1 Effects of 0.05% Fermented Rooibos and Selected Methamphetamine 
Concentrations (Combination 1) 
 
3.3.1.1 Effects of 24 hr Exposure to Combination 1 on Cell Numbers using the 
Trypan Blue Exclusion Method  
 
 
Figure 3.28 Live cell number in response to 24 hr exposure of 0.05% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are expressed as 
mean ± SEM (n=5). Significant (P<0.05) increases in live cell number are denoted with * 
whereas significant decreases are denoted with #. 
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After exposure to the combinations of Rf and MA, no statistically significant decreases 
were observed at 48 and 96 hrs, with a small significant decrease observed at 24 hrs 
when exposed to only 0.05% Rf and 100 µM MA (P=0.0012). However, at 72 hrs, 
exposure to all combinations displayed statistically significant decreases (P≤0.0059) 
with exception to 0.05% Rf and 10 µM MA when compared to the controls. (Figure 
3.28 and Appendix D: Table 3.20). 
 
3.3.1.2 Effects of 24 hr exposure to Combination 1 on Cell Viability (%) using 
the Trypan Blue Exclusion Method  
 
 
Figure 3.29 Cell Viability (%) in response to 24 hr exposure of 0.05% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are expressed as 
mean ± SEM (n=5). Significant (P<0.05) increases in cell viability are denoted with * whereas 
significant decreases are denoted with #. 
 
No significant differences were observed for all exposed concentrations at 24, 48 and 72 
hrs. However at 96 hrs, exposure to the combination containing 1, 10 and 100 µM MA 
resulted in significant decreases (P≤0.0024) in cell viability in comparison to controls 
Despite the small statistically significant decreases observed at 96 hrs, the results 
illustrated a non-toxic effect in response to the 0.05% Rf and the selected MA 
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concentrations as seen with an overall cell toxicity of <4.82% (cell toxicity was 
determined by expressing the dead cell numbers over an entire (live and dead cells) 
population) (Figure 3.29 and Appendix D: Table 3.21). 
 
3.3.1.3 Effects of 24 hr exposure to Combination 1 on Cell Viability (%) using 
the Reduced Formazan Method (Observing Metabolic Activity) 
 
 
Figure 3.30 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of 0.05% 
fermented rooibos in combination with selected methamphetamine concentrations, and time. 
Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% and 
experimental groups expressed relative to controls. Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #. 
 
Exposure of cells to all concentrations of Rf resulted in statistically significant increases 
(P≤0.0174) in MDH activity at 24 hrs. However, marked decreases (P≤0.0105) were 
observed when exposed to Rf and 1 and 10 µM MA at 48 hrs. The MDH activity was 
especially suppressed after exposure to 10 µM MA. All concentrations resulted in 
significant decreases (P≤0.0180) at 72 hrs in comparison to controls. In addition, no 
statistically significant differences were observed at 96 hrs when compared to controls 
(Figure 3.30 and Appendix D: Table 3.22). 
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3.3.1.4 Effects of Daily Exposure to Combination 1 on Cell Viability (%) using 
the Reduced Formazan Method (Observing Metabolic Activity) 
 
 
Figure 3.31 Mitochondrial dehydrogenase activity (%) in response to daily exposure of 0.05% 
fermented rooibos in combination with selected methamphetamine concentrations, and time. 
Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% and 
experimental groups expressed relative to controls. Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #. 
 
As seen with 24 hr (once-off) exposure, there were significant increases in % viability 
at 24 hrs after the cells were exposed to all combinations of Rf and MA (P≤0.0174). 
However, the combinations containing 0.1 and 1 µM MA displayed marked suppression 
(P≤0.0071) at 48 hrs when compared to the controls. No statistical significant 
differences were observed at 72 and 96 hrs, however, a small statistical significant 
increase (P=0.0071) in MDH activity was observed in response to the highest MA-
containing combination. When comparing once-off exposure to that of daily, the MDH 
activity in response to the Rf and MA combinations resulted in similar observations at 
24, 48 and 96 hrs. In contrast to 72 hrs, which displayed decreased MDH activity when 
the cells were exposed to singular combinations (Figure 3.31 and Appendix D: Table 
3.23). 
0
20
40
60
80
100
120
140
160
180
24 48 72 96
%
 M
ito
ch
on
dr
ial
 D
eh
yd
ro
ge
na
se
 A
ct
iv
ity
Time (Hrs)
Ctrl
0.05%+0.1µM
0.05%+1µM
0.05%+10µM
*
# *
70 
 
 
 
 
 
3.3.1.5 Effects of Daily Exposure to Combination 1 on Monolayer Electrical 
Resistance (TEER)  
 
 
Figure 3.32 Electrical resistance in response to daily exposure of 0.05% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are expressed as 
mean ± SEM (n=4). Significant (P<0.05) increases in TEER are denoted with * whereas 
significant decreases are denoted with #. 
 
Exposure of cells to the combinations resulted on dose-dependent increases (P<0.0001) 
across the time intervals with exception to 72 and 96 hrs which displayed small 
statistically significant decreases (P≤0.0128) and a flat-patterned increase (P≤0.0066), 
respectively. The lowest MA-containing combination displayed the lowest TEER 
(P≤0.0128) with highest MA-containing combination (P≤0.0066) resulting in the 
highest resistance across all time intervals with exception to 96 hrs (Figure 3.32 and 
Appendix D: Table 3.24). 
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3.3.1.6 Effects of Combination 1 on bEnd5 Cell Cycles 
 
3.3.1.6.1 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 24 hours  
 
 
Figure 3.33 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 24 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.05% Rf and 0.1 µM MA. C 
0.05% Rf and 1 µM MA. D 0.05% Rf and 10 µM MA.  
 
 
Figure 3.34 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.05% fermented rooibos and selected MA concentrations at 24 hrs. Results 
are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are 
denoted with * whereas significant decreases are denoted with #. 
 
The G1-phase contained the highest relative cell number (≥41.56±2.47%) and G2-M 
phase possessed the least amount of cells (≤18.75±0.41%). All combination 
concentrations resulted in marked decreases (P≤0.0495) and increases (P≤0.0275) in the 
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G1- and G2-M-phases, respectively. Experimental groups were similar to that of 
controls in the S-phase. The experimental groups in the G1- and S-phases were also 
similar (See Figure 3.33 and 3.34, Appendix D: Table 3.25 and Appendix N). 
 
3.3.1.6.2 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 48 hours  
 
 
Figure 3.35 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 48 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.05% Rf and 0.1 µM MA. C 
0.05% Rf and 1 µM MA. D 0.05% Rf and 10 µM MA. 
 
Figure 3.36 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.05% fermented rooibos and selected MA concentrations at 48 hrs. Results 
are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are 
denoted with * whereas significant decreases are denoted with #. 
 
The S-phase contained the highest amount of cells (≥24.56±6.27%). The experimental 
groups in the G1- and S-phases were similar with exception to the lowest MA-
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containing combination in the S-phase. The least cells were detected in the G2-M phase 
(1.39±0.57%) after exposure to the 10 µM MA combination. A significant decrease 
(P=0.0356) and increase (P=0.0356) was observed when exposed to the highest MA 
combination in the G1- and S-phases, respectively. Rf and 0.1 µM MA exposure in the 
G2-M phase displayed a marked increase (P=0.0430) in comparison to controls (See 
Figure 3.35 and 3.36, Appendix D: Table 3.26 and Appendix O). 
 
3.3.1.6.3 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 72 hours  
 
 
Figure 3.37 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 72 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.05% Rf and 0.1 µM MA. C 
0.05% Rf and 1 µM MA. D 0.05% Rf and 10 µM MA. 
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Figure 3.38 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.05% fermented rooibos and selected MA concentrations at 72 hrs. Results 
are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are 
denoted with * whereas significant decreases are denoted with #. 
 
At 72 hrs, the highest cell number was observed in the S-phase (59.81±3.46%) when 
exposed to the 1 µM MA combination with the least cells detected in the G2-M phase at 
2.15±2.63% after exposure to the Rf and 10 µM MA combination. A significant 
decrease (P=0.0128) was observed at the G1-phase when exposed to the intermediate 
combination. The highest combinations resulted in marked increases at both S- 
(P=0.0415) and G2-M-phases (P=0.0025) when compared to controls (See Figure 3.37 
and 3.38, Appendix D: Table 3.27 and Appendix P). 
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3.3.1.6.4 Effects of 24 hr Exposure to Combination 1 on Cell Cycles at 96 hours  
 
 
Figure 3.39 Histograms illustrating cell cycle results after exposure to 0.05% fermented 
Rooibos in combination with selected methamphetamine concentrations at 96 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.05% Rf and 0.1 µM MA. C 
0.05% Rf and 1 µM MA. D 0.05% Rf and 10 µM MA. 
 
 
Figure 3.40 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.05% fermented rooibos and selected MA concentrations at 96 hrs. Results 
are expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are 
denoted with * whereas significant decreases are denoted with #. 
 
Experimental groups in the G1- and S-phase were similar in relative cell number. 
However, the highest numbers (51.22±1.21%) were detected in the S-phase when 
exposed to the intermediate-MA combination. Exposure to all combinations in the G1-
phase resulted in marked decreases (P≤0.0436). The highest combination displayed a 
marked increase (P=0.0243) in the S-phase. The least amount of cells was observed in 
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the G2-M phase at 1.21±1.30% and 1.21±3.15% when exposed to combinations 
containing 0.1 and 1 µM MA, respectively. Moreover, the lowest combination resulted 
in a marked decrease (P=0.0420) when compared to controls (See Figure 3.39 and 3.40, 
Appendix D: Table 3.28 and Appendix Q). 
 
3.3.2 Effects of 0.1% Fermented Rooibos and selected Methamphetamine 
Concentrations (Combination 2) 
 
3.3.2.1 Effects of 24 hr Exposure to Combination 2 on Cell Numbers using the 
Trypan Blue Exclusion Method  
 
 
Figure 3.41 Live cell number in response to 24 hr exposure of 0.1% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are expressed as 
mean ± SEM (n=5). Significant (P<0.05) increases in live cell number are denoted with * 
whereas significant decreases are denoted with #. 
 
A dose-dependent increase was observed at 24 hrs however exposure of the cells to 
these combinations initially displayed decreased cell numbers with the two lowest MA-
containing (0.1 and 1 µM MA) combinations displaying statistically significant 
decreases (P≤0.0273) when compared to controls. No statistically significant differences 
were observed at 48 and 72 hrs with exception to the MA-containing combinations of 
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10 µM MA and 100 µM MA, respectively, which resulted in small statistically 
significant decreases (P≤0.0233). This effect was also observed at 96 hrs with the two 
higher MA-containing combinations causing cell suppression (P≤0.0371) (Figure 3.41 
and Appendix E: Table 3.29). 
 
3.3.2.2 Effects of 24 hr Exposure to Combination 2 on Cell Viability (%) using 
the Trypan Blue Exclusion Method  
 
Figure 3.42 Cell Viability (%) in response to 24 hr exposure of 0.1% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are expressed as 
mean ± SEM (n=5). Significant (P<0.05) increases in cell viability are denoted with * whereas 
significant decreases are denoted with #. 
 
There were no statistically significant differences observed when the cells were exposed 
to all 0.1% Rf and MA combinations at 24 and 48 hrs. However, at 72 and 96 hrs, 
exposure to Rf in combination with 1 and 10 µM MA (P≤0.0096), and 10 and 100 µM 
(P≤0.0113) MA respectively, resulted in small statistically significant decreases in cell 
viability. Despite the small statistically significant decreases observed at 72 and 96 hrs, 
the results illustrated a non-toxic effect in response to the 0.1% Rf and the selected MA 
concentrations as seen with an overall cell toxicity of <5.77% (cell toxicity was 
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determined by expressing the dead cell numbers over an entire (live and dead cells) 
population) (Figure 3.42 and Appendix E: Table 3.30). 
 
3.3.2.3 Effects of 24 hr Exposure to Combination 2 on Cell Viability (%) using 
the Reduced Formazan Method (Observing Metabolic Activity)  
 
 
Figure 3.43 Mitochondrial dehydrogenase activity (%) in response to 24 hr exposure of 0.1% 
fermented rooibos in combination with selected methamphetamine concentrations, and time. 
Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% and 
experimental groups expressed relative to controls. Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #. 
 
Similar to combination 1, statistically significant increases (P≤0.0220) in MDH activity 
were observed after exposure of cells to all 0.1% Rf and MA combinations. There were 
no statistically significant differences observed at 48 and 96 hrs when compared to the 
respective controls. However, 72 hr exposure to all combinations resulted in a 
statistically marked decline (P≤0.0071) (Figure 3.43 and Appendix E: Table 3.31). 
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3.3.2.4 Effects of Daily Exposure to Combination 2 on Cell Viability (%) using 
the Reduced Formazan Method  
 
 
Figure 3.44 Mitochondrial dehydrogenase activity (%) in response to daily exposure of 0.1% 
fermented rooibos in combination with selected methamphetamine concentrations, and time. 
Results are expressed as mean ± SEM (n=5). Controls were normalized to 100% and 
experimental groups expressed relative to controls. Significant (P<0.05) increases in cell 
viability are denoted with * whereas significant decreases are denoted with #. 
 
As was observed with once-off (24 hr) exposure, exposure of the cells to all 0.1% Rf 
and MA combinations displayed statistically significant increases (P≤0.0220) in 
comparison to controls. However, exposure to all combinations at 48 hrs resulted in 
statistically significant decreases (P≤0.0105). No differences were observed at 72 and 
96 hrs, however, a small statistically significant increase (P=0.0025) was observed at 
the lowest MA (0.1 µM) combination when compared to controls (Figure 3.44 and 
Appendix E: Table 3.32).  
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3.3.2.5 Effects of Daily Exposure to Combination2 on Monolayer Electrical 
Resistance (TEER)  
 
 
Figure 3.45 Electrical resistance in response to daily exposure of 0.1% fermented rooibos in 
combination with selected methamphetamine concentrations, and time. Results are expressed as 
mean ± SEM (n=5). Significant (P<0.05) increases in TEER are denoted with * whereas 
significant decreases are denoted with #. 
 
Exposure of the cells to the combination range of Rf and MA resulted in statistically 
significant increases (P≤0.0210) in TEER across all time intervals with exception to 72 
hrs in which Rf and 1 µM MA exposure resulted in a small statistically significant 
decrease (P<0.0062). In addition, a dose-dependent increase (P≤0.0210) in TEER at 24, 
48, 96 and 120 hrs was observed. Although the TEER was significantly greater 
(P≤0.0001) than the controls at 96 hrs, it should be noted that the data took form of a 
dose-dependent decreased trend (Figure 3.45 and Appendix E: Table 3.33).  
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3.3.2.6 Effects of Combination 2 on bEnd5 Cell Cycles 
 
3.3.2.6.1 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 24 hours  
 
 
Figure 3.46 Histograms illustrating cell cycle results after 24 hr exposure to 0.1% fermented 
rooibos in combination with selected methamphetamine concentrations at 24 hrs using flow 
cytometry as follows (≥ 10 000 events analysed). A Control. B 0.1% Rf and 0.1 µM MA. C 
0.1% Rf and 1 µM MA. D 0.1% Rf and 10 µM MA.  
 
 
Figure 3.47 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.1% fermented rooibos and selected MA concentrations at 24 hrs. Results are 
expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are denoted 
with * whereas significant decreases are denoted with #. 
 
The highest relative cell numbers were detected in the S-phase at 57.76±0.77% when 
exposed to the highest MA-containing (10 µM) combination which also resulted in least 
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detected cell populations in the G2-M phase at 0.46±0.33%. Exposure of the cells to all 
combinations in the G1-phase resulted in significant decreases (P≤0.0346) with marked 
increases occurring in the S-phase when exposed to 0.1% Rf in combination with 0.1 
µM MA (P=0.0346) and 10 (P=0.0108) µM MA (See Figure 3.46 and 3.47, Appendix 
E: Table 3.34 and Appendix R). 
 
3.3.2.6.2 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 48 hours  
 
 
Figure 3.48 Histograms illustrating cell cycle results after exposure to 0.1% fermented rooibos 
in combination with selected methamphetamine concentrations at 48 hrs using flow cytometry 
as follows (≥ 10 000 events analysed). A Control. B 0.1% Rf and 0.1 µM MA. C 0.1% Rf and 1 
µM MA. D 0.1% Rf and 10 µM MA.  
 
 
 
Figure 3.49 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.1% fermented rooibos and selected MA concentrations at 48 hrs. Results are 
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expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are denoted 
with * whereas significant decreases are denoted with #. 
 
The greatest relative cell numbers were detected in the G1 phase (≥43.57±1.09%) while 
the least amount was observed at the G2-M phase (≤10.75±3.13%). Significant 
decreases were observed in the G1- and G2-M-phases when exposed to 0.1 (P=0.0436) 
and 1 (P=0.0406) µM MA combinations, respectively. It was noted that the 
experimental groups in the G1-phase were similar to that in the S-phase (See Figure 
3.48 and 3.49, Appendix E: Table 3.35 and Appendix S). 
 
3.3.2.6.3 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 72 hours 
 
 
Figure 3.50 Histograms illustrating cell cycle results after exposure to 0.1% fermented rooibos 
in combination with selected methamphetamine concentrations at 72 hrs using flow cytometry 
as follows (≥ 10 000 events analysed). A Control. B 0.1% Rf and 0.1 µM MA. C 0.1% Rf and 1 
µM MA. D 0.1% Rf and 10 µM MA.  
 
 
84 
 
 
 
 
 
 
Figure 3.51 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.1% fermented rooibos and selected MA concentrations at 72 hrs. Results are 
expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are denoted 
with * whereas significant decreases are denoted with #. 
 
The G1-phase displayed the greatest relative cell numbers (≥44.36±1.16%) with the G2-
M phase displaying the least (≤18.12±0.90%). A significant decrease (P=0.0309) was 
observed when exposed to only lowest combination in the G-phase (See Figure 3.50 and 
3.51, Appendix E: Table 3.36 and Appendix T). 
 
3.3.2.6.4 Effects of 24 hr Exposure to Combination 2 on Cell Cycles at 96 hours 
 
 
Figure 3.52 Histograms illustrating cell cycle results after exposure to 0.1% fermented rooibos 
in combination with selected methamphetamine concentrations at 96 hrs using flow cytometry 
as follows (≥ 10 000 events analysed). A Control. B 0.1% Rf and 0.1 µM MA. C 0.1% Rf and 1 
µM MA. D 0.1% Rf and 10 µM MA.  
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Figure 3.53 Relative cell numbers (%) at distinct phases of the cell cycle after 24 hr exposure to 
a combination of 0.1% fermented rooibos and selected MA concentrations at 96 hrs. Results are 
expressed as mean ± SEM (n=3). Significant (P<0.05) increases in relative cell no. are denoted 
with * whereas significant decreases are denoted with #. 
 
When he cells were exposed to the combinations containing 0.1% Rf and the selected 
MA concentrations, the S-phase displayed the highest relative cell numbers at 
53.14±1.20% when compared to the controls. The least cells detected were observed at 
the G2-M phase (≤7.70±2.00). The highest MA-containing combination resulted in a 
marked decrease (P=0.0483) in the G1-phase. In the G2-M phase, the combinations 
containing 1 µM MA (P=0.0422) and 10 µM MA (P=0.0208) also resulted in decreases 
when compared to controls (See Figure 3.52 and 3.53, Appendix E: Table 3.37 and 
Appendix U). 
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CHAPTER 4 
 
4. Discussion and Conclusions 
 
The blood-brain barrier (BBB) is important as it protects the brain from the circulatory 
environment and subsequent disturbance in this structure results in detrimental effects. 
Methamphetamine (MA) is known for its adverse effects on the brain since it easily 
passes through the BBB of which the precise mechanisms have not been fully 
elucidated. However, oxidative stress has been reported to be a contributing factor. 
Numerous studies have illustrated herbal teas to be potential treatments in the 
elimination or inhibition of the reactive oxygen species (ROS) which in turn protects 
against the detrimental physiological effects of the oxidants. To date, very few studies 
have investigated possible mechanistic approaches of MA on endothelial cells of the 
BBB, and even more so analysed the potential beneficial effects that fermented rooibos 
(Rf) herbal tea may have against MA on these endothelial cells.  
 
In this study, physiologically relevant MA concentrations (0.1-11.1 µM) as well as 
supraphysiological (supra) concentrations (>11.1 µM) (Melega et al., 2007), were used. 
In addition, a broad Rf range (0.00325-0.1%) was utilized in order to establish the 
appropriate concentrations at which the bEnd5 cells would display above 50% viability. 
These concentrations were then used in combination with physiological MA 
concentrations for the analysis of the monolayer permeability and cell cycles. 
 
Of great concern noted at MA rehabilitation centres as well as out-patient programmes 
are the number of patients who relapse which is the main hurdle in the treatment of drug 
dependence (Huber et al., 1997; Anggadiredja et al., 2004). It is reported that since the 
monoaminergic (MOA) systems are disturbed as a result of MA-induced oxidative 
stress (Nordahl et al., 2003; Ramirez et al., 2009), it increases the chances of patients 
relapsing. Studies have demonstrated that anti-oxidants have the ability to reverse the 
negative effects that MA has on the MOA systems which lends merit to the 
administration of Rf during this sensitive time of recovery. Since MA has potent ROS 
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production potential, it is possible that these radicals may also contribute to the change 
in the properties of the BBB and thus compromise its protective functions. 
 
In the viability (%) assays, the bEnd5 cells were exposed to selected MA, and Rf 
concentrations as well as their combinations for 24 hrs only (once-off) at various time 
intervals (24-96 hrs). Viability based on intact cell membranes, were similar to that of 
the control cells for both single compounds and their combination at all, time intervals. 
Toxicity reflected <5.33%, which further validated the viability results (data not 
shown). Chen et al. (2012) observed similar results also incorporating the exclusion 
assay in which no difference was observed between the viability and cell survival rates 
when exposing adenocarcinomic human alveolar basal epithelial (A549) cells and 
Madin-Darby canine kidney cells to 25-250 µM for 72 hrs. To date, there are no studies 
reporting on the effects of once-off exposure to Rf on viability. A study by Macharia et 
al. (2008), however, confirmed that 6 cups of Rf consumption exerted no toxicity on 
kidney and liver function after illustrating that liver and kidney function enzymes 
(aspartate transferase, alanine amino transferase, alkaline phosphatase etc.) were not 
associated with any adverse effects. 
 
Although viability (%) was not affected by exposure to the compounds, distinct 
differences were observed in live cell numbers across the time intervals. All MA 
concentrations decreased cell numbers at 96 hrs. Interestingly, Rf (0.0625-0.1%) also 
decreased cell numbers at this time interval which also occurred at the preceding time 
intervals in a dose-dependent manner. It should be noted that when exposed to the 
combination consisting of 0.05% Rf and MA, the cell numbers were similar to the 
controls at 96 hrs. This was also seen when exposed to 0.1% Rf in combination with 0.1, 
and 1 µM, however, the remaining concentrations resulted in a decrease. The potential 
of Rf to ameliorate MA effects on cell numbers at 96 hrs was seen with the 
combinations, which was interesting since cells exposed to Rf alone especially at the 
higher concentrations (0.25-1%) illustrated a greater inhibitory effect on cell numbers 
after exposure. Further studies needs to be conducted in order to explain these results 
and the possible mechanisms involved will be proposed towards the end of this section. 
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Viability (%) was also investigated under daily exposure conditions, in which the cells 
received fresh compounds from 24 through to 96 hrs. For chronic MA exposure, a 
decrease in viability at 72 and 96 hrs was observed which was accompanied by a similar 
trend in live cell numbers. Exposure at the earlier time intervals showed higher viability 
compared to the controls while the live cell numbers also correlated to the trend. The 
increased viability observed may be an indication of cellular stress as a result of MA-
induced insult. Numerous studies (Zhang et al., 2009; Martins et al., 2010; Martins et 
al., 2013) involving the viability of endothelial cells assessed the effects that MA had 
for 24 hrs. Using rat brain vascular endothelial (GPNT) cells, Martins et al. (2010) 
observed low cell death when exposed to 0.1, 1, 10, 30 and 100 µM MA. Another study 
performed by Martins et al. (2013) using primary brain microvascular endothelial cells 
exposed to MA concentrations up to 100 µM showed that the cell viability was 
unaffected. This study at 24 hrs supports findings of Zhang et al., 2009; Martins et al., 
2010 and Martins et al., 2013 
 
Since the selected concentrations of MA had no effect on the viability (%) of the bEnd5 
cells under both 24 hr as well as chronic exposure, it was of interest to determine which 
supraphysiological concentrations of MA would result in a significant change in the 
viability. In this study, 24 hr exposure to supra concentrations resulted in a marked 
decrease in viability specifically at 2000 and 3000 µM. Chronic exposure already 
displayed a significant decline in viability at 1000 µM when compared to controls 
which may be attributed to the constant presence of the MA unlike that of the once off 
exposure which required higher concentrations to exert similar inhibitory effects. 
Exposures using high MA concentrations are commonly used to investigate potential 
toxicity of selected compounds. Zhang et al. (2009) exposed human brain microvascular 
endothelial cells (hBMVECs) for 24 hrs and observed no differences in cell viability at 
MA concentrations of 100 and 500 µM. They did, however, report that the cells 
exposed to supraphysiological concentrations of 2500, 5000 and 10 000 µM resulted in 
significant decreases in the viability, with the minimum dose being 2500 µM (20% cell 
death). Moreover, 5000 µM and 10 000 µM resulted in 40% and 80% cell death, 
respectively. These findings correlated with the results of this study. Although in vitro 
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studies may use different endothelial cell line models, bEnd5 cells share structural 
similarities with other endothelial models which therefore explain the similar effects 
observed with the hBMVECs model. 
 
Apart from experiments involving endothelial cell lines, MA’s effects on other cell lines 
have also been documented with results similar to that of the endothelial cells. Carey et 
al. (2012) investigated the effects of 200, 500, 750, 1000 and 2000 µM MA on retinal 
pigment epithelial (ARPE-9) cells after 24 hrs. Exposure to 200 µM resulted in no 
effect. However, a marked decrease was observed when exposed to the higher 
concentrations with 500 µM having the least effect. Furthermore, Chen et al. (2012) 
used a high concentration range of 1250 and 2500 µM in addition to 2.5, 25, 125, 250, 
on A549- and Madin-Darby canine cells for 72 hrs. Treatment with 2.5-250 µM resulted 
in no differences in comparison to untreated groups. When exposed to 1250 and 2500 
µM, a notable decrease in cell viability (%) was observed, however, dead cell counts 
were not notably significant between 2.5 and 2500 µM. Moreover, the cell survival rates 
were not markedly different for the range 2.5-250 µM but a decrease of 50% and 70% 
was observed when exposed to 1250 and 2500 µM, respectively. Exposure to 250, 500, 
1000, 2000 and 3000 µM MA on rat cerebellum neural (R2) cells resulted in a 
concentration-dependent cell death at 48 hrs (Zhou et al., 2004) and treatment with 
1000 µM MA on human neuroblastoma carcinoma (SH-SY5Y) cells at 24 hrs resulted 
in a significant decrease in cell viability compared to control values (Parameyong et al., 
2013). Ajjimaporn et al. (2005) and Ayadi and Zigmond (2011) investigated MA effects 
on dopaminergic cells (SK-N-SH and MN9D cells, respectively). Ajjimaporn et al. 
(2005) observed a dose dependent decrease in cell viability after exposure to 10, 100, 
500 and 1000 µM with 1000 µM reaching 47% at 24 hrs. When the time period was 
extended, exposure to 1000 µM at 72 hrs resulted in a 32% viability status. Ayadi and 
Zigmond (2011) observed no effect on the MN9D cells when exposed to 500 and 1000 
µM however they reported higher MA concentration (e.g. 3000 µM) to be toxic. The 
above-mentioned studies support the findings that for most cell types (endothelial, 
epithelial, neuronal and fibroblast-like), higher MA concentrations above physiological 
ranges have a greater suppressive effect on viability in vitro.  
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In contrast to MA effects, 24 hr Rf exposure resulted in fluctuated viability (%) levels at 
different time intervals. An increase was noted at 24, 48 and 96 hrs, while no difference 
was observed at 72 hrs when compared to non-exposed cells. Interestingly, the live cell 
numbers of cells exposed to Rf were suppressed in a dose-dependent manner even 
though the viability was either increased or unaffected. This could indicate that the 
suppression is not a result of metabolic activity and may have its mechanism in another 
cell pathway linked to cell growth. The data illustrated similar effects after both acute 
and chronic exposure on metabolic activity. The viability increased in a dose-dependent 
manner followed by either an increase or a metabolic activity similar to their respective 
controls at the highest Rf concentrations at all time, intervals with the exceptions of 96 
hrs which showed a significant decrease in viability at the higher Rf concentrations. To 
date, this study is the only of its kind to report on the effects of Rf on the viability and 
cell numbers on bEnd5 endothelial cells. 
 
Moreover, there are no studies that have reported on any other forms of endothelial 
cells. There were, however, only a few reports on the effects of Rf on other cell lines. 
The effects of Rf on chick skeletal muscle primary cells were illustrated by Lamosova et 
al. (1997). Growth and proliferation was affected by concentrations greater than 2%. 
The authors suggested that rooibos may have inhibited the low levels of ROS required 
for normal cell division which could be attributed to its potent scavenging activity as a 
result of its high polyphenol contents. This could explain the decrease in cell numbers 
observed in this study even though the viability (%) was not affected as much. Could it 
be that this herbal tea may have initially insulted homeostasis because of its potent ROS 
scavenging effect? In addition, Beltran-Debon et al. (2011) showed that after 
continuous exposure to the herbal tea, the 3T3-L1 adipocytes’ viability was not 
affected. However, rooibos affected the cell metabolism and regulated cellular energy 
homeostasis in which they proved the involvement in the cells energy pathways. 
Moreover, the effects of rooibos on adrenal steroidogenesis using human adrenocortical 
carcinoma (H295R) cell line, demonstrated its effects on glucocorticoids which play a 
large role in cell metabolism (including that of the central nervous system). The 
viability of these cells were unaffected by rooibos, however, the decrease in 
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glucocorticoids was metabolically related (Scholms et al., 2012). The findings in this 
study in combination with previous literature illustrate the potential of Rf to regulate 
cellular metabolic activity and energy production in both endothelial cells and on other 
cell types. 
 
Cells exposed to the combinations of 0.1 and 0.05% Rf, and MA for 24 hr and chronic 
exposure, resulted in an initial increase in viability at 24 hrs of exposure when 
compared to controls. A decrease in cell viability was noted at 48 and 72 hrs, while at 
96 hrs the experimental cells were similar to that of the controls. Overall, while 
different trends were observed with viability, it is interesting that the live cell numbers 
at the same time intervals were not different from the controls. Even more surprisingly, 
while both single compounds resulted in decreased cell numbers compared to controls, 
the combinatorial effects of these compounds showed similar cell numbers. To date, no 
studies have analysed the effects of MA in combination with A. linearis, however, other 
plants and antioxidant agents have been investigated on other cell types and tissues.  
 
A flavonoid derived from milk thistle (Silybum marianum also known as silibinin) was 
co-administration with MA for 7 days in mice. Silibinin had shown to attenuate the 
memory impairment as well as the decreased DA and serotonin levels of the prefrontal 
cortex and hippocampus (respectively) induced by MA (Shanmugam et al., 2008; Lu et 
al., 2010). Wang and co-workers (2008) reported that treatment with vitamin E (which 
also acts as an antioxidant) prevented MA-induced Jun-N-terminal kinase (JNK) 
phosphorylation and inhibited MA-activated caspases-3 in SH-SY5Y cells. JNKs and 
caspases are known to play a role in the regulation of stress responses including stress 
adaptation, cell survival and death (McCubrey et al., 2006). Another study also 
concluded that pre-treatment with vitamin E reduced MA-induced ROS formation and 
prevented cell death (Wu et al., 2007). Wu et al. (2006) conducted an experiment 
involving repeated intra-peritoneal MA administration (5 mg/kg, 4 injections at 2 hrs 
intervals) pre-treated with baicalein (0.3-1.0 mg/kg) which is a flavonoid derived from 
the root of Scutelaria baicalensis Georgi shown to demonstrate free radical scavenging 
and lipid peroxidation (Hara et al., 1992; Gao et al., 1999). They observed lowered 
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MA-induced striatal myeloperoxidase, lipid peroxidation markers and neutrophils. MA-
induced striatal DA loss was also improved. Since MA causes increased ROS activity 
and Rf has potent antioxidant potential both of which demonstrated an imbalance in 
cellular homeostasis when administered singularly, it is plausible that the combination 
of MA and Rf may restore the redox state of the cells resulting in the re-established cell 
numbers and minimal cell death observed at 96 hrs.  
 
The permeability of the endothelial monolayer was assessed in response to daily 
exposure of the compounds and their combinations from 24 through to 144 hrs. Overall, 
dose-dependent increases in electrical resistance were observed across all time lines in 
response to single compound exposure of MA and Rf. The increase was concurrent with 
an increase in cell viability (%) at 24 hrs, while decreased viability was observed at 48 
and 72 hrs with the viability remaining unchanged at 96 hrs. Since permeability and 
electrical resistance are inversely proportional, exposure to the individual compounds of 
MA and Rf resulted in the monolayer being less permeable. It is conceivable that the 
monolayer would respond in this manner to the presence of the herbal tea. However, it 
is unexpected that the resistance would also increase in the presence of MA. It may be 
possible that this lipid-soluble compound causes the endothelial cells to “tighten” as a 
protective response to the presence of MA. 
 
Interestingly, the lower concentrations of MA (0.1 and 1 µM mostly) had the greatest 
effect by increasing permeability with the highest concentrations resulting in an 
opposite effect. It is also the higher MA concentrations that resulted in the lowest 
viability (%). Since viability is linked to changes in metabolic and energy pathways of a 
cell, it may be possible that the decrease in viability observed reflects the cells’ effort to 
increase the integrity of the monolayer by using its energy resources to change 
expression of tight junction proteins, which therefore increased TEER. 
 
Zhang et al. (2009), Martins et al. (2010), Carey et al. (2012) and Rosas-Hernandez et 
al. (2013) observed a decrease in TEER readings when the cells were exposed to higher 
MA concentrations in contrast to the results seen in this study. Martins et al. (2010) 
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illustrated no changes in electrical resistance when GPNT cells were exposed to 1 and 
50 µM MA. In addition, Rosas-Hernandez and colleagues (2013) also observed no 
significant differences when bovine BMVECs were exposed to 100 µM MA. However, 
electrical resistance dose-dependently decreased when cells were exposed to 250, 500, 
1000 and 2500 µM MA. Carey et al. (2012) reported a decrease in electrical resistance 
by 10% as compared to controls when ARPE-9 cells were exposed to 500 µM MA 
whereas Zhang et al. (2009) observed a significant drop by 60% when hBMVECs were 
exposed to 5000 µM. It should be noted that the latter authors used supraphysiological 
concentrations of MA. Furthermore, the TEER results of the above mentioned studies 
were subjected to short durations with the longest time interval reaching only 24 hrs. 
Thus, since this study exposed the cells to the compounds for up to 144 hrs and also 
incorporated hydrocortisone (which fortifies the synthesis of blood-brain barrier 
characteristics in serum-free in vitro systems as established by Hoheisel et al., 1998) in 
the growth medium as well as the utilization of a different cell type, it is difficult to 
compare to previous reports. Moreover, while most authors expose their monolayer with 
a once-off single exposure, this study replaced the growth medium with fresh MA-
containing media every 24 hrs. 
 
Other studies also investigated the effects of MA within less than 24 hr time intervals 
(Abdul-Muneer et al., 2011 and Ramirez et al., 2009; Martins et al., 2013). 1 and 50 
µM MA had no effect on primary BMVECs when exposed for 6 hrs (Martins et al., 
2013). Abdul-Muneer et al. (2011) observed a significant decline in electrical resistance 
when hBMVECs were exposed to 20 and 200 µM (the highest concentration had the 
greatest effect) for 10 hrs. Ramirez et al. (2009) reported a 20-50% dose-dependent 
decrease after hBMVECs were exposed to 50 and 250 µM MA for 21 hrs in which they 
proposed the observation to be as a result of partial loss of monolayer integrity. The 
decline in electrical resistance observed in these studies may possibly be due to 
supraphysiological concentrations being more toxic to the cells. It is clear that the 
effects of MA exposure are both dose- as well as time-dependent. 
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Mahajan and colleagues (2008) exposed BMVECs to MA concentrations 20-fold less 
than the lowest concentration used in this study. The time period of exposure was, 
however, longer than 24 hrs (10, 25 and 50 nM). They reported that for 24, 48 and 72 
hrs a dose-dependent decrease in TEER was observed. The maximum effect was 
observed when the endothelial cells were exposed to 50 nM at 48 hrs post-MA 
treatment. Since the cells in this study were constantly exposed to the same 
concentration of MA in fresh growth medium daily, it could explain the direct 
relationship observed between the dose and permeability, since most waste products are 
removed and the cells are supplied with fresh nutrients. The reason for replacing the 
medium on a daily basis is founded on the logic that MA abusers seldom skip 24 hrs of 
not administering MA. Thus, the in vitro is always exposed to the same concentration of 
MA for 144 hrs unlike the once-off exposed cells that metabolize the MA over the time 
period. It should be highlighted at this point that there are as yet no reports on the 
metabolism or bioavailability of MA in mouse brain endothelial cells both, in vitro or in 
vivo. 
 
Exposure to Rf initially resulted in increases in TEER (correlating with an increased 
viability). At 72 hrs, TEER was still elevated; however, viability (%) was unaffected. 
While at 96 hrs only higher concentrations of Rf, resulted in similar TEER readings 
compared to controls but viability had decreased. Electrical resistance remained higher 
than controls for 120 and 144 hrs, however, this study did not investigate the effect of 
Rf on viability at these time intervals. Overall, as the Rf concentrations increased for all 
time intervals, the permeability decreased. Chronic exposure to Rf may, thus, have 
resulted in an increase in the integrity of the monolayer. Since there are currently no 
reports on the effect of Rf on TEER, the author is left with only the current results of 
this study. Thus, further analysis specifically at the biochemical and molecular level are 
required in order to explain the possible mechanisms involved in the decrease in 
permeability observed. 
 
While there are no reports on Rf, studies have, however, investigated the effect of 
polyphenols on endothelial cells. Youdim et al. (2003) reported on the uptake of citrus 
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flavonoids by rat brain endothelial and bEnd5 cells. These results demonstrated the 
ability of flavonoids and other metabolites to traverse the BBB. However, the authors 
could not explain how the flavonoids impacted the endothelial cells, directly. These 
studies do give insight into the potential of flavonoids as a treatment for 
neuroprotection. Youdim et al. (2004) also assessed the ability of flavonoids to traverse 
the in vitro ECV304/rat-C6 co-culture and in situ (rat) BBB models. The study 
concluded that flavonoids from certain families are able to penetrate the BBB and 
convey protection in a neuronal setting. 
 
The studies conducted by Youdim et al. (2003 and 2004) implicated the possible 
involvement of the drug efflux transporters as a means by which flavonoids could 
potentially traverse the BBB and exert their neuroprotective effect. Although the precise 
efflux transporters have not yet been fully elucidated, they suggested the involvement of 
P-glycoprotein (P-gp). P-gp operates as an adenosine triphosphate (ATP)-driven efflux 
pump by controlling the movement of structurally diverse compounds across the BBB. 
Interestingly, Beltran-Debon and co-workers (2011) reported that viability (%) of 
adipocytes was not affected by continuous Rf exposure and that these effects were 
proven to be energy-related. It may be that the energy-affiliated role of P-gp strongly 
links to the findings of this study. Previous literature also illustrated the energy 
regulatory effects of rooibos on other cells types (as discussed with viability). This is 
also supported by the possible interactions between P-gp, epicatechin (Youdim et al., 
2003) and quercetin (Youdim et al., 2004), the latter also known to be a potent 
antioxidant of rooibos herbal tea (Ferreira et al., 1995; Joubert and Ferreira, 1996; 
Nijveldt et al., 2001). This further supports the possibility that energy pathways play a 
role in the modulatory effects of daily Rf on the viability of the endothelial cells coupled 
with a decrease in barrier permeability. A more detailed investigation of Rf flavonoid P-
gp interaction is required, which focuses on the efflux proteins as well as pathways 
linked to the actions of these transporters. 
 
Exposure to combinations of MA and Rf resulted in increased TEER readings as well as 
viability (%). These readings were the highest recorded when compared to the effects of 
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the single compounds. Similar relationships were observed for the viability, in which 
the single compounds resulted in decreased viability up until 96 hrs while their 
combinations resulted in an increase. It is therefore highlighted that the increased 
viability occurred simultaneously with the increased resistance. Thongsaard and 
Marsden (2002) reported that Thunbergia laurifolia (TH) Linn an herbal plant which 
also possesses flavonoids (Rice-Evans et al., 1996; Chanawirat, 2000) stimulated DA 
release in the same manner as AMPH. Since MA and some polyphenolic as well as non-
polyphenol compounds in Rf are lipophilic it can be suggested based on the above-
mentioned study, that they are agonistic and result in the increased effects in 
permeability observed. This section of the study demonstrated that Rf reversed the 
permeability caused by physiological concentrations of MA.  
 
The effects on the bEnd5 cell cycles were also investigated in response to once-off 
exposure to the compounds. This section of the study made use of only physiological 
concentrations of MA (0.1, 1 and 10 µM) and selected Rf concentrations (0.05 and 
0.1%) as well as their combinations. Exposure to MA between 24 and 96 hrs increased 
cell populations in the G1-phase with a decreased cellular fraction in the S- and more 
specifically in the G2-M-phases. This suggested that the cells accumulated in the G1-
phase where preparation for DNA replication occurs. Comparably, an increase in 
viability (%) and a decrease in cell numbers were observed at 96 hrs. The arrest at the 
G1-phase may have been as a result of the interference observed at the G2-M phase 
where cell division should occur. In other words, MA may have blocked the G1-to-S 
phase transition resulting in the retardation of the cell cycle and thus a decrease in the 
G2-M population. The decreased cell numbers observed at 96 hrs potentially reflects the 
inability of cells to proliferate while the increased viability may indicate compensatory 
mechanisms activated in order to provide more energy for cell division. 
 
To date, few studies have investigated the effects of MA on cell cycles. Shao et al. 
(2012) demonstrated that supraphysiological concentrations of 1000 µM MA resulted in 
apoptosis and cell cycle arrest in human embryonic endothelial (EA.hy926) cells at 24 
and 48 hrs. The authors, however, did not elaborate nor allocate which specific phase of 
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the cycle was affected. Their results were not unexpected since their cells were exposed 
to supra MA concentrations. For the same time intervals, Capélôa et al. (2014) observed 
no differences in cell cycle phases when exposing human glioblastoma (U-118) cell 
lines to 1 µM MA. This is consistent with the effect of 1 µM MA on the cell cycle 
phases observed at 24 and 48 hrs in this study. Yuan and colleagues (2011) observed 
modified cell cycle dynamics and altered stages of development in response to chronic 
in vivo administration of MA on rat hippocampus progenitor cells. Without influencing 
phase length, MA had resulted in decreased cell populations in the S-phase which 
displayed association with G1-phase arrest. The observations made by Yuan et al. 
(2011) mirrored the altered cell numbers observed in the S-phase in this study. 
 
The rate of cell proliferation and growth is largely influenced by the ability of cells to 
enter and undergo cell division and thereby completing an entire cell cycle. Studies 
have demonstrated that alterations in endothelial proliferation and S-phases have been 
linked to glutathione (GSH)-deficient states (Maxine et al., 2008) and in vitro ROS 
(Buşu et al., 2013), which both play major roles in the regulation of cell redox states. In 
this study, it is evident that MA has influenced both cell growth and cell cycles. Since 
the adverse effects of MA have been attributed to mechanisms which involved 
increased ROS production (Fleckenstein et al., 1997; Lin et al., 1999; Cervinski et al., 
2005; Ramirez et al., 2009), the change in redox state in the endothelial cells may have 
modulated the S-phase and resulted in the adverse effects on the BBB. 
 
By 96 hrs, bEnd5 cells exposure to once-off Rf showed an increase in relative cell 
numbers in the G1-phase across all time intervals (as was also noted with MA 
exposure). This was accompanied by cell population suppression in the S-phase, 
however Rf resulted in a greater decrease when compared to the MA exposed cells. No 
differences were observed in the G2-M phase for all time intervals when compared to 
controls but the cell population was notably higher than the MA group. The viability 
(%) increased and cell numbers had decreased by 96 hrs to the once-off exposure to Rf. 
The decreased cell numbers did not reflect the cellular fractions observed in the G2-M 
phase. The effect on the G1-phase and the two latter parameters were similar to that 
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observed with MA exposure. It should be noted that decreased S-phase cellular fractions 
are accompanied by reduced numbers in the G2-M phase since the synthesis of DNA 
components are required prior to mitosis.  
 
The findings in this study could have been more specific if the exposure groups and 
controls were synchronized. Unsynchronized whole cultures do not properly distinguish 
between closely spaced phases e.g. the late G1- form the early S-phase (Schorl and 
Sedivy, 2007), and therefore synchronization offers a method for a more critical study 
of molecular and biochemical events (Davis et al., 2001, Lee et al., 2011; Vecsler et al., 
2013). It allows for specific expression of critical cell cycle components such as tumour 
suppressor proteins at the restriction point in the late G1-phase (Lee et al., 1988; Chen 
et al., 1989), cyclin A expression at late G1 to S-phase transition (Solomon, 1993; Sherr 
and Roberts, 1995) and cyclin B/cdc2 activity onset at the G2 to M-phase transition 
(Draetta et al., 1988; Ducommun et al., 1991). Thus, the unsynchronized phases of the 
cells in this study could have influenced the results observed at the S- and G2-M- phase 
after exposure to Rf when compared to MA, since these single compounds had 
mirroring effects with respect to viability, permeability and the G1-phases. 
 
To date, no studies have investigated the effects of Rf on cell cycle phases in brain 
endothelial cells. It has been reported that human microvascular endothelial cells 
exposed to the plant flavonoid, apigenin for 48 hrs resulted in inhibition of cell 
proliferation by blockage in the G2-M phase (Trochon et al., 2000). However, it 
resulted in arrest at the G2-M and/or G1-phase of keratinocytes, human diploid 
fibroblasts and neuronal cells (Sato et al., 1994; Lepley et al., 1996; Lepley and Pelling, 
1997; Casagrande and Darbon, 2001). Martin et al. (2003) observed an accumulation of 
cells in the G1-phase with suppressed cell numbers in the S-phase after an 18 hr 
treatment of delphinidin (DP), a class of potent antioxidants viz. anthocyanins, on 
bovine aortic endothelial cells. When normal human embryonic fibroblasts (NHF) were 
exposed to DP, a decrease in cellular fraction in G1-phase and an increase in S-phase 
were observed after 24 hr treatment (Lazzé et al., 2004). Moreover, using human 
umbilical vascular endothelial cells, Arakaki et al. (2004) observed arrested progression 
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in the G1-phase after exposure to selected flavones (the “parent” compound of 
flavonoids). Lazzé and colleagues (2004) also exposed NHFs to cyanidin (an aglycone 
anthocyanin) and trans-resveratol (polyphenol found in grapes and red wine) for 24 hrs. 
Both antioxidants resulted in growth inhibition characterized by decreased cells in S-
phase and cell accumulation in G1-phase.  
 
Studies have also reported on the effects of flavonoids found in A. linearis on cancer 
cell lines. Luteolin exposure resulted in G1-phase arrest in human gastric-and human 
melanoma cancer cells (Matsukawa et al., 1993) whereas G2-M phase arrest was 
observed in human prostate cancer cells (Haddad et al., 2006). Exposure to quercetin 
resulted in G1 arrest in colon- (Ranelletti et al., 1992), gastric- (Yoshida et al., 1990), 
leukemic cancer cells (Yoshida et al., 1992) and human melanoma (OCM-1) cells 
(Casagrande and Darbon, 2011). It, however, resulted in G2-M phase arrest when 
breast- (Avila et al., 1994) and laryngeal cancer cells (Ferrandina et al., 1998) were 
exposed to the compound. Furthermore, arrested G1- and/or G2-M-phases of numerous 
cancer cells have also been observed when exposed to other polyphenolic agents such as 
daidzein (Matsukawa et al., 1993; Casagrande and Darbon, 2001), genistein 
(Matsukawa et al., 1993; Kuzumaki et al., 1998; Casagrande and Darbon, 2001; 
Kobayashi et al., 2002), silibinin, baicalin and its metabolite baicalein (Chen et al., 
2001; Hogan et al., 2007). All the above-mentioned reports highlight the challenges of 
the cell specific effects of individual polyphenols when analysing their cell cycles. 
Moreover, the effect of the whole herbal tea extract would undoubtedly also display 
varying effects. 
 
Endothelial and epithelial cells share similar markers (Hoyer et al., 1973; Gimbrone et 
al., 1978; Folkman et al., 1979; Hial et al., 1979; Cines et al., 1998; Hur et al., 2004) 
and even characteristics with cancer cells. These include TJ involvement associated 
with cell motility (Kojima and Sawada, 2012; Webb et al., 2014), the presence of 
tumour suppressor protein (p53) involved in cell death (Rivlen et al., 2014), endothelial 
cell surface markers (Carson-Walter et al., 2001; Hilda et al., 2004), Thoc1 protein 
expression involved in cell proliferation (Li et al., 2007), and various other gene 
100 
 
 
 
 
 
expressions (Zhang et al., 1997). These common characteristics amongst the various 
cell types and even cancer cells could support the similarities observed in the current 
study pertaining to cell growth and cycle. It is, however, pertinent to acknowledge that 
these cells also contain their own distinct levels of expression of specific proteins which 
present themselves as different phenotypic characteristics. 
 
Exposure on cell cycles to the combinations of MA and Rf resulted in a significant 
decrease in G1-phase cell populations across all time intervals when compared to 
controls. While the effects of the single compound exposure of MA and Rf resulted in 
relative cell numbers greater than controls. In the G2-M phase, combinatorial effects 
displayed a decreased cellular fraction at 96 hrs which interestingly was comparable to 
that of single compound MA and Rf exposure. The S-phase populations were greater 
than controls and that of the cell numbers of the single compounds’ exposure. Since it 
becomes difficult to properly distinguish between closely spaced phases between the 
late G1- form and the early S-phase (Schorl and Sedivy, 2007) in unsynchronized whole 
cultures, increased population numbers observed in the S-phase may not be indicative of 
the combinatorial effects of the compounds but as a result of non-synchronicity. 
Additional biochemical pathways, their biomarkers and a synchronized state is required 
in order to properly elucidate whether these effects are indeed as a result of the exposure 
to the combinations. However, these findings are seen significant albeit exploratory. 
 
To date, the effects of MA and Rf’s combinations on endothelial cell cycles have not 
been investigated. Studies performed by Zaragoza et al. (2000 and 2001) do, however, 
report on the effects of cocaine in combination with different antioxidant reagents and 
rat hepatocytes. The cells were exposed to cocaine in vitro in the presence of 
deferoxamine (DO) and N-acetylcysteine (NAC) for 24 hrs. In the absence of 
antioxidants, cocaine exposure resulted in the activation of apoptotic pathways using 
flow cytometry and DNA fragmentation analysis. In the presence of NAC and DO, 
these effects were abrogated. This study did not however look at specific cell cycles. 
They concluded that NAC and DO, when incubated in the presence of cocaine, exerted 
a protective effect against cocaine toxicity. MA and cocaine have been shown to exert 
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similar effects on the dopaminergic system (Schechter and Glennon, 1985; Washton and 
Zweben, 2009) and since antioxidants could reduce the effects of cocaine, it is plausible 
that the antioxidant potential of Rf could protect against the effects of MA. However, it 
is acknowledged that the cell-specific nature of the BBB endothelial cells, may give rise 
to varying results. The improved cell viability and cell numbers at 96 hrs as a result of 
Rf’s addition to MA suggests that the herbal tea may be conveying protection against 
MA. This potential protective effect was also demonstrated with the increased electrical 
resistance to the bEnd5 cell monolayer and the alleviated G1-phase cell numbers when 
compared to the effects of the single MA exposure. The synergistic effect may have 
potentially modulated the synthesis of DNA and ultimately replication resulting in the 
redistribution of the cell cycle phases’ populations. 
 
In conclusion, while the effects of once-off exposure to Rf on bEnd5 cell viability was 
similar to that of MA, MA resulted in lower cell numbers when compared to Rf. 
Interestingly, while chronic exposure to Rf did not affect viability, the exposure to MA 
suppressed it.  Moreover, both compounds decreased permeability and saw the arrest of 
the G1-phase in the cell cycle. The cells exposed once-off to the combination of MA 
and Rf, resulted in similar viability compared to controls, however, exhibited increased 
levels when exposed chronically. Once-off exposure also resulted in similar cell 
numbers to that of controls. The increase in electrical resistance was more profound 
with exposure to the combinations than the single compounds and a reversal of cell 
cycle arrest at G1-phase accompanied by an increase in S-phase cell population was 
observed. The findings of this study suggest that Rf may act antagonistically to MA by 
restoring cell numbers, viability and cell cycle phases. The agonistic effects of Rf and 
MA on permeability may be seen as a protective mechanism by the endothelial cells in 
response to the presence of exogenous compounds. Thus, the protective potential of Rf 
on the central component of the BBB viz. the endothelial cells is illustrated using the 
above-mentioned parameters. Although in its infancy, this study gives insight into the 
possible mechanisms by which MA affects the BBB and the potential of Rf as a 
protective agent, and allowing for a possible non-invasive treatment with which to 
reduce the rate of MA relapse and addiction. 
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CHAPTER 5 
 
5. Future Perspectives 
 
This study gave broad insight into the ability of MA and Rf to alter the bEnd5 cell 
monolayer profile. However in order to validate these observations, it is necessary to 
identify specific markers that correspond to the activation or inhibition of certain 
cellular pathways. Since viability and proliferation may be linked to energy related 
pathways, studies ranging from ATP analysis to observing specific mitochondrial 
enzyme activity should be elucidated. These observations may be fundamental in 
explaining the effects on BBB integrity and cell cycle phases when exposed to these 
lipophilic compounds. It would not be unexpected if MA affects the energy production 
pathways since it is reported to a stimulant of exothermic reactions. 
 
It is imperative for the BBB to maintain a low permeability status which has been 
demonstrated in this study to be altered by MA and Rf in a similar manner. Since the 
current study is novel, mechanisms of these alterations on BBB integrity are vastly 
unclear and future studies should attempt to investigate post- translational and -
transcriptional tight junction expression to fully determine their effects. Furthermore, 
since only whole cell cultures were used, studies should incorporate synchronized cells 
and specific cell cycle checkpoints addressing phase length in order to fully understand 
the effects on the endothelial cell cycle phases. In addition, since the BBB does not only 
consist of endothelial cells, co-cultures (either bi- or tri-cultures) should be used in 
order to closely mimic an in vivo model. 
 
Incorporating the above mentioned approaches would allow for a more accurate method 
in which to assess MA, Rf and their combinations’ ability to modulate the cellular 
activity. 
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APPENDIX A 
 
Table 2.1 Preparation of gallic acid stock standard concentrations with respective contents per 
tube for the measurement of polyphenols 
Tubes 
Gallic acid 
stock solution  
(µl) 
10% EtOH  
(µl) 
Final gallic acid 
Concentration 
(mg/l) 
Well no. 
A 0 1000 0 A1-A3 
B 25 975 20 A4-A6 
C 62.5 937.5 50 A7-A9 
D 125 875 100 A10-A12 
E 312 688 250 B1-3 
F 625 375 500 B4-6 
 
 
Table 2.2 Preparation of quercetin stock standard concentrations with respective contents per 
tube for the measurement of flavonols 
Tubes 
Quercetin stock 
(µl) 
95 % EtOH  
(µl) 
Final quercetin 
concentration 
(mg/l) 
Wells no. 
A 0 1000 0 A1-A3 
B 75 925 5 A4-A6 
C 125 875 10 A7-A9 
D 250 750 20 A10-A12 
E 500 500 40 B1-B3 
F 1000 0 80 B4-B6 
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Table 2.3 Preparation of catechin stock standard concentrations with respective contents per 
tube for the measurement of flavanols 
Tubes 
Catechin 
stock (µl) 
Methanol  
(µl) 
Final catechin 
concentration 
(µM) 
Final catechin 
concentration 
(mg/l) 
Well no. 
A 0 1000 0 0 A1-A3 
B 5 995 5 1.36 A4-A6 
C 10 990 10 2.72 A7-A9 
D 25 975 25 6.8 A10-A12 
E 50 950 50 13.6 B1-B3 
F 100 900 100 27.2 B4-B6 
 
 
Table 2.4 Preparation of Trolox stock standard concentrations with respective contents per tube 
for the Oxygen Radical Absorbance Capacity (ORAC) assay 
Tubes 
Trolox stock 
solution  
(µl) 
Phosphate 
Buffer 
(µl) 
Final Trolox 
concentration 
(µM) 
Well no. 
A 0 750 0 A1-A3 
B 125 625 83 A4-A6 
C 250 500 167 A7-A9 
D 375 375 250 A10-A12 
E 500 250 333 B1-3 
F 625 125 417 B4-6 
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Table 2.5 Preparation of Trolox stock standard concentrations with respective contents per tube 
for the ABTS (2,2’-azino-di-3-ethylbenzthialozine sulphonate) (TEAC) radical cation 
scavenging assay 
Tubes 
Trolox standard 
(µl) 
Ethanol  
(µl) 
Final Trolox 
concentration 
(µM) 
Well no. 
A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 
D 150 850 150 A10-A12 
E 250 750 250 B1-3 
F 500 500 500 B4-6 
 
 
Table 2.6 Preparation of ascorbic acid stock standard concentrations with respective contents 
per tube for the Ferric Reducing Antioxidant Power (FRAP) assay 
Tubes 
Ascorbic acid 
stock solution 
(µl) 
Distilled water 
(µl) 
Final ascorbic 
acid 
concentration 
(µM) 
Well no. 
A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 
D 200 800 200 A10-A12 
E 500 500 500 B1-3 
F 1000 0 1000 B4-6 
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APPENDIX B 
 
Table 3.2 Effects on bEnd5 live cell numbers after 24 hr exposure to selected MA concentrations using trypan 
blue over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 0.50±0.10 9.55±0.88 26.88±0.88 119.22±5.35 
0.1 µM 1.96±0.49 6.55±0.88 29.88±6.8 77.19±6.96 
1 µM 2.07±0.44 8.88±1.43 36.85±8.89 59.90±4.06 
10 µM 1.82±0.38 15.52±2.11 46.66±5.00 80.67±3.56 
100 µM 0.70±0.12 11.90±273 40.36±6.40 94.15±5.03 
1000 µM 0.73±0.14 9.32±1.51 22.25±2.46 63.13±5.16 
 
Table 3.3 Effects on bEnd5 % viability after 24 hr exposure to selected MA concentrations using trypan blue 
viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 98.47±0.52 99.87±0.39 100.00±0.00 99.42±0.89 
0.1 µM 100.00±0.00 97.92±0.61 99.51±0.13 96.10±0.69 
1 µM 100.00±0.00 100.00±0.00 99.78±0.11 98.97±0.24 
10 µM 100.00±0.00 100.00±0.00 94.78±1.41 99.58±0.16 
100 µM 100.00±0.00 97.49±0.69 99.70±0.15 96.54±0.97 
1000 µM 97.62±1.71 94.67±1.71 99.42±0.29 99.43±0.22 
 
Table 3.4 Effects on bEnd5 % viability after 24 hr exposure to selected MA concentrations using XTT viability 
assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.1 µM 92.43±6.07 97.23±16.45 119.34±11.44 76.05±6.06 
1 µM 98.20±9.42 89.76±9.40 132.31±13.44 93.97±9.12 
10 µM 107.24±6.38 88.06±19.38 150.51±1.09 108.93±7.93 
100 µM 102.34±10.17 79.15±9.23 101.65±3.10 102.43±4.82 
1000 µM 93.47±12.99 84.83±3.31 115.73±3.72 84.03±2.40 
2000 µM 98.90±1.39 89.11±6.35 126.10±9.06 81.92±2.80 
3000 µM 79.27±9.99 55.07±0.96 73.17±3.25 38.60±10.97 
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Table 3.5 Effects on bEnd5 % viability after daily exposure to selected MA concentrations using XTT viability 
assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.1 µM 92.43±6.07 116.33±16.28 72.30±0.90 83.43±4.26 
1 µM 98.20±9.42 108.80±20.53 90.38±1.57 76.38±3.51 
10 µM 107.24±6.38 113.65±8.74 88.05±3.62 74.50±4.13 
100 µM 102.34±10.17 112.76±3.65 74.63±6.11 87.54±2.24 
1000 µM 93.47±12.99 72.58±14.74 74.05±8.22 47.47±0.24 
 
Table 3.6 Effects on bEnd5 monolayer electrical resistance after daily exposure to selected MA concentrations 
using transendothelial electrical resistance (TEER) assay over various time intervals (Mean ± SEM, n=4) 
Time/ 
Compound 
Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 120 hrs 144 hrs 
Ctrl 16.84±0.68 18.35±0.67 21.35±0.51 19.30±0.65 18.98±0.61 14.55±0.51 
0.1 µM 18.22±0.62 14.23±0.30 16.73±0.40 16.78±0.23 16.90±0.36 14.63±0.46 
1 µM 18.49±0.64 15.75±0.30 18.98±0.32 20.00±0.37 20.28±0.18 16.60±0.69 
10 µM 19.05±0.58 18.03±0.56 20.68±0.37 21.78±0.36 21.23±0.37 18.43±0.71 
100 µM 18.28±0.68 21.78±0.99 18.42±1.02 24.96±0.56 22.38±0.83 21.35±0.96 
 
Table 3.7 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected MA concentrations using flow 
cytometry at 24 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 55.79±3.29 37.07±5.34 7.15±3.76 
0.1µM 45.19±2.40 44.81±2.75 9.99±5.00 
1 µM 63.38±0.00 34.43±0.00 2.19±0.00 
10 µM 67.05±1.15 32.37±1.18 0.57±0.49 
 
Table 3.8 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected MA concentrations using flow 
cytometry at 48 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 50.31±5.10 38.94±6.30 10.75±3.13 
0.1µM 67.56±3.76 24.01±12.06 8.43±8.43 
1 µM 64.36±7.23 35.65±2.40 0.22±0.01 
10 µM 70.19±7.15 29.53±7.01 0.28±0.28 
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Table 3.9 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected MA concentrations using flow 
cytometry at 72 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 52.71±3.06 35.40±5.33 11.90±2.75 
0.1µM 74.92±1.81 16.84±2.61 8.24±4.16 
1 µM 54.04±7.23 44.24±8.67 1.72±1.72 
10 µM 58.88±7.66 28.90±0.72 12.22±8.34 
 
Table 3.10 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected MA concentrations using flow 
cytometry at 96 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 60.66±6.65 33.04±7.34 7.70±2.00 
0.1µM 80.70±0.00 18.77±0.00 1.53±0.00 
1 µM 85.34±0.44 13.89±0.77 1.77±0.34 
10 µM 79.27±2.72 15.08±7.74 5.65±1.73 
 
APPENDIX C 
 
Table 3.11 Effects on bEnd5 live cell numbers after 24 hr exposure to selected Rf concentrations using trypan 
blue over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Fermented Rooibos 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 5.20±0.73 18.00±0.81 28.83±2.10 38.59±1.65 
0.0625% 5.64±0.25 28.95±1.07 33.25±0.97 27.13±1.37 
0.125% 7.50±0.49 28.88±0.76 26.20±1.17 31.63±2.11 
0.25% 7.30±0.68 22.10±2.66 21.30±1.07 25.83±1.36 
0.5% 7.08±0.96 18.83±2.16 16.35±1.86 23.00±1.88 
1% 4.30±0.18 9.10±2.06 9.25±2.37 15.75±2.27 
 
Table 3.12 Effects on bEnd5 % viability after 24 hr exposure to selected Rf concentrations using trypan blue 
viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Fermented Rooibos 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 99.93±0.07 
0.05% 98.06±1.25 100.00±0.00 100.00±0.00 99.21±0.45 
0.0625% 100.00±0.00 100.00±0.00 100.00±.0.00 99.70±0.22 
0.125% 100.00±0.00 100.00±0.00 99.41±0.41 100.00±0.00 
0.25% 100.00±0.00 100.00±0.00 100.00±0.00 97.53±1.13 
0.5% 99.41±0.40 100.00±0.00 100.00±0.00 99.81±0.13 
1% 98.27±0.88 100.00±0.00 100.00±0.00 100.00±0.00 
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Table 3.13 Effects on bEnd5 % viability after 24 hr exposure to selected Rf concentrations using XTT viability 
assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Fermented Rooibos 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.003125% 63.51±3.51 119.19±1.69 105.96±1.63 113.81±1.79 
0.0625% 70.58±6.87 114.13±3.85 96.89±2.63 119.88±3.99 
0.0125% 74.36±8.04 112.19±4.97 95.51±2.73 112.32±6.26 
0.025% 92.60±6.47 109.95±8.72 103.81±2.49 108.90±4.74 
0.05% 96.88±9.63 115.21±2.77 100.69±2.18 115.47±6.48 
0.1% 93.53±4.36 94.55±9.11 94.83±11.86 83.15±7.99 
 
Table 3.14 Effects on bEnd5 % viability after daily exposure to selected Rf concentrations using XTT viability 
assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Compound 
Fermented Rooibos 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.003125% 63.51±3.51 81.97±4.52 101.51±3.86 97.95±8.66 
0.0625% 70.58±6.87 86.94±2.56 105.61±8.46 95.34±1.22 
0.0125% 74.36±8.04 109.27±10.95 112.36±7.81 100.10±2.30 
0.025% 92.60±6.47 110.02±8.24 116.63±12.78 91.73±2.87 
0.05% 96.88±9.63 129.43±10.88 109.13±11.04 80.95±5.08 
0.1% 93.53±4.36 100.05±11.36 108.23±7.25 61.19±7.58 
 
Table 3.15 Effects on bEnd5 electrical resistance after daily exposure to selected Rf concentrations using 
transendothelial electrical resistance (TEER) assay over various time intervals (Mean ± SEM, n=4) 
Time/ 
Compound 
Fermented Rooibos 
24 hrs 48 hrs 72 hrs 96 hrs 120 hrs 144 hrs 
Ctrl 15.03±0.90 13.46±0.77 17.74±0.57 17.73±0.54 12.67±0.37 13.07±0.47 
0.0625% 18.83±0.57 18.81±0.70 19.99±0.60 18.04±0.71 16.14±0.71 17.53±0.82 
0.0125% 17.90±0.75 18.34±0.41 21.21±0.48 18.85±0.34 19.50±0.26 20.25±0.76 
0.025% 21.81±0.67 19.44±0.56 22.76±0.45 17.11±0.71 20.24±0.37 16.95±0.86 
0.05% 22.29±0.44 18.18±0.66 23.13±0.38 16.12±0.41 21.48±0.35 18.60±1.23 
0.1% 20.36±0.73 20.22±0.40 25.22±0.36 16.20±0.40 23.44±0.33 15.10±0.68 
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Table 3.16 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected Rf concentrations using flow 
cytometry at 24 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 55.79±3.29 37.07±5.34 7.15±3.76 
0.05% 63.21±2.70 29.32±4.217 7.47±4.20 
0.1% 63.40±2.94 17.02±7.82 19.57±4.89 
 
Table 3.17 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected Rf concentrations using flow 
cytometry at 48 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 50.31±5.10 38.94±6.30 10.75±3.13 
0.05% 66.28±0.63 26.11±1.31 7.62±1.87 
0.1% 73.18±2.26 22.46±6.62 4.36±4.36 
 
Table 3.18 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected Rf concentrations using flow 
cytometry at 72 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 52.71±3.06 35.40±5.33 11.90±2.75 
0.05% 71.61±2.69 24.57±1.11 3.82±1.59 
0.1% 64.25±1.49 33.04±1.94 2.46±1.01 
 
Table 3.19 Effects on bEnd5 cell cycle phases after 24 hr exposure to selected Rf concentrations using flow 
cytometry at 96 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 60.66±6.65 33.04±7.34 7.70±2.00 
0.05% 83.66±0.70 3.27±0.84 13.05±1.59 
0.1% 86.41±0.13 3.13±0.36 10.46±0.46 
 
APPENDIX D 
 
Table 3.20 Effects on bEnd5 live cell numbers after 24 hr exposure to 0.05% Rf and selected MA concentrations 
using trypan blue over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 3.78±0.56 19.00±1.15 31.35±1.41 45.13±3.53 
0.05%+0.1 µM 3.53±0.27 21.81±0.64 22.00±1.67 37.78±6.65 
0.05%+1 µM 4.10±0.50 16.33±1.69 21.83±1.24 43.10±4.57 
0.05%+10 µM 2.63±0.39 18.53±0.70 32.75±1.14 37.15±2.37 
0.05%+100µM 1.88±0.28 20.68±1.97 24.88±1.31 41.85±2.44 
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Table 3.21 Effects on bEnd5 % viability after 24 hr exposure to 0.05% Rf and selected MA concentrations using 
trypan blue viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.05%+0.1 µM 100.00±0.00 100.00±0.00 100.00±0.00 99.34±0.48 
0.05%+1 µM 100.00±0.00 100.00±0.00 100.00±0.00 97.56±0.62 
0.05%+10 µM 100.00±0.00 100.00±0.00 99.73±0.20 95.18±1.30 
0.05%+100µM 100.00±0.00 100.00±0.00 99.67±0.24 95.76±0.99 
 
Table 3.22 Effects on bEnd5 % viability after 24 hr exposure to 0.05% Rf and selected MA concentrations using 
XTT viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.05%+0.1 µM 172.28±14.32 111.34±9.84 78.67±3.77 100.89±1.04 
0.05%+1 µM 136.79±10.36 94.75±13.61 76.79±4.23 103.43±2.67 
0.05%+10 µM 127.52±9.16 65.37±10.63 91.13±7.62 106.42±1.17 
 
Table 3.23 Effects on bEnd5 % viability after daily exposure to 0.05% Rf and selected MA concentrations using 
XTT viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.05%+0.1 µM 172.28±14.32 81.44±9.26 109.05±5.96 114.43±3.61 
0.05%+1 µM 136.79±34.75 65.82±3.40 98.06±6.40 113.99±5.69 
0.05%+10 µM 127.52±9.16 70.17±4.26 84.91±9.44 110.78±2.27 
 
Table 3.24 Effects on bEnd5 electrical resistance after daily exposure to 0.05% Rf and selected MA 
concentrations using transendothelial electrical resistance (TEER) assay over various time intervals (Mean ± 
SEM, n=4) 
Time/ 
Compound 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 120 hrs 144 hrs 
Ctrl 13.18±0.29 16.46±0.70 19.38±0.25 15.62±0.41 14.98±0.24 11.76±084 
0.05% + 0.1µM 13.05±0.33 15.28±0.31 17.51±0.68 18.20±0.56 20.38±0.88 22.91±0.58 
0.05% + 1 µM 13.83±0.29 18.00±0.39 18.76±0.38 19.13±0.50 23.04±0.52 24.58±0.58 
0.05% + 10 µM 16.15±0.35 20.23±0.35 17.94±0.23 18.10±0.69 22.86±0.62 25.16±0.83 
 
Table 3.25 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and selected MA 
concentrations using flow cytometry at 24 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 55.79±3.29 37.07±5.34 7.15±3.76 
0.05%+0.1 µM 43.21±0.26 38.04±0.35 18.75±0.41 
0.05%+1 µM 41.56±2.47 40.01±0.89 18.43±2.62 
0.05%+10 µM 44.08±1.10 38.27±1.15 17.64±0.90 
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Table 3.26 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and selected MA 
concentrations using flow cytometry at 48 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 50.31±5.10 38.94±6.30 10.75±3.13 
0.05%+0.1 µM 48.92±2.35 24.56±6.27 26.52±0.50 
0.05%+1 µM 44.97±6.41 52.03±5.31 3.00±0.57 
0.05%+10 µM 41.74±4.52 56.87±0.96 1.39±0.57 
 
Table 3.27 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and selected MA 
concentrations using flow cytometry at 72 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 52.71±3.06 35.40±5.33 11.90±2.75 
0.05%+0.1 µM 46.81±2.86 49.58±2.36 5.43±3.14 
0.05%+1 µM 36.15±1.24 59.81±3.46 2.15±2.63 
0.05%+10 µM 44.51±5.43 20.32±1.01 35.16±1.34 
 
Table 3.28 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.05% fermented rooibos and selected MA 
concentrations using flow cytometry at 96 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 60.66±6.65 33.04±7.34 7.70±2.00 
0.05%+0.1 µM 48.77±2.55 50.02±3.84 1.21±1.30 
0.05%+1 µM 50.72±2.91 48.07±3.60 1.21±3.15 
0.05%+10 µM 45.50±0.39 51.22±1.21 3.18±3.28 
 
APPENDIX E 
 
Table 3.29 Effects on bEnd5 live cell numbers after 24 hr exposure to 0.1% Rf and selected MA concentrations 
using trypan blue over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 13.38±1.79 23.43±1.89 34.40±3.25 68.80±5.55 
0.1%+0.1 µM 7.30±0.86 21.53±1.33 32.08±2.84 65.98±3.32 
0.1%+1 µM 8.43±0.49 25.96±0.31 30.25±2.25 57.18±3.32 
0.1%+10 µM 10.80±0.69 17.78±0.55 35.75±4.12 51.08±1.60 
0.1%+100 µM 12.85±1.13 22.89±1.20 24.53±3.04 50.20±2.71 
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Table 3.30 Effects on bEnd5 % viability after 24 hr exposure to 0.1% Rf and selected MA concentrations using 
trypan blue viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 99.81±0.10 
0.1%+0.1 µM 100.00±0.00 100.00±0.00 99.63±0.20 99.36±0.27 
0.1%+1 µM 100.00±0.00 100.00±0.00 97.81±0.66 98.84±0.28 
0.1%+10 µM 100.00±0.00 100.00±0.00 95.03±1.16 96.11±1.08 
0.1%+100 µM 100.00±0.00 100.00±0.00 99.29±0.39 94.23±0.86 
 
Table 3.31 Effects on bEnd5 % viability after 24 hr exposure to 0.1% Rf and selected MA concentrations using 
XTT viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.1%+0.1 µM 135.43±9.26 80.63±13.88 63.02±9.66 102.61±3.56 
0.1%+1 µM 157.94±10.19 80.30±6.89 74.53±6.96 95.26±3.89 
0.1%+10 µM 125.72±11.65 63.75±16.24 70.38±5.44 99.89±0.41 
 
Table 3.32 Effects on bEnd5 % viability after daily exposure to 0.1% Rf and selected MA concentrations using 
XTT viability assay over various time intervals (Mean ± SEM, n=5) 
Time/ 
Concentration 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.1%+0.1 µM 135.43±9.26 59.09±2.79 102.80±3.40 112.46±3.48 
0.1%+1 µM 157.94±10.19 62.50±9.29 98.06±6.20 114.56±12.25 
0.1%+10 µM 125.72±11.65 58.05±6.25 109.05±6.76 113.74±8.77 
 
Table 3.33 Effects on bEnd5 electrical resistance after daily exposure to 0.1% Rf and selected MA concentrations using 
transendothelial electrical resistance (TEER) assay over various time intervals (Mean ± SEM, n=4) 
Time/ 
Compound 
Fermented Rooibos and Pure Methamphetamine 
24 hrs 48 hrs 72 hrs 96 hrs 120 hrs 144 hrs 
Ctrl 13.18±0.29 16.46±0.70 19.39±0.25 15.63±0.41 14.98±0.24 11.76±0.84 
0.1% + 0.1µM 14.23±0.30 16.62±0.39 20.84±0.30 18.15±0.90 24.76±0.58 27.33±0.85 
0.1% + 1 µM 15.45±0.37 18.35±0.65 17.21±0.54 18.97±0.52 25.23±0.58 25.68±0.48 
0.1% + 10 µM 16.32±0.25 20.58±0.46 21.38±0.47 19.45±0.81 25.78±0.38 24.38±0.55 
 
Table 3.34 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and selected MA 
concentrations using flow cytometry at 24 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 55.79±3.29 37.07±5.34 7.15±3.76 
0.1%+0.1 µM 41.93±2.19 57.11±2.98 0.92±0.79 
0.1%+1 µM 44.38±0.55 37.06±0.56 8.55±0.43 
0.1%+10 µM 41.77±0.95 57.76±0.77 0.46±0.33 
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Table 3.35 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and selected MA 
concentrations using flow cytometry at 48 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 50.31±5.10 38.94±6.30 10.75±3.13 
0.1%+0.1 µM 43.57±1.09 46.29±0.78 10.15±0.33 
0.1%+1 µM 51.82±8.02 47.08±7.51 0.07±0.07 
0.1%+10 µM 53.25±1.77 46.05±2.32 0.71±0.71 
 
Table 3.36 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and selected MA 
concentrations using flow cytometry at 72 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 52.71±3.06 35.40±5.33 11.90±2.75 
0.1%+0.1 µM 44.36±1.16 37.52±1.74 18.12±0.90 
0.1%+1 µM 48.20±1.43 36.59±1.44 15.21±0.88 
0.1%+10 µM 46.90±1.97 47.84±1.60 5.25±2.97 
 
Table 3.37 Effects on bEnd5 cell cycle phases after 24 hr exposure to 0.1% fermented Rooibos and selected MA 
concentrations using flow cytometry at 96 hrs (Mean ± SEM, n=3, ≥ 10 000 events analysed) 
Phases/ 
Concentration 
Flow Cytometry Analysis 
G1 S G1-M2 
Ctrl 60.66±6.65 33.04±7.34 7.70±2.00 
0.1%+0.1 µM 45.47±3.67 47.51±6.11 7.03±2.44 
0.1%+1 µM 47.96±3.83 50.89±4.91 1.14±1.14 
0.1%+10 µM 46.32±0.65 53.14±1.20 0.55±0.55 
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APPENDIX F 
 
 
Appendix F These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph. 
 
APPENDIX G 
 
 
Appendix G These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph. 
Fig A. Ctrls Fig B. 0.1 µM 
Fig C. 1 µM Fig D. 10 µM 
Fig A. Ctrls Fig B. 0.1 µM 
Fig C. 1 µM Fig D. 10 µM 
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APPENDIX H 
 
 
Appendix H These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph. 
 
APPENDIX I 
 
 
Appendix I These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to B 0.1µM. C 1 µM. D 10 µM methamphetamine and control cells represented by A 
(≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph. 
Fig A. Ctrls Fig B. 0.1 µM 
Fig C. 1 µM Fig D. 10 µM 
Fig A. Ctrls Fig B. 0.1 µM 
Fig C. 1 µM Fig D. 10 µM 
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APPENDIX J 
 
 
Appendix J These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. 
 
APPENDIX K 
 
 
Appendix K These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. 
Fig A. Ctrls Fig B. 0.05%
Fig C. 0.1% 
Fig A. Ctrls Fig B. 0.05%
Fig C. 0.1% 
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APPENDIX L 
 
 
Appendix L These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. 
 
APPENDIX M 
 
 
Appendix M These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to B 0.05%. C 0.1% fermented rooibos and control cells represented by A (≥ 10 000 
events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. 
Fig A. Ctrls Fig B. 0.05%
Fig C. 0.1% 
Fig A. Ctrls Fig B. 0.05%
Fig C. 0.1% 
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APPENDIX N 
 
 
Appendix N These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
 
APPENDIX O 
 
 
Appendix O These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
Fig A. Ctrls Fig B. 0.05% Rf + 0.1 µM MA
Fig C. 0.05% Rf + 1 µM MA Fig D. 0.05% Rf + 10 µM MA 
Fig A. Ctrls Fig B. 0.05% Rf + 0.1 µM MA
Fig C. 0.05% Rf + 1 µM MA Fig D. 0.05% Rf + 10 µM MA 
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APPENDIX P 
 
 
Appendix P These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
 
APPENDIX Q 
 
 
Appendix Q These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to 0.05% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph.
Fig A. Ctrls Fig B. 0.05% Rf + 0.1 µM MA
Fig C. 0.05% Rf + 1 µM MA Fig D. 0.05% Rf + 10 µM MA
Fig A. Ctrls Fig B. 0.05% Rf + 0.1 µM MA
Fig C. 0.05% Rf + 1 µM MA Fig D. 0.05% Rf + 10 µM MA 
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APPENDIX R 
 
 
Appendix R These Scatter plots display results obtained at 24 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
 
APPENDIX S 
 
 
Appendix S These Scatter plots display results obtained at 48 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
Fig A. Ctrls
Fig C. 0.1% Rf + 1 µM 
Fig B. 0.1% Rf + 0.1 µM MA
Fig D. 0.1% Rf + 10 µM MA
Fig A. Ctrls Fig B. 0.1% Rf + 0.1 µM MA
Fig C. 0.1% Rf + 1 µM Fig D. 0.1% Rf + 10 µM MA 
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APPENDIX T 
 
 
Appendix T These Scatter plots display results obtained at 72 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
 
APPENDIX U 
 
 
Appendix U These Scatter plots display results obtained at 96 hrs using flow cytometry when 
exposed to 0.1% fermented rooibos in combination with B 0.1 µM. C 1 µM. D 10 µM 
methamphetamine and control cells represented by A (≥ 10 000 events analysed). Scatter plots 
were used to generate histogram and the data was tabled and represented as bar graph. 
Fig A. Ctrls Fig B. 0.1% Rf + 0.1 µM MA 
Fig C. 0.1% Rf + 1 µM MA Fig D. 0.1% Rf + 10 µM MA 
Fig A. Ctrls Fig B. 0.1% Rf + 0.1 µM MA 
Fig C. 0.1% Rf + 1 µM MA Fig D. 0.1% Rf + 10 µM MA 
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